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Abstract 
Oxidative stress is often seen as a result of ischaernic-reperfusion injury during liver 
transplant. A result of this is the dissipation of the mitochondrial transmembrane 
potential which can lead to cell death when the antioxidant defence system, including 
MnSOD found in mitochondria, becomes overwhelmed. If MnSOD can be up regulated 
in some way then this could potentially be averted. 
Human serum transferrin (hTf) is a 80 kDa bilobal glycoprotein that transports iron 
around the body. It is typically loaded at only 30% saturation and has been shown to be 
capable of transporting other metal ions. This thesis is concerned with the loading of 
transferrin with manganese and some of its chemical and biological properties. 
Manganese is bound to transferrin as Mn(III) with a characteristic ligand (Tyr) to metal 
(Mn(III)) charge-transfer band at a wavelength of 430 nm. 
Caeruloplasmin is shown to enhance the uptake of manganese from MnC12 by apo-hTf. 
However binding is often incomplete and slow. A novel method of loading hTf with Mn 
using KMn04 is reported. This method leads to rapid uptake and inductively coupled 
plasma atomic emission spectroscopy (ICP-AES) determinations confirmed the binding 
of at least two Mn per hTf molecule. The possible oxidising effects of Mn0 4 on protein 
amino acid side chains was considered. In model systems Mn0 4 oxidises methionine to 
methione sulfoxide and methionine sulfone. Evidence of structural changes in apo-hTf 
induced by Mn(III) binding was obtained by studies using [-' 3 C]Met-hTf. Preliminary 
work suggests that Mn(III), like several other metals studied, preferentially binds to the 
C-lobe first, although this may result in an open domain conformation. 
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Fe(III) as Fe(NTA) 2 was found to displace Mn(III) from hTf but displacement was 
slower when hTf had been loaded using KMn0 4 rather than MnC1 2 . KMn04 was not 
able to displace Fe(III) from Fe 2 -hTf. 
Attempts to crystallise Mn-hTf to characterise these structural changes proved difficult. 
Crystals grew but were of poor quality and did not diffract. Many large crystals were 
obtained from solutions of Fe 2 -hTf. The crystals were red/orange and ellipsoidal in 
shape. Of the Fe 2-hTf crystals grown, one diffracted to 3.3 A with the data being 
complete to 90%, but not enough information was gained for adequate molecular 
replacement and structural solution. 
The effect of apo-, Fe- and Mn-hTf on human hepatocytes (WRL-68 cells) was studied. 
Fe and Mn was found to be taken up by these cells, as confirmed by ICP-AES. Cells 
grown in apo- and Fe-hTf maintained high cell numbers and viability. Mn-hTf treated 
cells resulted in decreased cell numbers and an increase in non-adherent cells, as 
determined by cell counting and MTT assays. This was not as a result of a cytotoxic 
effect and cell death, as confirnied by staining with Feulgans. A noticeable change in 
colour of the growth medium for cells incubated with 25 tM Mn-hTf, indicative of a fall 
in pH, suggested a metabolic effect on the cells. Further, there appeared to be a slight 
increase in mitotic activity in these cells and there was also a morphological effect. 
Dendritic-like processes grew from the cells. These processes, like the cells, contained 
mitochondria. The use of CMXRos dye showed that the mitochondrial transmernbrane 
potential was maintained in these treated cells showing that the effect of Mn-hTf on 
WRL-68 cells was not on mitochondria. These novel findings suggest transferrin can 
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transport manganese, with the potential of carrying more than two manganese per 
protein molecule. Future work to investigate the effect of Mn-hTf on cells at varying 
concentrations and whether this leads to up-regulation of anti-oxidant defence 
mechanisms including namely Mn-SOD should be worthwhile. 
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ICP-AES Inductively coupled plasma atomic emission spectroscopy 
mC1CCP Mesoxalonitrile 3 -chlorophenyihydrazone 
Met (M) L-methionine 
NAc-met N-acetyl-L-methionine 
Mn-hTf Manganese transferrin 
MPT Mitochondrial permeability transition 
MTT 3 -(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
NTA Nitrilotriacetate 
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PAGE 	 Polyacrylamide gel electrophoresis 
PDB 	 Protein data bank (http://www.rcsb.org/pdb/)  
PEG 	 Poly (ethylene glycol) 
pH* 	 pH meter reading uncorrected for effects of deuterium 
ROS 	 Reactive oxygen species 
Tris 	 Tn [hydroxymethyi]aminomethane 
Trp (W) 	 L-tryptophan 
TSP 	 Sodium trimethylsilyl-d4-prop ion ate 
Tyr (Y) 	 L-tyrosine 
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Chapter 1: Introduction 
Chapter 1 Introduction - Cellular Redox Status, 
Transferrin and Manganese 
Manganese is an important trace element that plays a role in mitochondrial protection 
from oxidant stress through its association with manganese superoxide dismutase 
(MnSOD). Manganese exists in a variety of redox states with most manganese 
bound within the mitochondrial matrix as Mn(II) and Mn(Ill). Dysregulation of 
manganese homeostasis suggests it has functions or effects beyond just association 
with MnSOD [1]. 
A major problem seen early in liver transplantation is injury related to ischaemia and 
reperfusion. The basis of this injury is at least in part the result of superoxide 
generation leading to apoptosis of liver cells. An alternative treatment strategy to 
SOD mimics is to deliver manganese to the cells in order to aid up-regulation of 
MnSOD that may be required to prevent oxidative stress. A feasible method of 
achieving this is by using the iron transport protein, transferrin. By loading 
transferrin with manganese, this may then result in delivery of manganese to cells 
and the effect of manganese on cells and mitochondria can then be studied. Further, 
chemical characterisation of the protein loaded with manganese may provide 
information on the protein and help elucidate the transport pathway of this metal in 
cell systems. 
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1.1 Generation of Reactive Oxygen Species (ROS) 
Recent interest has arisen in oxidative stress and redox cycling of cells and their 
involvement in cell signalling and other mechanisms, including apoptosis. 
Mitochondria are now known to be important in controlling cell life and death. Their 
role in cell death includes energy production, disruption of electron transport, 
oxidative phosphorylation, release of proteins that activate caspases and alteration of 
cellular redox cycling. Redox reactions have recently gained attention as being 
important chemical processes of the cell. Exchanging of reducing equivalents serves 
as an important element of signal transduction and other cellular mechanisms. 
However, as a result of this redox cycling, potentially damaging free radicals 
including reactive oxygen species (ROS), are often produced. 
Aerobic organisms generate reactive oxygen species by the partial reduction of 
molecular oxygen to form superoxide (02), hydrogen peroxide (14202) and the 
hydroxyl radical (OW). Superoxide is formed in the endoplasmic reticulum by the 
cytochrome P450 family [2] and in the cytoplasm by enzymes such as xanthine 
oxidase [3]. The activation of enzymes such as phospholipase A 2 and NAD(P)H 
oxidases can also produce superoxide in the plasma membrane of most cells [4]. It is 
suggested that NO and 02  react rapidly to form the peroxynitrite anion which 
decomposes when protonated into the potent oxidants 0H and NO 2 [5]. However, 




Mitochondria consume about 90% of inhaled oxygen and are a particularly rich 
source of ROS since about 1-2% of oxygen reduced in mitochondria is converted to 
superoxide during respiration by complexes I and III [7, 8]. A rat liver 
mitochondrion normally produces around 3x10 7 superoxide radicals per day [7]. In 
respiring mitochondria, oxygen is reduced to water in four consecutive one-electron 
steps by the respiratory chain as shown in Figure 1.1. 
Superoxide can act both as an oxidant and as a reductant and it can give rise to other 
dangerously reactive species. The standard redox potential of 02/02-*is —0.16 V [9]. 
MnSOD 	GPXICatatase 
002 	H 202 	
HO 	ATP 
e- 	e- 	e- 	e- 
Complex 	Ubiquinone 	Complex 	Cyt c 	Complex 
Ill I I IV 
Figure 1.1 The Respiratory Chain and Production of Free Radicals. Energy 
production via the respiratory chain can also result in production of superoxide 
radicals by complexes I and III. In mitochondria these are converted by manganese 
superoxide dismutase (MnSOD) to dioxygen and hydrogen peroxide, which is 
further converted to water by glutathione peroxidase (GPX) or catalase. 
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1.1.1 Cellular Defence 
Generation of superoxide is a continuous and physiological occurrence. Thus, cells 
have an efficient antioxidant system made up of enzymes such as superoxide 
dismutase (SOD), glutathione peroxidase (GPX), thiol peroxidases, glutathione 
reductase, and catalase. Other antioxidants are also involved, such as NAD(P) 
transhydrogenase, NADPH, glutathione, vitamins E and C, ubiquinol-10, lipoic acid, 
uric acid and mitochondrial respiration itself [7, 10-12]. SOD and catalase are 
metalloproteins that use efficient dismutation reactions in their mechanisms to 
detoxify ROS. A dismutation reaction involves a series of one or two electron 
transfers where the electrons are accepted from one 02  or 1-1202 and then donated to 
another (Equation 1.1, Equation 1.2) [13, 14]. These efficient reactions do not 
require reducing equivalents and so do not require energy from the cell in order to be 
carried out [13]. 
Two types of SOD have been found in mammalian liver; one enzyme contains 
manganese (MnSOD) and is found in the mitochondrial matrix. The other contains 
copper and zinc (Cu/ZnSOD) and is found primarily in the cytosol. Superoxide 
radicals produced in mitochondria readily undergo dismutation catalysed by MnSOD 
leading to the production of hydrogen peroxide (H 202), which is further detoxified 
by glutathione peroxidase or catalase [8]. 
to 
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Equation 1.1 Superoxide dismutation reaction 
02 	 02 	+ 
02 + 	e 	+ 	2W 	No H0 
202 + 	2W 	 ' 02 	+ 	H202 
Equation 1.2 Hydrogen peroxide dismutation reaction 
H202 NoL 02 + 2e + 2W 
H202 + 	2e- + 	2W 	No 2H0 
2H20 2 	 • 02 + 2H20 
It has been hypothesised that in addition to their important role in respiration, 
mitochondria may also help in maintaining the cellular redox status by eliminating 
superoxide radicals from the cytosol [12, 15]. At the inner mitochondrial membrane, 
02 protonates to form the uncharged hydroperoxyl radical, 1-10 2 , that could diffuse 
into the mitochondrial matrix. This radical could then be dismutated by enzymatic 
action. Spontaneous dismutation reactions of 02  and H02 are most rapid at pH 4.7: 
the protonation/deprotonation equilibrium has a pKa of 4.69 [16]. As the pH 
increases, the rate of dismutation decreases. Thus, at pH 7.4 the effective rate 
constant for spontaneous dismutation is Ca. 2 x 105 M' s_ i [17]. However, the 
reaction catalysed by superoxide dismutase is about 104  times faster having a rate 
constant of 2 x 10 9 M1 s' [17]. 
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1.1.2 Oxidative Stress 
When ROS production is in excess or antioxidant defence systems become 
overwhelmed or dysfunctional, oxidative stress may occur. This can then go on to 
cause cellular damage and possibly even lead to cell death. A number of 
circumstances can lead to increased ROS production such as tumour necrosis factor-
a (TNF-a), elevated Ca 2 , hypoxia and reperfusion. Reperfusion injury is a major 
problem during organ transplant. Following a period of anoxia, the sudden influx of 
oxygen into a hypoxic cell can lead to the increased formation of ROS [18, 19]. This 
increased level of ROS can actually cause more damage than the ischaemia itself 
[18]. Some key features of hypoxialreperfusion injury seen after organ 
transplantation include a rise in cytosolic Ca 2 , an increased ROS production in 
mitochondria and cytosol, cellular ATP depletion and finally necrosis [7]. Cellular 
damage caused by ROS and oxidative stress can be seen as oxidative modification of 
cellular macromolecules such as lipids, carbohydrates, proteins and DNA, causing 
cell damage and hence tissue malfunction. As previously mentioned, mitochondria 
are major producers of ROS so they are particularly susceptible to ROS attack. 
1.1.3 Mitochondrial Induced Apoptosis 
There is an early and important mitochondrial involvement in the apoptotic cascade 
[19-21]. Cytochrome c is found in the inter-membrane space of the mitochondria 
and acts as a diffusable electron carrier used in the respiratory chain [22]. It was 
recently shown that caspase cascades can be activated or amplified after release of 
cytochrome c from the mitochondria into the cytosol during the early stages of 
apoptosis [23, 24]. Once cytochrome c is released from mitochondria it is involved 
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in a series of interactions leading to activation of caspases [25, 26]. This then leads 
to initiation of apoptosis. Overexpression of the protein Bcl-2, prevents TNF-ct-
induced apoptosis and increases mitochondrial membrane potential [15, 27, 28]. 
1.1.3.1 Mitochondrial Permeability Transition 
Under normal physiological conditions the outer membrane of the mitochondria is 
permeable to all molecules <6,000 Da, whereas the inner mitochondrial membrane is 
seemingly impermeable resulting in the creation of a membrane potential and a pH 
gradient which are essential for mitochondrial function [28]. Zamzami et a! [29] 
have previously shown that cells undergo a reduction of the mitochondrial 
transmembrane potential before they exhibit signs of nuclear apoptosis. The 
mechanism of membrane potential disruption is thought to involve the opening of the 
mitochondrial permeability transition (MPT) pore [28, 30, 31]. It has been shown 
that MPT causes uncoupling of the respiratory chain with collapse of the 
mitochondrial membrane potential, calcium (Ca 2 ) release, hypergeneration of 
superoxide radicals and mitochondrial release of apoptotic proteins such as 
apoptosis-inducing factor (AIF). These events lead to apoptosis [15, 32-34]. 
Kroemer and co-workers [35] have shown in a series of experiments that induction of 
the MPT is sufficient to induce chromatin condensation and internucleosomal DNA 
fragmentation, these being well established signs of apoptosis. The result of MPT 
and pore formation may then go on to cause further membrane potential disruption 
and ROS generation. Thus MPT and the MPT pore may themselves cause a self-
propagating mechanism. 
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The MPT pore is also thought to regulate the permeability of the outer membrane 
[36, 37]. Opening of the MPT pore will cause an increase in matrix volume leading 
to disruption of the outer membrane which has been described in several models of 
apoptosis [7, 38]. 
Bcl-2 and Bcl-X L have been shown to prevent the opening of the MPT pore in 
isolated mitochondria and to prevent oxidant-mediated MPT [20, 28, 35, 37]. 
1.1.4 Oxidative Stress Induced Apoptosis 
The role of ROS and oxidative stress in mitochondrial- induced apoptosis still 
remains somewhat controversial. A large amount of experimental data [7, 21, 23, 24, 
37-41] indicates an involvement of oxidative stress and MPT in mitochondrial 
induced apoptosis. However, the exact mechanism still remains unclear. 
It has been demonstrated that cells undergo apoptosis in very low levels of oxygen 
and that many antioxidants fail to protect cells against apoptosis suggesting that ROS 
are not involved in some apoptotic pathways [42]. However, this may be due to the 
antioxidants not reaching the specific part of the cell where they are needed. In 
many experimental models used to study the MPT pore, oxidative stress was 
involved in the mechanism of cell injury supporting a possible connection between 
oxidative stress and permeability transition, and hence also to cell injury and even 
cell death. 
Apoptosis induced by oxidative stress appears to involve some of the same steps in 
the commitment and execution stages in other causes of apoptosis, i.e. cytochrome c 
release and caspase activation [21, 43]. However, oxidative stress may represent an 
early intrinsic component of an apoptotic cascade rather than being one of several 
ci' ci] 
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signals required to commit a cell to apoptosis. A possible fundamental step in 
apoptosis due to oxidative stress is the opening of the MPT pore leading to a fall of 
the mitochondrial membrane potential [21, 31, 35]. The correlation between MPT 
and mitochondria-mediated nuclear apoptosis suggests that MPT is a critical event in 
the regulation of apoptosis induction by mitochondria due to oxidative stress. 
It also must be remembered that oxidative stress can lead to necrosis as well as 
apoptosis, as does MPT [44]. Loss of membrane potential associated with MPT and 
pore opening would result in collapse of mitochondrial respiration and thus stop 
production of ATP. Hence the cell would then undergo necrosis as opposed to 
apoptosis, which is an energy requiring process. What factors determine which path 
the cell takes? Energy in the form of ATP could possibly be one of these switches. 
In conditions with low ATP, necrotic cell death may occur instead of apoptosis. If 
MPT involves only a subpopulation of mitochondria, as seen at least initially during 
TNF-a-induced apoptosis in hepatocytes, then the remaining normal mitochondria 
may maintain membrane potential and thus produce enough ATP to allow apoptosis 
to proceed as the membrane potential is maintained [36]. 
It is possible that cells experiencing only slight assault from oxidative stress may 
undergo a transient opening of the MPT pore which then closes again, allowing re-
establishment of vital ion gradients and ATP production. When this occurs there 
may be sufficient stimuli for the release of cytochrome c to initiate the apoptotic 
cascade. If insult is severe and prolonged MPT pore opening may stay open for 
longer periods or even permanently and so lead to necrosis. Hence necrosis is 
possibly more of a catastrophic event in response to severe oxidative stress. 
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1.1.4.1 Target Tissues 
A major problem seen early in liver transplant is injury related to ischaemia and 
reperfusion; this is thought to be a consequence of oxidative stress. Other tissues 
may also be affected by oxidative stress from ischaemic or toxic damage. These 
include the heart, kidney and lungs which are all thought to be in danger from the 
action of free radicals. Ide et al. [45] provide evidence for the involvement of ROS, 
produced by the respiratory chain in the mitochondria, in the myocardium during 
heart failure. This and other work has lead to investigations into antioxidants and 
their use in organs. Metallothionein has recently been proposed as a useful 
antioxidant in the heart [46]. Red wine has also been implicated as containing 
antioxidants and may impart some protection against coronary heart disease. The 
cardio-protective effects of resveratrol, an ingredient of red wine, following 
ischaemialreperfusion injury were recently investigated [47]. The results from this 
study suggest that the protective effects of red wine may be due to its free radical 
scavenging ability. Venditti et al. [48] have shown that vitamin E treatment gives 
some protective action against lipid peroxidation and cardiac dysfunction associated 
with ischaemialreperfusion, possibly by acting as a scavenger of free radicals 
produced as a result of reperfusion. 
Lungs are also affected by free radicals, and have their own antioxidant system 
including glutathione to deal with oxidative stress. This defence mechanism may be 
altered in inflammatory lung diseases such as chronic obstructive pulmonary disease 
and also in cigarette smoke-induced airway disease [49]. There is also evidence that 
asthma sufferers are subject to increased oxidative stress indicated by reduced levels 
of lung lining fluid ascorbic acid (vitamin C), a-tocopherol (vitamin E) and 
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increased amounts of oxidised glutathione in their airways [50]. ROS have also been 
implicated in other disorders and have even been suggested as mediators of the 
development of malformations in diabetic pregnancy [51]. As such, loss of control or 
dysregulation of ROS may have important roles in the pathogenesis of a variety of 
diseases in multiple tissues. 
1.2 Redox-Active Metal Ions 
The d-block elements are a family of metals with generally similar characteristics 
and represent the 'transition' between the highly electropositive s-block metals and 
the electronegative p-block. The first row is home to many biologically important 
metals: V, Cr, Mn, Fe, Co, Ni, Cu and Zn. Their behaviour as ions in solution 
mainly entails co-ordination and redox chemistry. 
The transition elements show variable oxidation states and are usually present in 
biological systems as co-ordination complexes, with ligands ranging from cellular 
components such as water, small organic molecules and porphryins, to the side 
chains of amino acids. This group of cations can coordinate all types of donor atoms. 
The transition metals tend to hydrolyse at physiological pH values so to prevent this, 
the metal ions are chelated allowing transport in living systems. All first-row 
transition metals, except Zn, which exists invariably in the +2 state, have rich redox 
chemistry. The d-block metal ions can be associated with both small molecule 
binding and oxidoreductase enzyme activity. Alternatively the metal centre can act 
as a channel for electron transfer. One of the most important redox active metals is 
iron. 
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1.2.1 Iron in Biological Systems 
The involvement of iron in biological systems is somewhat complicated. It has many 
functions including oxidation-reduction catalysis, bioenergetics and is connected to 
several control systems. Some iron containing proteins and enzymes are listed in 
Table 1.1. 
Iron can exist in oxidation states 0, II, III, IV and VI, although the stability of each 
state varies. Iron (II) has the 3d 6 electronic configuration. In octahedral complexes, 
the arrangement of the six d electrons can be in two dispositions (high spin and low 
spin) which plays an important role in iron-protein chemistry. 
Table 1.1 Some iron proteins and enzymes [52]. 
Protein or enzyme Localisation Function 
Haemoglobin Cytoplasm Transport of 02 
Transferrin Plasma Transport of Fe 
Ferritin Cytoplasm Storage of Fe 
Rubredoxin, ferrodoxin Cytoplasm (prokaryotes) and 
membranes 
Electron transfer 
Hydroxylases Cytoplasm and membranes Hydroxylation 
Peroxidases Vesicles and extracellular Utilisation of H 202 
Acid phosphatases Vesicles and extracellular Hydrolysis of phosphate 
groups 
Superoxide dismutase Mitochondria (prokaryotes) Dismutation of 02 
Cytochromes are haem proteins and electron transfer is usually between the Fe(II) 
and Fe(III) forms. Electron transfer is facile since there is little structural change 
during the redox reaction. There are a large number of non-haem proteins containing 
an oxo-bridged unit, Fe-0-Fe, mononuclear iron proteins where the ligands are 
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nitrogen and oxygen donors and iron sulfur proteins displaying a variety of FeS 
clusters [52]. In these FeS clusters the high-spin iron is often co-ordinated to four 
sulfurs from inorganic sulfide and protein cysteines in an approximately tetrahedral 
arrangement around the metal ion. They make particularly effective redox centres. 
Iron and the other transition metals have to be moved from ingestion to organs where 
they are needed. However, some of the ions precipitate at biological pH values and 
are often toxic. Therefore, carrier ligands are required for transport. 
Iron homeostasis is maintained by the liver where it is the major site for iron storage 
and synthesis for the plasma iron transport protein, transferrin [53]. The hepatocyte 
synthesises and secretes transferrin into plasma where it can then be delivered to sites 
where iron is required. Alterations in storage depend on the balance between iron 
sequestration and the need for synthesis of haem [53]. 
A normal 70 kg adult man has a total body iron of ca. 4 or 5 g, most of this (60 - 
65%) is located in haemoglobin in circulating erythrocytes. About 10% is in skeletal 
muscle as myoglobin and about 20 - 30% is present in the liver, spleen and bone 
marrow in the form of ferritin and haemosiderin [53]. A small (< 5%) but vital 
amount of tissue iron is associated with several metabolically important intracellular 
proteins such as the cytochromes and iron-sulfur proteins (ferredoxins) and about 7 
mg is bound to transferrin. Approximately 80 - 85% of absorbed iron is transported 
by transferrin to the bone marrow where it is used in haemoglobin in developing red 
blood cells [53]. 
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1.3 Metal Ion Transport 
The transferrins are a class of iron binding proteins. Serum transferrin is an iron 
transport protein found in blood at a concentration of Ca. 2.5 mg!mL (35 .LM) [54]. 
Lactoferrin is found in a variety of secretory fluids such as saliva, milk and tears. 
Ovotransferrin is mainly present in egg whites. Melanotransferrin is a membrane-
bound protein found at low levels on the surface of most cells [55]. Ferric-ion 
binding protein (FBP), also of the transferrin family of proteins, is found in several 
Gram-negative bacteria and is structurally similar to one half of the transferrin 
molecule [56-59]. 
Human serum transferrin (hTf) is a single chain glycoprotein with a molecular 
weight of about 80 000 Da made up of approximately 700 amino acids [60]. The 
structure of hTf has been determined using X-ray crystallography [61, 62]. It is a 
bilobal protein with two structurally similar lobes known as the N-lobe (the amino 
terminus) and the C-lobe (the carboxy terminus). In human serum transferrin there is 
ca. 40% homology between lobes [60]. Transferrins are glycoproteins, with the 
exception of some fish transferrins [63], with the glycan chains attached to the 
proteins by N-glycosidic linkages to asparagine residues. The glycan chains appear 
to play no direct role in the function of the protein. Human transferrin has two 
biantennary glycan chains both of which are attached to the C-lobe of the protein 
(Asn413 and Asn6l 1) [60], whereas rabbit serum transferrin has only a single glycan 
chain bound to the C-lobe (Asn491) [64, 65]. There are two carbohydrate chains, 
one on each lobe, in human lactoferrin (Asn137 and Asn490, N- and C-lobe 
respectively) [66] The structure of the principal glycan chains is shown in Figure 
1.2. 
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NeuAc(a2-b)-GaI(3I -4)-GI cNAc(1 -2)-Man(al -3) 
Man(131 -4)-GI cNAc( I -4)-GI cNACI31 -Asn 
NeuAc(cL2-6)-GaI(131 -4)-GI cNAc(I -2)-Man(al -6) 
Figure 1.2 The sequence of the glycan chains of human serum transferrin [671. 
The protein can bind two Fe" ions tightly but reversibly, with one ion in each lobe 
[541. Figure 1.3 shows the crystal structure of Fe-hTf, where Fe(111) is bound to the 
C-lobe. This is the only structure of human transferrin which has been reported and 
then only in a thesis [62]. Each lobe is further divided into two domains (Ni, N2, Cl 
and C2) which have alternating a-helical and p-sheet segments. A cleft that 
separates the two domains in each lobe contains the metal binding site of transferrin. 
Both lobes have similar folding patterns. The N-terminus of many helices is directed 
towards the central binding cleft which creates a positive charge to attract anions to 
the binding cleft. Two extended n-strands run anti-parallel to each other behind the 
metal binding site which form a hinge that allows the lobes to open and close to 





Figure 1.3 X-ray Crystal Structure of Fe-transferrin at 2.6 A [62]. The C-lobe with 
Fe" bound is in the closed form and the N-lobe with no metal bound is in the open 
form. 
Each metal binding site has a distorted octahedral geometry and consists of five 
oxygen donors: two from the phenolate groups on the tyrosine residues, one 
carboxylate from an aspartate residue and a bidentate carbonate anion, and one 
nitrogen donor from a histidine residue. The binding site can be seen in Figure 1.4. 
In order for Fe34 to bind strongly to transferrin a suitable anion must be present, the 
synergistic anion. Physiologically this is carbonate [68, 75]. 
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_r 
Asp392 (63) 
Tyr517 (188) j 
Lv 	c032- 
,rr426 (95) 
Figure 1.4 Metal Binding Site of Transferrin [62]. The binding site consists of five 
oxygen donors and one N donor. Fe3 (shown as a red ball) can be seen in the 
binding site of the C lobe. Residue numbers are for the C-lobe site with N-lobe 
analogues in brackets. 
1.3.1 Receptor Mediated Endocytosis 
Receptor mediated endocytosis involves the binding of a substrate such as a protein, 
to a specific membrane bound receptor. The receptor and substrate are then 
internalised as the membrane invaginates to form a membrane bound vesicle which 
takes the receptor and substrate into the cell. Transferrin enters the cell by receptor 
mediated endocytosis, an ATP-dependent process [76] with the diferric form strongly 
bound to the receptor (TFR) [63]. The binding strength of apotransferrin for the 
receptor on the surface of human leukaemia K562 cells was found to be significantly 
His'-585 (249 
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lower than that of diferric transferrin [77]. Each Fe 2-hTf binds to a monomer of the 
receptor. Iron-loaded transferrin binds to the receptor at neutral pH. After binding, 
diferric transferrin is internalised by endocytosis via clathrin-coated pits which bud 
from the plasma membrane as membrane-bound vesicles, the transferrin-TFR 
complex is routed into the endosomal compartment. Within 2 - 6 minutes [63], the 
diferric transferrin is inside the cell and retained in endosornes where upon 
maturation and loss of the clathrin coat, the endosomes become competent to pump 
protons in an ATP-requiring process so that the pH is lowered from that of cellular 
pH of 7.4 to about 5.5. This then leads to the release of Fe 3+  where it is later found 
associated with cytosolic ferritin [63, 77, 78]. In cell studies, diferric transferrin was 
found to give up iron more readily than monoferric transferrin [79]. The 
acidification of endosomes is due to ATP-dependent proton pumps and protons are 
actively transported from the cytosol to the interior of the endosomes. The free Fe 3+  
released from transferrin into the endosome is reduced to Fe 2 on the cis-side of the 
endsomal membrane probably by oxidoreductase [80]. Free Fe 2+  is then transported 
to late endosomes and lysosomes followed by transport into the cytoplasm by 
NRAMP2 (natural resistance-associated macrophage protein 2)/DMT 1 (divalent 
metal transporter 1). The passage of iron from early to late endosomes is thought to 
occur by one of two mechanisms; vesicles pinch off from the early endosomes 
delivering the iron to late endosomes by specific carriers or the early endosomes and 
their contents mature into late endosomes with recruitment of late endosomal 
components [81]. 
NRAMP2 is a pH-dependent divalent metal transporter that shows a broad substrate 
range and mediates active proton-coupled transport [82]. Use of the microcytic 
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anaemia (rn/c) mouse and Belgrade (b) rat, both of which have autosomal recessive 
defects in iron metabolism [83-85] due to the same mutation of the Nramp2 gene [86, 
87], has shown that NRAMP2 is localised to the membrane of late endosomes and 
lysosomes and acts as an iron transporter in the transferrin cycle [81]. 
Once iron has been removed from the protein, apo-transferrin remains bound to the 
receptor at low pH and is taken back to the cell membrane in the endosome. Once at 
cellular pH the apotransferrin then dissociates from the receptor and is exocytosed 
(see Figure 1.5) [77, 88, 89]. At p1-I 5.4 apotransferrin binds to the receptors with the 
same affinity as diferric transferrin binds at pH 7.0. However, at pH 7.0 
apotransferrin readily dissociates [78]. The free receptor is then available for another 
cycle of receptor mediated endocytosis. The half-life of apo-transferrin in humans is 
7.6 days while that of Fe-hTf is 1.7 hours [90]. A molecule of transferrin will 
undergo approximately 100 cycles of iron binding and release. The major receptor 
recognition sites on hTf are thought to be localised to the C-lobe [91-95]. 
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Figure i.s 
Receptor mediated endocytoSiS of transferrin. Fe-hTf binds to its receptor 
at neutral pH and is internalised inside vesicles. The transferrinrecePt0r complex 
then moves into acidic endosomes where Fe 
3+ is released and passed onto ferritin. 
The apotransferrifl_rePtor complex is then returned to the cell surface where the 
neutral pH allows the dissociation of transferrin from the receptor. 
1.3.2 Transferrifl as a Metal Ion Mediator 
TransferrinS are predominantly iron binding proteins, however, in human serum 
transferrin is only about 30% saturated with iron [541. 
This suggests this protein may 
also transport other metals of importance. Of those metals studied so far, Fe
3 has 
the highest affinity for transferrin but other metals have been found to bind in the 
presence of a synergistic anion. Other main-group metal ions include Bi 3 
 [96], Ga3 
[971 and J 3 




[100]. The determining factors for metal ion binding to transferrin are not clearly 
understood. There may be an optimum radius of the metal ion for secure binding 
into the cleft of the protein. However, Bi 3 (ionic radius of 0.103 nm) which is 
considerably larger than Fe 3 (0.065 nm), binds very tightly to serum transferrin [96]. 
It appears that the strength of metal ion binding is determined by the type of amino 
acid side-chain donors, mainly 0 donors, in transferrin rather than the size of the 
binding cleft [96]. Further, the most readily hydrolysed (most acidic) metal ions bind 
most strongly to transferrin. Hence, highly acidic trivalent metal ions such as Fe 3 , 
Bi 3 and Ti 3 bind more strongly than divalent metal ions [54]. 
1.4 Caeruloplasmin 
Caeruloplasmin is found in serum and is a copper-containing glycoprotein with a 
molecular weight of Ca. 132 kDa. Caeruloplasmin is synthesised in hepatocytes and 
secreted as a holoprotein and secreted locally within some non-hepatic tissues [101]. 
It belongs to a family of multi-nuclear 'blue' copper oxidases which includes 
ascorbate oxidase and laccase. At least four functions have been assigned to 
caeruloplasmin: copper transport, ferroxidase activity and amine oxidase activity, 
and it is an antioxidant in serum. 
Caeruloplasmin is a plasma protein known for its oxidising activity. It is a multi-
copper oxidase which contains most of the copper present in the plasma [102]. The 
precise physiological role of this enzyme is still unknown, but it is thought to have a 
multi-functional role including oxidising activity and is possibly a storage protein for 
copper. It has been suggested that caeruloplasmin has a distinct active site for 
glutathione-linked peroxidase activity apart from the copper complex giving it its 
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ferroxidase activity [101]. Anion binding studies have supported the theory that 
caeruloplasmin has multifunctional oxidase activity [103]. 
Caeruloplasmin is thought to be involved in the release of iron from cells, oxidation 
of the iron to Fe(III) and its subsequent incorporation onto apo-transferrin [104]. 
However, there is no firm evidence that transferrin interacts directly with 
caeruloplasmin or that caeruloplasmin oxidises Fe(II) to Fe(III) for uptake by 
transferrin. Since apo-transferrin has a high affinity for Fe(III), caeruloplasmin may 
act to prevent the release of harmful Fe(II) ions which might then participate in 
Fenton and Haber-Weiss-type reactions and hence production of 0H [105]. In 
tissues where oxygen levels are low caeruloplasmin may be essential for 
ferroxidation. 
The crystal structure of caeruloplasmin has been solved and can be seen in Figure 1.6 
[106]. The structure comprises six domains arranged in a triangular array. Each of 
the domains contains a 13-barrel with the strands organised in a manner typical of the 
small blue cupredoxin proteins. The barrels are orientated so that they are all the 
same way up but the even-numbered domains point inwards towards the pseudo-
threefold axis, similar to the feet of a tripod, whereas the odd numbered domains 
point outward. There are six copper atoms present in the structure, three of these 
occupy mononuclear centres in domains 2, 4 and 6. The remaining three form a 
trinuclear cluster site at the interface between domains 1 and 6. The positioning of 
the trinuclear cluster and the nearest mononuclear copper in domain 6 is similar to 
that seen in ascorbate oxidase, suggesting that human serum caeruloplasmin may 
also exhibit an oxidase function [106]. Each of the mononuclear coppers is co-
ordinated to a cysteine and two histidine residues and the coppers in domains 4 and 6 
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also coordinate to a methionine residue, in domain 2 the methionine is replaced by a 
leucine residue which may form van der Waal type bonding with the copper. Four 
pairs of histidine residues with Cu-N distances of approximately 2.1 A, two pairs 
from domain 1 and the other two from domain 6, surround the trinuclear cluster. 
/ 
) 
Figure 1.6 X-ray crystal structure of human serum caeruloplasmin [106]. Structure 
solved to 3.1 A. The six domains are displayed in different colours: red, blue, green, 
light blue, yellow, pink. The six copper atoms are shown as orange spheres, the two 
oxygen atoms as blue spheres. 
The distances of around 18 A between the mononuclear coppers is well within the 
range for effective electron transfer [104]. At the trinulcear cluster, oxygen is 
reduced to water. The extra distance between the coppers in domains 2 and 4 would 
lead to a slower oxidation rate than that involving the copper in domain 6, this may 
imply that the enzyme is able to oxidise more than one substrate molecule at a time 
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[104]. 
Upon further study of the crystal structure of caeruloplasmin, Lindley et al [104] 
proposed the presence of two copper labile sites in domains 4 and 6. The function of 
the sites is as yet unknown, however they could be used for copper transport. 
1.5 Manganese 
Manganese has the atomic number 25 and atomic weight of 54.938 atomic mass 
units. It is the fifth element of the first transition series in group 7. Manganese was 
recognised as an element in 1774 by Scheele, Bergman and others and isolated by 
Galin in the same year by reduction of manganese dioxide with carbon. High purity 
manganese was only produced much later in the 1930s by electrolysis of Mn(IJ) 
solutions. Manganese minerals are widely dispersed with oxides, silicates and 
carbonates being the most common [107]. 
Manganese is relatively abundant making up about 0.085% of the earth's crust [108]. 
It is widely distributed as a number of substantial deposits which are mainly found as 
oxides, hydrous oxides or carbonate with large quantities also being found in seabeds 
of deep oceans as Mn0 2. A large industrial use of Mn is in ferrornanganese for 
steels. 
1.5.1 Manganese Chemistry 
Manganese can exist in eleven oxidation states from —3 to +7. The aqua Mn 2 ion is 
the most common and most stable as shown in Figure 1.7. Free Mn 2 can be present 
at high concentrations in neutral solutions as it does not begin to hydrolyze until pH 
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10 [108]. Divalent manganese (Mn 2 ) is a d5 ion and typically forms high-spin 
complexes lacking crystal field stabilisation energies. These properties and the 
rather large ionic radius and small charge/radius ratio lead to manganese forming 
relatively weak complexes with many ligands [109]. 
] 
7+ 
I 	2 	3 	4 	5 	6 	7 
Oxidation State 
Figure 1.7 Plot of volt-equivalent versus oxidation state for Mn in aqueous, acidic 
solutions [110]. 
As seen with Ti, V and Cr, the highest oxidation state of Mn, Mn(VII), corresponds 
to the total number of 3d and 4s electrons. This state occurs only in the oxo 
compounds Mn0 4 (permanganate), Mn 207 (manganese oxide) and Mn03F 
(manganese trioxide fluoride). 
A summary of the co-ordination numbers and geometries of some of the most 
























2 Linear Mn[C(SiMe3)2 ] 2 
4 Tetrahedral MnC142 , MnBr2(OPR) 
4 Square planar [Mn(H20)4 SO4 .H20] 
5 Trigonal [Mn(trenMe6)Br]Br 
Mn(II),  d5 
bipyramidal 
5 Distorted trigonal MnBr2 [(MeI-IIN)2C0] 3 
bipyramidal 
6 Octahedral [Mn(H20)6] 2+  [Mn(NC S)6] 4 
4 Square planar [Mn(S2C61-I3Me)2 1 -  
5 Square pyramidal MnX sal2en, [bipyH2]MnC15 
Mn(III), d4 5 Trigonal Mn13 (PMe3 ) 2 
bipyramidal Mn(acac) 3 , [Mn(ox)3 ] 3 , 
6 Octahedral MnF3 (distorted) 
4 Tetrahedral Mn( 1 -norbonyl) 4 
Mn(TV), d3 




4 Tetrahedral Mn04 , Mn03F 
Mn(VII) is a powerful oxidising agent usually being reduced to Mn(IJ). Only a few 
intermediate Mn(V) species have been identified in the reduction of permanganates 
[108]. Although Mn(II) is the most stable state, it is quite readily oxidized in 
alkaline solution. In neutral or acid aqueous solutions the very pale pink hexaaqua 
ion [Mn(H20)6] 2 forms which is resistant to oxidation as shown in Figure 1.8 [108]. 
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Figure 1.8 Oxidation potentials of Mn in neutral or acid aqueous solution 
In basic media the hydroxide Mn(OH) 2 is easily oxidised by air as shown in Figure 
1.9 [108]. 
-0.1 V_ 	 -0.2 V 
Mn02.yH20 - 	Mn203 H20 	Mn(OH) 2 
Figure 1.9 Oxidation potentials of Mn in basic aqueous solution 
Mn(II) forms a large number of salts with all common anions. Most are soluble in 
water with the exception of phosphate and carbonate salts, which are only marginally 
soluble. Most of the salts crystallise from water as hydrates. Mn(1II) exists naturally 
as salts of acetate, phosphate or trioxide, none of which are readily water soluble. 
The Mn(III) ion is important in the complex redox reactions of the higher oxidation 
states of manganese in aqueous solutions. It is most stable in acid solutions as it is 
easily hydrolysed with the initial monomer slowly polymerising [ill]. 
Mn3 + 	H2O = 	Mn(OH)2 	+ 	H 	 K=0.93 
Under suitable conditions the Mn3+Mn2*  couple is reversible (E° = 1.559 V in 3 M 
LiC104). The Mn3 ion is slowly reduced by water: 
2Mn3 + 	H20 = 	2Mn2 	+ 	2H + 	V202 
Complexing ions can stabilise the Mn(III) state in aqueous solution, however even 
the most stable species [Mn(EDTA)(H20)1 -  undergoes slow oxidation of the ligand 
leading to decomposition. 
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In many Mn(III) octahedral compounds a Jahn-Teller distortion in the form of 
elongation of two trans bonds with little difference in lengths of the other four, is 
often observed. 
The Mn(III)/Mn(II) redox potential is highly dependent on the co-ordination sphere 
of the metal ion. Binding of nitrogen ligands to Mn(III) lowers the reduction 
potential of the Mn(III) complex and carboxylate ligands have the same although 
smaller effect. Five- and seven-coordinate Mn(II) complexes are more difficult to 
oxidise to Mn(III) than octahedral complexes. The behaviour of Mn bound proteins 
is consistent with the behaviour of the simple complexes; Mn(III) in enzymes such as 
catalase and superoxide dismutase is bound to two or more histidines although the 
conformation is not always octahedral. The Mn(II) ion in manganese-dependent 
peroxidases, which is oxidised to Mn(III), has a co-ordination sphere of two water 
molecules, a propionate from the haem group and three carboxylate residues. 
The best known compounds of Mn(VII) are salts of the permanganate ion Mn0 4 , 
particularly sodium and potassium, with the latter being used as a common oxidising 
agent in the production of saccharin and benzoic acid and medically as a disinfectant. 
In acid solution: 
Mn04 + 8H + 5e -- 	Mn2 + 4H20 
E°=+1.51 V 
In alkali solution: 
Mn0 4 	+ 2H 20 + 3e- -  - 
E°= +1.23 V 




Permanganate is also being used in water purification having the advantage over 
chlorine in that the taste is not affected and the Mn0 2 produced acts as a coagulant 
for colloidal impurities. 
The Mn04 ion has no unpaired electrons, but it does have a small temperature 
independent paramagnetism [110]. 
1.5.2 Biology of Manganese 
The average human body contains between 200 and 400 jimol of manganese with 
serum concentrations being typically less than 10 nM while tissue concentrations are 
generally less than 4 jtM [112]. It is an essential metal which is particularly critical 
during development, however much is still unknown concerning basic aspects of 
manganese bioavailability, cellular uptake, processing and release. The estimated 
safe and adequate daily dietary intake (ESADDI) of manganese for adults is given as 
2-5 mgMnlday[1l3]. 
The valence state of Mn appears to have a critical role in the metals plasma-binding 
characteristics. This may have relevance to the toxicology and pharmacology of Mn 
and the degree to which it exerts its cytotoxicity [114]. Manganese in oxidation state 
+3 might have a significantly different profile to Mn(ll) in terms of its uptake, 
distribution, accumulation and excretion. 
Mitochondria have a higher concentration of manganese than the cytoplasm so 
tissues with high levels of mitochondria such as liver, bone, pancreas and kidney 
generally have high manganese concentrations. 
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1.5.3 Manganese Transport 
Albumin, transferrin and 'transmanganin' have all been suggested as possible 
transport agents for Mn in plasma [115]. In studies using radio-labelled metals, 
Mn(II) was found to bind poorly to albumin compared with Cd(II), Zn(II) and 
Fe(III). However, the amount of Mn found to bind to transferrin increased as 
incubation time was increased, probably due to oxidation of Mn(II) to Mn(III), but 
not as readily as Fe(III). Further, saturation with Fe(III) prevented Mn(II) binding 
supporting the suggestion of Mn binding to the Fe-binding sites on the protein [115]. 
The mechanism of manganese transportation to and from extra-hepatic tissue has still 
not been identified. However, transferrin is thought to be the major transport protein 
[116, 117]. Gibbons et a! [118] have shown that injected Mn(II) is cleared from the 
blood within 5 minutes whereas injected Mn(III)-hTf has a clearance of 
approximately 3 hours, which is comparable to clearance rates of ferric transferrin. 
Manganese and iron are taken up into cells via transferrin-dependent and 
-independent pathways requiring the divalent metal transporter I (DMT 1) [119]. 
Currently it is thought that manganese is absorbed from the gastrointestinal tract and 
enters the portal blood where it remains either as free manganese or binds to 
a2-macroglobulin which is then taken up by the liver [118]. A small amount, up to 
10%, enters the systemic circulation where it can be oxidised to Mn(III) and bound to 
transferrin [116, 117]. Once manganese has entered the liver it can be transferred to 
the bile canaliculus via lysosomes. Some manganese is taken up by the mitochondria 
where it may be used to produce MnSOD. Uptake and release is thought to occur via 
the transport protein DMTJ and also through calcium channels [119]. Some 
manganese is thought to be retained by the nucleus although its function remains 
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unresolved. Alternatively, manganese can be incorporated into or is associated with 
newly synthesised manganese proteins [109]. Accumulation of manganese is tightly 
regulated due to metal toxicity so uptake is generally regulated by the bioavailability 
of the metal. As well as uptake into the cell, manganese must also be transported 
across the cell lumen to organelles where it can then be utilised. 
Microorganisms also require manganese for survival in trace amounts. Certain 
oxygen-consuming organisms use manganese as the cofactor for antioxidant defence 
systems. Photosynthetic bacteria use manganese for oxygen evolution and metabolic 
processes such as DNA synthesis, sugar metabolism and protein modification. 
The mechanism of manganese transport in Bacillus is not completely understood. A 
putative regulator of manganese, MntR, that responds to changes in manganese 
bioavailability has recently been discovered [112]. Possible targets for regulation by 
MntR include a member of the natural-resistance-associated macrophage protein 
(Nramp) family of metal transporters and putative ATP-binding-cassette (ABC) 
metal transport protein. Nramp is localised in the phagosomes of macrophages. 
Mammalian Nrampl is believed to deprive mycobacteria of the redox-active metals 
iron and manganese as part of the oxygen radical defence against pathogens. 
The unicellular cyanobacterium Synechocystis 6803 uses a tetramanganese cluster to 
produce molecular oxygen during photosynthetic growth [112]. 
The manganese transporter MntABC complex shows significant homology to 
polypeptide components of the ABC superfamily of transporter proteins. MntA 
appears to represent the ATP-binding cytoplasmic protein; MntB is a possible 
integral membrane protein and MntC may be the periplasmic component that 
captures the metal. Together these three subunits form the manganese permease at 
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the cell surface. 
As is the case with bacteria, yeast also rely on manganese for growth. The 
acquisition of manganese in yeast cells involves the action of Smfl p, a member of 
the Nramp family. Smflp, like other members of the Nramp family contains 12 
transmembrane spanning domains. Smflp, like Nramp2, is not specific for 
manganese, and transports other essential ions [112]. 
Multiple genes involved in the transport of manganese ions have been identified for 
yeast, however it is still to be understood how the ion is moved in a 
compartmentalised eukaryotic cell. For example, how is manganese transported to 
the mitochondria inside a cell for activation of proteins such as MnSOD? 
1.5.4 Manganese-Containing Proteins 
Manganese functions as a constituent of metalloenzymes and as an enzyme activator. 
Examples of some of these can be found in Table 1.3. 
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Table 1.3 Examples of some Mn-containing proteinsl1121 
Protein O.S. Function of protein Examples 
Phosphatases II Phosphate removal from Mn-activated 
proteins and sugars phosphatases, inositol 
monophosphatase 
Oxidoreductases 111111 Oxidation/reduction MnSOD, amine oxidase, 
cytochrome c oxidase 
Dehydrogenases II Catalyse reduction with NAD Isocitrate dehydrogenase 
Peroxidases II Catalysis Mn-dependent 
peroxidase, 
chioroperoxidase 
Transferases II Transferase reactions Kinases, DNA and RNA 
including glycosyl and polymerises, sugar 
phosphate groups transferases 
Isomerase II Isomerisation reactions Xylose isomerase, keto- 
aldose isomerases 
O.S. = Oxidation State 
Manganese-containing enzymes include MnSOD, arginase and pyruvate carboxylase. 
Arginase is a cytosolic enzyme responsible for the formation of urea and L-omithine 
by the hydrolysis of L-arginine. It contains 4 mol Mn 2 per mol of enzyme and is 
most concentrated in mammalian liver. Manganese binding is critical for the pH 
sensing of arginase in the omithine cycle. Hence, manganese may be involved in pH 
regulation [112]. Pyruvate carboxylase catalyses the first step of carbohydrate 
synthesis from pyruvate and also contains 4 mol Mn 2 per mol of enzyme [112]. 
There are a large number of manganese activated enzymes where the metal can act 
by binding the substrate directly such as ATP and/or by binding to the protein 
resulting in a conformational change. 	Manganese-activated proteins include 
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glycosyltrans ferases, phosphoenolpyruvate carboxykinase and glutamine synthetase 
[112]. 
1.5.4.1 Manganese Superoxide Dismutase 
The role of MnSOD in defence against free radicals can be clearly shown in MnSOD 
knockout models. Knockout mice for MnSOD die within the first few weeks of life 
and mice that are heterozygous for MnSOD show a 50%  decrease in liver MnSOD 
activity and severe oxidative damage to tissue [120]. Over-expression of MnSOD is 
characterised by improved resistance to various stresses [121]. 
MnSOD catalyses the disproportionation of 02  to H202 and 02 by using a reaction 
mechanism that involves cyclic oxidation and reduction of the active metal site 
coupled to the protonation of the co-ordinated anion [122]: 
M 1 + 	02 	 M 	+ 	02 
+ 	02 	+ 	2H 	M' + 	H202 
The enzyme works by way of a 'ping-pong' mechanism, which follows a relatively 
low-energy pathway. The first 02  binds to the oxidative Mn(III) centre, transfers an 
electron and releases a molecule of 02.  The second 02 attaches to the reduced 
Mn(II) and an electron is transferred and coupled with proton transfer, forming H02 
[16]. The actual reaction pathway is more complicated. For example, an inactive 
form of MnSOD has been observed which results from the oxidative addition of 02 
to a Mn(II) centre which slowly inter-converts back to the active form [123]. 
Borgstahl et al [124] have determined the crystal structure of MnSOD from 
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Escherichia co/i (Figure 1.10). 
I.. 
I .. - 
~, ~4 
Figure 1.10 Crystal Structure of MnSOD [124]. E. co/i MnSOD crystals were 
grown at pH 8.5 and cryocooled to 100 K. Resolution of 1.55 A was achieved. 
Monomers are coloured blue and green. Manganese atoms are shown as red spheres. 
This MnSOD is a homodimer with the active manganese sites separated by 18.3 A. 
Each monomer is made up of a N-terminal a-helical domain and a C-terminal a/3 
domain. The active site is between the two domains with each contributing ligands 
to the active site co-ordination. The manganese in the active site is ligated by three 
histidine nitrogens (His26, His81, Hisl7l), one aspartate carboxylate 
oxygen(Asp 167) and a water molecule (or a hydroxide group depending on the metal 
oxidation state) in a trigonal bipyramidal arrangement [112, 125]. The active site is 
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Figure 1.11 
Active site of Mn superoxide dismutase 1112511. Mn is bound to three 
histidineS (purple), an aspartate (yellow) and a molecule of co-ordinated solvent 
(water or hydroxide, shown as blue sphere). Manganese is shown as a red sphere. 
1.5.4.2 Mimics 
The recent interest in oxidative stress and its involvement in disease and cell death 
has lead to the possible development of antioxidants as therapeutics. Many groups 
are currently working on the metalloPrOteins catalase and SOD. Most catalytic SOD 
mimics are designed with a redox-reactive metal centre that catalyses the dismutation 
reaction with superoxide in a manner similar to that found naturally in mammalian 
SODs. An ideal mimetic should be stable with high specificity for interaction with 
02 and a high rate constant. M
etalloporphyrins are a relatively new class of metal 
containing SOD mimetics. Others include salen and macrocyclic SOD 
mimetics 11 13 , 
1261. A functional mimic being investigated is a manganese(II) complex with a bis 
(cyc1ohexy loyrid1ne)b5tit1t macrocyclic ligand (M40403). M40403 has a high 
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catalytic SOD activity and is chemically and biologically stable in vivo [127]. 
However, these new products are not without their drawbacks in terms of expense, 
antigenicity and size. Further, if effective mimics are produced they must be targeted 
to the correct part of the tissue and act in the correct sequence of events when 
required. A general problem for SOD mimics is that they can react with most ROS; 
hence targeting to areas such as the mitochondria to deal with superoxide only may 
prove to be difficult. 
1.5.4.3 Contrast Agents 
Magnetic resonance imaging has proved to be a useful medical tool for looking at 
abnormal tissue. Differences between the 'H NMR resonances of normal and 
abnormal tissue can be detected by the use of contrast agents. Useful contrast agents 
are paramagnetic metal ions such as Mn(II) (3d 5 , 5 unpaired electrons) [128]. 
Toxicity is associated with the free metal ions therefore chelation of Mn(II) is 
necessary. The design of the ligand allows paramagnetic ions to be targeted to a 
particular organ, e.g. the liver, thereby increasing the signal intensity of the tissue 
containing the agent. 
MnDPDP (manganese(II) N, N '-dipyridoxyl-ethylenediarnine-N,N '-diacetate-5 ,5', 
bis(phosphate)) is the active ingredient of mangafodipir trisodium injection 
(Teslascan®) used as a contrast agent for MRI of the liver and hepatobiliary system 
[129]. 
37 
Chapter 1: Introduction 
1.6 Conclusion 
The natural transferrin cycle for the delivery of iron to cells offers a potential 
strategy for metallo-drug targeting to hepatocytes undergoing oxidative stress. 
It is known that hepatocytes have a high requirement for manganese due to its use in 
the mitochondrial matrix i.e. for incorporation into MnSOD. Hepatocytes are known 
to express high levels of the transferrin receptor due to the liver being a major site of 
haemlred blood cell synthesis [53, 130]. 
Although Fe(III) is the natural metal bound by transferrin, many other metal ions can 
also bind at the same specific sites [131]. In blood plasma, less than 30% of the iron 
sites in human transferrin are occupied by iron and the vacant sites could be used to 
transport other metal ions as well. 
Investigation of transferrin as a potential carrier of manganese to hepatocytes may 
therefore aid understanding of the mechanisms of uptake, action and toxicity. 
Since Mn(III) can bind transferrin, it is of interest to investigate the methods 
available for loading the protein and how this may effect the biological and chemical 
characteristics of the protein such as alteration to the binding site and/or protein 
conformation. More specifically, successful crystallisation of the protein with iron 
and manganese bound will allow direct comparisons between the two metal forms. 
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1.7 Aims of Thesis 
To develop an efficient method of loading human serum transferrin with 
manganese with possible use of Mn(II) and the serum oxidant caeruloplasmin, or 
Mn(VII). 
This may then help us to understand the possible mechanism(s) used by the 
body to transport manganese from ingestion to cells. 
To investigate the reaction of apo-transferrin with potassium permanganate, 
including studies of the possible oxidation of the protein and of insertion using 
labelled transferrin and NMR techniques. 
Potassium permanganate is a well known oxidant so any reaction with the 
protein could lead to oxidation of the protein and possibly altered protein 
conformation. 
To grow crystals of transferrin with iron and manganese bound to one or both 
lobes. 
If this can be achieved then a direct comparison can be made between the two 
different loaded proteins in terms of protein conformation and metal binding site. 
This may then provide further information on the behaviour of transferrin when 
metals other than iron are loaded with respect to receptor binding. 
To determine whether the highly efficient transferrin endocytosis pathway 
can be exploited for the targeted delivery of manganese to hepatocytes. 
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This could then lead onto further work as to what signalling systems are 
affected and if MnSOD can be up-regulated when a cell is experiencing oxidative 
stress. 
V) 	To investigate if manganese transferrin has an effect on the mitochondria of 
hepatocytes. 
As most of hepatocytes' manganese content is found in the mitochondria any 
excess manganese transported to the cell is likely to take effect here. Primarily it 
needs to be established if excess manganese alters mitochondrial function in terms of 
alteration of the transmembrane potential. 
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Chapter 2 Experimental Techniques 
In this Chapter, some specific techniques used in this study are briefly described. 
2.1 Source of Chemicals 
2.1.1 Reagents 
Some common reagents used in this work and their sources are shown in Table 2.1. 
Other reagents and their sources are listed in the text. 
2.1.2 Transferrin 
All transferrins used in this work were from human serum and were of a high grade. 
Holo-transferrin was obtained from Sigma, catalogue number T-4778, lot 131-19315. 
Apo-transferrin catalogue number T-4382, lot 50K7608. 
For cell studies, the highest quality of apo-transferrin suitable for cell culture was 
purchased, catalogue number T1147, lot 101K024825. This was then used to 
produce Mn2-hTf and Fe2-hTf. 
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Table 2.1 Reagents and sources 
Reagent Source 
Apo- and holo- transferrin, human serum Sigma 
MnCl2 .4H20 Sigma 
Sodium bicarbonate Aldrich 
Hepes Buffer (USP grade, powder) Sigma 
KMn04 (USP grade) Sigma 
Caeruloplasmin, human serum ICN Biomedical 
Tris-Borate EDTA buffer (x 10) Bio-Rad 
Amido Black lOB Acros 
Sodium cacodylate buffer Sigma 




Methionine sulfoxide Sigma 
Methionine sulfone Fluka 
mC1CCP Sigma 
Dulbeccos modified eagles medium DMEM Invitrogen 
Tryspin/EDTA (liquid, xl) Sigma 
DMSO Sigma 
2.1.3 Water Purification 
All water used in this work was purified using a Millipore Elix 5 system, followed by 
an Elgastat UHQ PS deioniser to give 18.2 MQ-cm at 298 K. The purified water 
obtained by this procedure is referred to herein as ultrapure water. 
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2.2 UV-Vis Spectroscopy 
Determination of the concentration of an aqueous sample of a protein is most simply 
done by measuring its absorbance in the near-ultraviolet region. However, this 
requires a prior knowledge of the protein's specific extinction coefficient at a given 
wavelength. 
The near UV (250-350 nm) absorbance spectrum of a protein is almost entirely 
generated from its aromatic amino acid residues. These include tryptophan (280 
5559 M'cm'), tyrosine (E280 1197 M 1 cm 1 ) and phenylalanine (6280 0.7 M"cm', 6257 
Ca. 195 M'cm) [1], with a small contribution from disulfide bonds. This results in 
a unique UV spectrum for each protein due to its particular aromatic acid content. 
Protein concentrations can then be calculated using the spectral absorbance at 280 
nm by the Beer Lambert law: 
A280 = c1 
Where c is the protein concentration (M), F. is the molar extinction coefficient of the 
protein (M"cm') at 280 nm and 1 is the path length (cm). 
For a protein with a known amino acid sequence, c can be calculated using the 
numbers of Trp (NT ?), Tyr (NTyr) and disulfide bonds (Nss) [2]: 
8280 = 5540NTrp + 148ONiyr + 134N55 
As well as absorption in the UV region, many metalloproteins show d-d transitions 
from the metal centre and charge-transfer absorption in the visible region. Most of 
the charge-transfer transitions involve a metal ion which acts as an electron acceptor 
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and side chains from the protein which act as electron donors. This can be seen in 
Fe2-transferrin which shows a ligand-to-metal-charge-transfer (LCMT) band at Ca. 
465 nm. This is from the charge transfer from Tyr to Fe(III) [3]. LMCT bands of 
transferrin vary depending on the metal bound hence, this provides a convenient and 
effective way for determining metal binding and release from the protein. 
UV-Vis spectra were recorded on a Shimadzu UV-2501PC UV/Vis 
spectrophotometer using 1 cm path length quartz cuvettes. The measurements were 
made at ambient temperature (unless described otherwise when the temperature was 
controlled using a Linkam Peltier stage controller PE60). 
2.3 ICP-AES 
Inductively coupled plasma atomic emission spectroscopy (ICP-AES) is a 
spectroscopic method used for quantitative and qualitative elemental analysis. A 
more detailed description of the theory of ICP-AES can be found in a number of 
textbooks [4-6]. 
ICP-AES was used for determination of metal concentration. A Thermal Jarrell Ash 
IRIS spectrometer equipped with a concentric Meinhard nebulizer and a CID camera 
detector was used. Aqueous samples were introduced into a cyclonic spray chamber 
by a peristaltic pump. The R.F. power was 1150 watts, the nebulizer flow was 30 
psi, the pump rate was 100 rpm and the purge time was 90 s. Iron, manganese, 
copper and zinc atomic absorption standard solutions (Aldrich and BDH 
Laboratories) at ca. 1000 ppm were diluted and used to calibrate the ICP-AES 
spectrophotometer. All samples were diluted with ultrapure water and metal content 
measured without further digestion. All data were interpreted using therniospec/CID 
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IRIS software. 
2.3.1 Emission Properties 
The elements studied in this thesis and their emission properties are given in Table 
2.2. The emission intensity at a characteristic wavelength of an element is 
proportional to the concentration of the element in the sample. 
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Table 2.2 Emission properties of metals used 
Sensitivity 
Element Emission Wavelength/) (nm) Relative Intensity 
(ppb) 









Copper 0.9 224.700 115 
324.754* 80 
327.396 79 







' Emission wavelengths used 
2.4 Gel Electrophoresis 
Polyacrylamide-gel electrophoresis was carried out in 6 M urea, as described by 
Makey and Seal [7]. 
Gels were either purchased or prepared from reagents obtained from Bio-rad (Bio- 
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Rad, Hemel Hempstead UK) and run using a Bio-rad Mini Protean IT system with a 
Bio-rad Powerpac 200 according to the manufacturer's instructions. Where cast by 
hand, 6 M urea polyacrylarnide gels were prepared using clean glass plates and 
10-well tooth combs. No stacking gel was used. Samples were diluted with 
ultrapure water and loaded into the gel either with Laemmeli sample buffer (Sigma) 
to aid visualisation of progression down the gel or with glycerol to help the sample 
sink to the bottom of the well of the gel. 
Electrophoresis was carried out at 100 V for 5-7 hours and run in lx Tris-Borate 
EDTA (TBE) buffer (Bio-rad) (pH 8.4). The electrophoresis apparatus was 
disassembled and the plates separated. The gel was removed from the glass plates 
and a corner of the gel marked uniquely for future orientation. The protein in the gel 
was stained for 5 min in 1% amido black 1 OB in a solvent of methanol/water/acetic 
acid (4:4:1) followed by de-staining in the same solvent with glycerol added to the 
final dc-stain in order to help maintain gel integrity. 
2.5 Nuclear Magnetic Resonance Spectroscopy 
Nuclear magnetic resonance (NMR) spectroscopy is a very powerful tool that can be 
used to study the structure and dynamics of a molecule. The physical basis of NMR 
spectroscopy is nuclear magnetisation. A number of textbooks have been published 
describing the theory and applications of NMR spectroscopy [8-10]. NMR signals 
can be detected with relative ease for many magnetic nuclei and most elements have 
at least one naturally occurring magnetic isotope. The magnetic properties of the 
nuclei used in this thesis are given in Table 2.3. 
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Table 2.3 Selected NMR properties of nuclei used in this study 
Nuclear Natural Frequency (MHz) at Relative 
Nucleus + 
Spin Abundance (%) 11.74 T Sensitivity 
1 H V2 99.985 500.0 1.000 
"c V2 1.108 125.7 0.016 
versus 1 H at constant field 
NMR spectra for biomolecules are normally recorded in aqueous media such as 
100% D20 or H20/D20 (90%I10% vlv) and referenced to a known standard. The 
large H20 signal often has to be suppressed for the NMR spectrum to be interpreted. 
NMR data interpretation was by multipulse sequences such as Shaka [11] or 
presaturatlon. 
2.5.1 Two-Dimensional NMR (2D NMR) 
2D NMR can often provide much more information about a sample compared with 
1D NMR. By use of a suitable pulse sequence and processing a 2D plot can be 
obtained. This is seen as a contour map with two axes, one of which is the 
conventional 1D axis. Shift-correlated 2D spectra allow the establishment of which 
nuclei are coupled, either through bonds, through space or even by chemical 
exchange processes. The coupling can be either homonuclear or heteronuclear. 
Heteronuclear single quantum correlation (HSQC) is a useful technique used to study 
proteins labelled with ' 3C or ' 5N. It is possible to run samples at very low 
concentrations. 
NMR data were acquired on a Bruker DMX500 spectrometer using 5 mm tubes 
operating at 500.13 MHz for 'H and 125.66 MHz for 13 C. Standard Bruker pulse 
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sequences were used for ID 'H and ' 3C and 2D ['H, ' 3C] HSQC experiments. 
Typically data were recorded using 10 or 20 mM solutions for 1D 'H NMR and 100 
mM solutions for 1D ' 3 C at 298 K and Ca. 0.3 mM solutions at 310 K for 2D NMR. 
All solutions used for NMR were made up in 100% D 20 (actual 99.9 atom % D, 
herein referred to as 100%). The 'H and 13C  chemical shifts for 1D spectra were 
internally referenced to sodium 3-trimethylsilylpropionic acid (TSP, 0 ppm). For 2D 
spectra 'H and 13C chemical shifts were referenced to TSP (external). The water 
signal was suppressed using excitation sculpting [11]. Data were converted to 
XWinNMR (Version 2.0, Bruker U.K., Ltd.) prior to Fourier transform. 
2.6 Electron Paramagnetic Resonance 
Electron paramagnetic resonance (EPR) spectroscopy, also known as electron spin 
resonance, can be used to investigate paramagnetic molecules. 
An X-band (ca. 9.25 GHz) Bruker ER200D-SRC electron spin resonance 
spectrometer was used with flat cells made of high purity fused quartz to minimise 
the absorption of microwave radiation by aqueous solutions. 
Mn(II) commonly has a high-spin d 5 electron configuration with five unpaired 
electrons giving rise to a S = 5/2 ground state. This often produces a well resolved 6-
line EPR spectra at ambient temperature due to a hyperfine interaction with 55  M (I = 
5/2). 
Mn(III) commonly has a high-spin d 4 electron configuration with four unpaired 
electrons resulting in a spin ground state of S2. Mn(III) complexes often display 
large zero-field splitting due to the low symmetry as a result of Jahn-Teller 
distortions of octahedral geometry. This, plus unfavourable (fast) spin relaxation 
Chapter 2: Experimental Techniques 
effects, makes the observation of EPR spectra at conventional microwave 
frequencies (X-band: 9 GHz; Q band: -35 GHz) of S = 2 systems relatively rare. 
2.7 pH Measurements 
All pH measurements were made using either a Corning 240 pH meter or a Corning 
145 pH meter, equipped with an Aldrich glass/calomel combination p1-I electrode and 
calibrated with reference standard pH buffer solutions of 4.00, 7.00 and 10.00, 
purchased from either Sigma Chemical Company or Aldrich Chemical Company. 
Adjustments of pH were made using HCI or NaOH. 
The pH-meter readings for D 20 solutions are recorded as pH values, i.e. uncorrected 
for the effects of deuterium on the glass electrodes. Adjustments of pH for samples 
in D20 were made with DC! or NaOD. 
2.8 Ultrafiltration 
All protein samples were ultrafiltered using Amicon Centricon®  centrifugal filter 
tubes (Millipore) that have a regenerated cellulose membrane with a 30 kDa 
molecular weight cut off. These were then centrifuged using a Beckman GS-15R 
centrifuge with temperature control. All tubes were thoroughly washed by 
centrifugation of ultrapure water prior to their use to remove any trace impurities 
from the membrane. The hydrophilic membranes allow low molecular weight 
solutes and solvents to pass through while retaining the high molecular weight 
protein above the membrane. The centricon tubes can then be inverted to collect the 
sample for further use. 
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2.9 Crystallisation of Transferrin 
The most successful method to induce protein crystal formation is to force the 
protein out of a supersaturated solution. The rate with which the protein precipitates 
out of solution determines whether suitable crystals will form. The hanging drop 
vapour diffusion method was used to crystallise apo-hTf, Fe-hTf and Mn-hTf (more 
detail is given in Chapter 4). Purified, concentrated protein samples (ca. 1 mM, 5 j.il) 
and precipitant well solution (5 p1) (20-26% PEG 400, 100 mM Na cacodylate 
buffer, pH 5.4 - 5.6) were placed on a siliconised cover-slip (Molecular Dimensions 
Ltd.) which was then placed upside down over a vacuum grease coated well lip (24 
flat bottomed multiwell plates, ICN Biomedicals) in a dropwise fashion. The 
droplets were incubated against 995 p1 of the precipitant solution in the well at 277 
IRFAI 
2.9.1 Screening Technique 
By carrying out the crystallisation in 24 well plates, the screening technique could be 
utilised to establish specific growth conditions which may give rise to optimum 
crystal growth. Each well solution can be made up of differing ingredients and the 
plate left and observations taken of crystal growth or other activity, such as 
precipitation or aggregation. This can then help in future crystallisation and is also a 
useful tool for crystallising novel compounds. More details of the screening 
technique and conditions used can be found in Chapter 4. 
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2.9.2 Seeding Technique 
If crystals do appear as a result of one of the above techniques but are not of the 
highest quality further steps can be taken on these pre-formed crystals in order to 
achieve better resolution. This involves seeding from a previously grown crystal 
(more detail is given in Chapter 4). Briefly, plates are set up using the same 
conditions in the well solution as found in the well of the sample which produced 
crystals. However, differing protein concentrations may be used in the drop. The 
crystals of low quality are then stroked with a cat's whisker and the new drop is 
streaked with the whisker. 
2.10 Cell Culture 
2.10.1 Standard Culture Conditions 
WRL-68 cells were cultured in DMEM (Dulbecco's modified eagles medium) 
supplemented with 10% NCS (newborn calf serum), Penicillin and streptomycin and 
x 1 concentrate NEAA (Non-essential amino acids). Cells were grown in 20 cm 2 , 80 
cm  or 175 cm  tissue culture grade flasks, 24 or 96 well tissue culture plates or 4 
well chamber slides at 37°C, in 5% CO 2 in an incubator. Cells were supplemented 
with fresh medium every 2-3 days or as required by monitoring the colour indicator 
(phenol red) in the medium, with a yellow colour indicating supplementation was 
necessary. Once the cells grown in flasks became confluent they were harvested 
using trypsin/EDTA and PBS. The cell suspension was centrifuged at 1000 rpm for 
10 minutes in a MSE Mistral 1000 centrifuge until a pellet was formed. The 
supernatant was removed and the pellet of cells resuspended in medium and used as 
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required. 
2.10.2 Cell Viability Counts: Trypan Blue Exclusion 
Trypan blue is used to estimate the proportion of viable cells in a population. The 
reactivity of the stain is based on the fact that the chromophore is negatively charged 
and does not react with the cell unless the membrane is damaged [12]. Live (viable) 
cells do not take up the dye and only dead (non-viable) cells do. 
To estimate the concentration of viable cells or total cell numbers in cultures, 200 p1 
of a well-mixed sample of cultured cells, 300 jtl PBS and 500 p1 of 0.4% trypan blue 
(Sigma) solution were mixed and left at room temperature for a 2-3 minutes. The 
cell suspension was transferred to a haemocytometer, viewed using an Olympus 
inverted phase-contrast light microscope and the number of dead (blue) and live 
(colourless) cells were counted within the 4 x 4 square grid. Counting was made 
using 10 square grids in total. These cell counts were used to estimate the 
concentration of cells to be used further or number of live cells (viability) according 
to the following equations: 
cells/ml = average cell count x 5 (dilution factor) x lx 1 0 (haemocytometer chamber 
factor) 
cell viability (%) = (total viable/total viable and nonviable) x 100 
2.10.3 MTT Assay 
MTT (3 -(4,5 -dimethylthiazol-2-yl)-2 , 5 -diphenyl tetrazolium bromide) is a water- 
11  It 
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soluble tetrazolium salt that gives a yellow solution when prepared in phenol red free 
media or salt solutions. The MTT assay depends upon the reduction of the 
exogenous yellow MTT tetrazolium salt (Sigma) to a purple formazan by 
mitochondrial succinate dehydrogenase in living cells [13, 14]. This water-insoluble 
formazan can then be solubilised using organic solvents such as DMSO. The 
resulting purple solution is measured spectrophotometrically to give absorbance as a 
function of concentration of converted dye. 
Cells used for the MTT assay were cultured on 24- or 96- well plates and incubated 
with MTT made up in PBS at a final concentration of 1 mg/ml in the medium at 310 
K for 3 hours. Cells were then washed twice with PBS after removal of 
mediumlMTT and left to dry completely. DMSO was added to dissolve the 
formazen dye and the absorbance was read at 490 nm by a MR 5000 Dynatech plate 
reader. Where cells were grown on 24-well plates, DMSO was added and 100 il 
was transferred to a 96-well plate and the absorbance was read. 
2.10.4 Evaluation of Apoptosis and Mitosis 
Apoptosis and mitosis were assessed morphologically by Feulgan staining of DNA. 
Cells used were cultured on 96-well plates and 4-well chamber slides. After removal 
of culture medium, plates and slides were fixed and stored in Bouin's fixative (85% 
methanol, 4% formaldehyde, 5% glacial acetic acid) at 277 K. When required, plates 
and slides were allowed to thaw and were denatured in 5 M HC1 for 45 minutes at 
room temperature. Slides were then stained in Schiffs reagent (Sigma, see 
Appendix B, diluted in water) for 1 hour at room temperature. Schiff s reagent was 
removed by washing three times in water and then held under running tap water for 5 
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minutes until a pink colour developed. The cell cytoplasm was then counterstained 
with 1% Light Green stain. Slides were cover-slipped using mowiol as a mountant 
(see Appendix C). Mowiol 4-88 is a high quality mounting medium with good anti-
fade characteristics. It hardens to match the refraction index of immersion oil and so 
is particularly suitable when using high magnification. Additional anti-fade 
(DABCO) is added to reduce photo-bleaching further. Apoptotic cells are 
recognisable by their distinct morphology, including condensed and fragmented 
DNA which is stained pink by the Schiff's reagent. Mitotic cells can easily be seen 
by their stained chromatin and alignment prior to cell division. Cells were then 
counted and percentage of apoptotic and mitotic cells determined. 
2.10.5 Induced Mitochondrial Depolarisation 
To induce mitochondrial depolarisation, cells were seeded at Ca. 4 x 104  cells/ml onto 
4-well chamber slides and left overnight in medium. Mesoxalonitrile 3-
chloropheny1hydrazone (mC1CCP) was then added to the medium at a concentration 
of 30, 40 and 50 mM simultaneously with chlorornethyl-X-Rosamine (CMX Ros, 
Molecular Probes) to give a concentration of 100 nM (see below, 2.10.6) and 
incubated in the dark at 310 K for 45 minutes. From this stage onwards cells were 
protected from light. The medium was then aspirated and the cells washed twice 
with PBS. Slides were then fixed in 4% paraformaldehyde for 10 minutes and 
washed again in PBS and allowed to dry before being cover-slipped using mowiol as 
a mountant. Cells were then assessed morphologically - see below (section 2.10.6). 
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2.10.6 Assessment of Mitochondrial Depolarisation 
Cells to be assessed for mitochondrial depolarisation were cultured on 4-well 
chamber slides. Where possible the procedure was carried out in minimum light to 
prevent fading of the dye. CMX was added to the medium to give a concentration of 
100 nM and slides were incubated in the dark at 310 K for 45 minutes. From this 
stage onwards cells were protected from light. Following incubation the medium and 
CMX was aspirated off and cells were washed with PBS. Cells were then fixed for 
10 minutes in 4% paraformaldehyde which was then removed and the slides were 
allowed to dry before cover-slipping using mowiol. Slides were then viewed using a 
Leica upright TCS-NT confocal microscope with the kind help of Linda Wilson 
(Pathology Department, University of Edinburgh). CMX Ros dye is a mitochondria-
selective dye that is sequestered by intact mitochondria but not a de-energised 
organelle [15]. The dye remains in the organelle following fixing and has been used 
to study mitochondrial membrane permeability transitions in rodent hepatocytes [16]. 
CMX is linked with a rhodamine fluorescent dye which appears as a red stain under 
green light. It is a charge-sensitive fluorochrome that binds to the inner 
mitochondrial membrane. The fluorescence decreases due to apoptotic-mediated 
loss of mitochondrial transmembrane potential. Cells can then be assessed 
morphologically for mitochondrial depolarisation. 
2.10.7 Analysis of Cellular Metal Content 
Using ICP-AES, Mn can be detected at levels as low as 0.01 ppm. For analysis 5 ml 
of sample was required. Preliminary studies were carried out on untreated cells in 
order to determine the number of cells required to give an accurate reading of metal 
Chapter 2: Experimental Techniques 
content using ICP-AES. 
Cells were typically cultured at an initial concentration of Ca. 106  cells/mi in large 
flasks until confluent. Medium that had been removed during cell growth was 
retained for metal analysis. All cells analysed in parallel were cultured in the same 
batch of supplemented DMEM medium. When the cultures were set up, samples of 
the medium used to culture the cells were taken for analysis to ensure that the media 
had uniform concentrations of the metals analysed. Samples of trypsin-EDTA were 
also analysed for metal content. 
Cells to be analysed were removed from the flasks using trypsin-EDTA and PBS. 
The cell suspension was transferred to sterile universal tubes (Rosslabs, Cheshire 
UK) and pelleted at 1000 rpm for 10 minutes. The supernatant was removed and the 
pellet was resuspended and counted for viability and total cell number as previously 
described in section 2.10.2. The cell suspension was then centrifuged again. The 
remaining pellet was then frozen and kept at 253 K until needed. The pellet was 
removed from the freezer and a known volume of ultrapure water added to ensure 
rupture of the cells. The cells and medium were then analysed for metal content 
using ICP-AES (section 2.3). 
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Chapter 3 Manganese Binding by Transferrin and Its 
Characterisation 
3.1 Introduction 
Manganese is an essential trace element however, the mechanisms involved in 
manganese transport are poorly understood [1]. 
As described in Section 1.3.2, transferrin is an 80 kDa protein found in blood serum 
at concentrations of Ca. 35 l.IM and transports iron [2]. It has two Fe(III) binding 
sites, one in the C-lobe and one in the N-lobe, each providing an approximately 
octahedral co-ordination from His, Asp, two Tyr and a bidentate carbonate anion as 
ligands. The major receptor recognition sites of transferrin are on the C-lobe, 
supported by the recent X-ray crystal structure of the human transferrin receptor [3-
7]. Initially, Fe(III) binds to apo-transferrin and induces a major conformational 
change of the protein from a lobe-opened to lobe-closed form [8-10]. Then the iron-
saturated holo-transferrin binds to the specific transferrin receptors on the cell 
surface and is internalised by clathrin-coated vesicles into endosomes where the 
acidic pH (pH ca 5.0-5.5) leads to the release of Fe(III) from transferrin [11, 12]. 
Serum transferrin is only 30% saturated with iron in blood. Previous work in this 
laboratory has shown that metals other than iron such as Bi 3 , Cu2 and Gd3 can 
bind strongly to transferrin [13-16]. Therefore, if other metals are able to bind to 
transferrin, could manganese be loaded onto the protein and be transported to sites 
where it may be useful against oxidative stress in the form of Mn SOD and so act as a 
carrier mechanism for manganese? 
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Electronic absorption spectroscopy is often used to study metal binding to the 
specific iron sites of transferrins. The apo form of the protein is colourless with an 
intense ultraviolet absorption near 280 nm which is used to determine the 
concentration of the protein. When metals are bound to transferrin the resulting 
complexes often have colour, for example when Fe 3+  is bound to the protein a 
characteristic red/orange colour develops. The complexation of metal ions to the 
phenolic groups of two tyrosine residues at each of the two transferrin specific metal-
binding sites perturbs the electronic transitions in the phenolic ring system, causing 
small shifts in the ultraviolet spectrum of the protein [17]. This allows the uptake of 
metals to be followed by UV/Vis spectroscopy. For some metal ions intense 
tyrosine-to-metal charge-transfer bands can be seen in the visible region of the 
spectrum (400 nm to 500 nm). The Mn(III)-HCO 3 -Tf complex has been reasonably 
well characterised by UV-Vis spectroscopy [18, 19]. 
When complexed with transferrin, Mn is expected to be present in the +3 oxidation 
state, with two metal ions tightly bound to each transferrin [19]. Since the 
characteristic deep brown colour of Mn(III)-Tf develops much slower under 
anaerobic conditions [19] this suggests that carbonate from the air is required for 
faster loading of Mn onto transferrin. Harris and Chen [20] have shown that air 
oxidation of Mn(II) in the presence of apo-hTf at pH 7.4 is a very slow process, 
however, oxidation of Mn(II) in serum is considerably faster [21-23]. Hence, the 
loading of Mn onto transferrin is most probably a redox process which is likely to 
involve participation from a serum oxidant to oxidise Mn(II) to Mn(III). 
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3.1.1 Caeruloplasmin 
Caeruloplasmin is a plasma protein known for its oxidising activity. It is a multi-
copper oxidase which contains most of the copper present in the plasma [24]. The 
precise physiological role of this enzyme is still as yet largely unknown but it is 
thought to have a multi-functional role including oxidising activity, and possibly as a 
pool for copper. It has been suggested that caeruloplasmin has a distinct active site 
for glutathione-linked peroxidase activity as well as the copper giving it its 
ferroxidase activity [25]. Anion binding studies have supported the theory of 
caeruloplasmin having multifunctional oxidase activity [26]. Caeruloplasmin may be 
the oxidising enzyme responsible for the loading of hTf with Mn(III) in serum. 
However, Critchfield and Keen [23] found that caeruloplasmin deficient plasma from 
rats that had been restricted with regard to dietary copper and exposed to a copper 
chelator showed no impairment of the kinetics of 54Mn appearance in hTf suggesting 
that caeruloplasmin plays no role in the loading of Mn onto hTf. 
An alternative route to using caeruloplasmin to oxidise Mn(II) to Mn(III) for binding 
to transferrin was employed in this study. This involved using potassium 
permanganate as a source of manganese and thus reducing Mn(VII) to Mn(III) for 
binding to transferrin. 
3.1.2 Potassium Permanganate 
The highest oxidation state of manganese corresponds to the total number of 3d and 
4s electrons and occurs only in the oxo compounds Mn0 4 , Mn207 and Mn0 3 F. The 
best known Mn(VII) compounds are sodium and potassium permanganates which are 
made industrially on a large scale by electrolytic oxidation of basic solutions of 
72 
Chapter 3. Manganese Binding by Transferrin and Its Characterisation 
Mn042 . 
Potassium permanganate is known for its characteristic intense purple colour. This is 
a result of the absorption corresponding to the charge-transfer between 02.  and 
Mn(VII) in the visible region of the spectrum. 
Potassium permanganate is used in the water industry primarily to control taste, 
odours and biological growth in treatment plants as an alternative to chlorine. 
Manganese (VII) is a powerful oxidising agent which is often reduced in reactions to 
Mn(II). Mn(V) species are thought to be intermediates in the reduction of 
permanganates. For the purposes of this study it is hoped that the reduction of 
Mn(VII) will result in the production of Mn(III) that will then bind to transferrin. 
However, whilst Mn(VII) is being reduced some other species must be oxidised. 
3.1.2.1 Oxidation of Amino Acids 
Pandey et al [27] suggest that oxidation of some amino acids in acidic conditions by 
Mn04 proceeds with oxidative decarboxylation and deamination. They suggest that 
five molecules of substrate require two molecules of permanganate for complete 
oxidation of each of the amino acids. The overall reaction proposed for their 
experiments is shown in Equation 3.1. 
5R.C1-TNH2.000H + 2Mn04 + 6H - 	5RCHO + 3fl20 + 2Mn
2 ± 5CO2 + 5NH3 
Equation 3.1 Oxidation of amino acids 
Brillas et al [28] carried out kinetic studies using UV/Vis spectroscopy on the 
oxidation of L-leucine by permanganate in neutral solutions. At the end of each 
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experiment the solutions were transparent but yellow/brown in colour. The spectra 
suggested the presence of a soluble form of colloidal manganese dioxide which 
gradually precipitated out of solution as brown manganese dioxide. 
Sahu et a! [29] suggest that the addition of Mn(II) in a sulphuric acid medium to a 
reaction catalyses oxidation of L-amino acids by permanganate and does so by two 
possible mechanisms: either Mn(IJ) forms a complex with amino acids which may 
then be oxidised by permanganate or initially Mn(II) may react with Mn(VII) to give 
Mn(III) which may accelerate the rate of the reaction. Under similar conditions, 
however, Mn(III) does not oxidise the amino acids directly hence the catalytic effect 
of Mn(II) may be due to complex formation between Mn(II) and substrate. 
Although Mn(III) has been reported to bind to transferrin [19], there has been little 
direct structural characterisation of the bound Mn ion. Since aquated Mn(III) ions 
are unstable in aqueous solution Mn(III) transferrins are difficult to prepare by 
methods usually available for other metal ions. 
In this chapter, routes for introduction of Mn(III) via oxidation of weakly bound 
Mn(II) were employed with the addition of a serum oxidant. As an alternative the 
strong oxidant potassium permanganate was also used to load transferrin by reducing 
Mn(VII) to Mn(III). UV/Vis spectroscopy was used to follow reactions between 
transferrins and metals. The effects of the use of KMn0 4 were also investigated by 
use of NMR techniques. In order to assess whether Mn(III) could dissociate from 
transferrin in a manner similar to that seen with iron in the endosomes, pH studies 
were conducted. Attempts were also made into investigating the order of lobe 
loading of metals onto transferrin. 
Chapter 3: Manganese Binding by Transferrin  and Its Characterisation 
3.2 Materials and Methods 
3.2.1 Purification and Characterisation ofApo-hTf 
Iron-free human apo-hTf was purchased from Sigma and weighed into a sample vial. 
It was then fully dissolved in 0.1 M KC1 and transferred to a 'Centricori 30' 
ultrafilter and washed three times using 0.1 M KC1 to remove low molecular weight 
impurities. The centricon tube was then inverted and the purified apo-hTf collected 
for further use. Concentrations of apo-hTf and other hTfs were determined by 
UV/Vis spectroscopy using E280  93, 000 M
1 cm 1 [30]. 
Iron was removed from recombinant (non-glycosylated) -[' 3C]Met-hTf (kindly 
supplied by Professor R. C. Woodworth and Dr. A. B. Mason, University of 
Vermont) [31] by treatment with NTA and EDTA (both 1 mM) in 0.5 M sodium 
acetate at pH 4.9 as previously described [32, 33] and centrifuged in 'Centricon 30' 
tubes until a colourless solution was obtained and the resulting solution was then 
concentrated down in the 'Centricon' tubes. The concentration of the apo-protein 
was then determined using UV/Vis spectroscopy as mentioned above. 
3.2.2 Preparation of Mn-h Tf 
Mn-hTf was prepared by the addition of one or two molar equivalents of Mn to apo-
hTf. Initially this was done by addition of 100 mM Mn(II) chloride solution to a 
solution of purified apo-hTf in 20 mM Hepes buffer, pH 7.4 with the addition of 10 
mM bicarbonate. Preliminary studies involved daily oxidation of the solution using 
02(g) from a standard cylinder: oxygen was allowed to blow over the surface of the 
solution (direct bubbling would result in the solution foaming) for approximately 10 
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minutes daily for up to two weeks. The solution was kept at 310 K until the solution 
was brown in colour. Mn-hTf was washed using centricon tubes with 0.1 M KC1 and 
concentrated down and then collected as described previously for purification of apo-
hTf in section 3.2.1. Once Mn-hTf had been prepared its concentration was 
determined by UV/Vis and ICP-AES. 
3.2.2.1 Addition of an Oxidant 
Human caeruloplasmin was added to the reaction of apo-hTf, bicarbonate and MnCl 2 
to act as an oxidant. The caeruloplasmin was made up into buffer at 1 mg/ml 
(Appendix A) and frozen in aliquots, each of known oxidant activity, and defrosted 
as required. Units of activity of caeruloplasmin are determined by the oxidation ofp-
phenylenediamine [34] and were given with receipt of the protein from the supplier. 
The solution of Hepes buffer containing apo-hTf, bicarbonate, MnC1 2 and 
caeruloplasmin was kept at 310 K until it was brown in colour. 
Potassium permanganate, a well known oxidant, was used as a source of Mn. Molar 
equivalents were added to a solution Hepes buffer containing apo-hTf and 
bicarbonate and the solution was kept at 310 K until brown in colour. 
3.2.3 Preparation ofFe-hTf 
Fe2-hTf was prepared by the addition of Fe(NTA)2 to holo-transferrin that had been 
purchased from Sigma, to ensure full saturation with Fe(III). A solution of 
[Fe(NTA)2] 3  was prepared from the iron atomic absorption standard solution and 2 
mol euiv of H 3NTA. The pH was slowly raised to 5.5 with microlitre amounts of 
NaOH (1 M). This solution was then diluted to 4 mM. Holo-transferrin was 
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weighed and transferred to a 'Centricon' tube and washed using 0.1 M KC1 as 
described earlier for apo-transferrin in Section 3.2.1. Two molar equivalents 
Fe(NTA)2 were then reacted with holo-hTf in Hepes buffer, pH 7.4 with the addition 
of 10 mM bicarbonate. The solution was kept at 310 K for Ca. i hour. Fe 1 -hTf was 
prepared by the addition of one mol equivalent Fe(NTA)2 to a solution of apo-hTf in 
Hepes buffer, pH 7.4 with 10 mM bicarbonate at 310 K. 
The reaction of apo-hTf with Fe(NTA)2 over a range of pH 6 - 8.5 results in the 
preferential binding of Fe(III) to the C-lobe of transferrin [2, 35]. Fec-hTf was 
prepared by reacting one mole equivalent Fe(NTA) 2 with apo-hTf that had been 
purified as described earlier in Section 3.2.1 in 20 mM Hepes buffer, pH 7.4 with 10 
mM bicarbonate at 310 K. 
The Fe-hTfs were washed using centricon tubes and 0.1 KC1 as previously 
mentioned. UV/Vis spectroscopy and ICP-AES was then carried out to establish 
concentrations of protein and metals. 
3.2.4 UV/Vis Spectroscopy 
Solutions were prepared by dilution with 20 mM Hepes buffer (pH 7.4). liv 
difference spectra after addition of MnC1 2, KMn04 or Fe(NTA)2 to apo-hTf, Mn-hTf 
or Fe-hTf were recorded immediately and at regular time intervals. For titration 
experiments aliquots of Mn were added and the solution was left to equilibrate at 310 
K for 3Omin. 
For pH experiments, the pH of a solution containing Mn-hTf in 20 mM Hepes buffer 
was lowered using 1 M HCI. Readings of pH were taken immediately and following 
30 min equilibrium time at 310 K when UV/Vis spectra were recorded. 
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The binding or release of Mn(III) was monitored by the increase or decrease in 
absorbance at 430 nm. The binding or release of Fe(III) was monitored by the 
increase or decrease in absorbance at 465 nm. 
Solutions of ca. 20 mM Hepes buffer, TRIS buffer and phosphate buffer were each 
reacted with molar equivalents of K1V1n0 4 and the reactions followed 
spectrophotometrically. 
All UV/Vis experiments were performed in 1 cm quartz cuvettes on a computer 
controlled Shimadzu UV- 1000 spectrometer with temperature control at 310 K using 
a Linkarn Peltier stage controller PE60 (except where stated otherwise). 
3.2.5 Gel Electrophoresis 
Gels were purchased or cast and run as described in Section 2.4. Protein in the form 
of apo-hTf, Fe-hTf and Mn-hTf was loaded at concentrations typically ranging from 
1-100 1.iM. Electrophoresis was then carried out at 100 V for 5-7 hours in TBE tank 
buffer (ph 8.4) until the samples were nearing the bottom of the gel (this was 
observed by adding Laemelli sample buffer to one of the samples in an end well). 
Once gels had been stained with 1% amido black lOB and destained using 
methanol/water/acetic acid (4:4:1), images were taken by placing the gel on a flatbed 
scanner attached to a PC. Gels were then scanned and saved as picture files for 
future examination. 
3.2.6 NMR Spectroscopy 
All NMR experiments were carried out on a Bruker 500 MHz spectrometer using 5- 
mm tubes operating at 500.13 MHz for 'H and 125.66 MHz for 13C. Standard 
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Bruker pulse sequences were used for 1D ['H] and [' 3 C] and 2D ['H, ' 3C] HSQC 
experiments as described in Section 2.5. Data were converted using XWinNMR 
(version 2.0, Bruker U.K. Ltd.) prior to Fourier transform. The pH-meter readings 
for D20 solutions were recorded as pH*  values, i.e. uncorrected for the effects of 
deuterium on the glass electrode. Adjustments of pH*  for samples in D20 were made 
with DC1 or NaOD. All solutions used for NMR experiments were made up in 
99.9% DO, herein referred to as 100% D 20. 
3.2.6.1 Hepes Buffer 
'H NMR spectra of ca. 20 mM Hepes buffer in D 20 were recorded and following the 
addition of 0.2 molar equivalents of 20 mM KMflO4 in D 20 and referenced internally 
to TSP (0 ppm). 
3.2.6.2 Amino Acids 
'H NMR spectra of amino acids N-acetyl L-methionine, L-histidine, L-tyrosine, L-
tryptophan, L-methionine sulfone and L-methionine sulfoxide were carried out in 
D20 at 298 K and referenced internally to TSP (0 ppm). Solutions were made up at 
ca. 10 mM in eppendorf tubes. One molar equivalent of KMn0 4 (using microlitre 
aliquots of a 99 mM stock solution of in D 20) was added to amino acid solutions and 
spectra recorded at various time intervals. In some instances solutions were filtered 
using a syringe filter prior to spectral acquisition. 
For ' 3 C NMR, spectra were collected for N-acetyl L-methionine, L-methionine 
sulfoxide and L-methionine sulfone at 298 K. Solutions were made up at Ca. 100 
mM in 100% D20 and referenced internally to TSP (0 ppm). One molar equivalent 
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KMn04 (using microlitre aliquots of a 1.02 M stock solution of in D 20) was added to 
a solution of 100 mM N-acetyl L-methionine and filtered prior to spectral 
acquisition. The spectrum was collected over night. 
3.2.63 HSQCNMR 
A NMR sample of E-[' 3 C]Met-hTf(ca. 0.3 mM) was prepared in 0.1M KC1 in D 20, 
and pH*  values were adjusted to 7.4 ± 0.1 using NaOD or Dcl. Sodium bicarbonate 
in D20 (0.25 M) was added to give a concentration of 10 mM. After addition of 
microlitre aliquots of KMn0 4 in D20 (ca. 17 mM) to give molar equivalents, the PH* 
was readjusted using NaOD or DC1 to pH 7.4 ± 0.1 if required and the samples were 
left at 310 K for 30 minutes for equilibration. 2D [111,  ' 3 C] HSQC spectra were 
acquired at 3 10 K. 'H and 13 C chemical shifts were referenced to TSP (external). 
The water signal was suppressed using excitation sculpting [36]. Spectra were 
collected with the kind help of Dr. H-S. Park. 
3.2.7 EPR 
EPR spectra were obtained for Hepes buffer (20 mM) at ambient temperature 
following addition of 1/30 molar equivalent KMn04 (using microlitre aliquots of a 
40 mM stock solution). Spectra were acquired using flat cells in a Bruker ER200D-
SRC X-band electron spin resonance spectrometer with the help of Dr. L. J. 
Yellowlees (University of Edinburgh). Reactions were followed at 298 K and 
spectra recorded at regular time intervals. 
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3.3 Results and Discussion 
3.3.1 Uptake of Mn (III) by apo-hTf 
Uptake of Mn(III) by apo-hTf from MnC1 2 in the presence of the serum oxidant 
caeruloplasmin and from KMn0 4 were studied by UV/Vis spectroscopy and ICP-
AES. Apo-hTf gives a colourless solution with an absorbance band at 280 nm in 
UV/Vis spectra. Mn-hTf is brown in colour and shows two extra absorbance bands 
at 430 and 330 nm. 
3.3.1.1 Uptake of Mn (III) by Apo-h Tf in the Presence of Caeruloplasmin 
The uptake of Mn(III) by apo-hTf was initially studied by reacting MnC1 2 in 20 mM 
Hepes buffer with 10 mM bicarbonate. Oxygen was added on a daily basis from a 
standard cylinder and the solution turned from colourless to yellow/brown suggesting 
Mn-hTf had been formed. However, the process was slow (typically about 2 weeks) 
and UV/Vis and ICP-AES showed that uptake of Mn(III) was incomplete. In an 
effort to speed up the process and improve lobe loading, the blood serum oxidant 
caeruloplasmin was introduced. Caeruloplasmin was added to the reaction to give 4 
units of oxidase activity. When 1 mol equivalent of MnC1 2 was added to an aqueous 
solution of apo-hTf(7.6 x 10-5M)  at 310 K, two new bands emerged at 430 nm and 
330 nm which increased in intensity over time as shown in Figure 3.1. The resulting 
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Figure 3.1 UV/Vis timecourse of reaction of apo-hTf with 1 mol equivalent MnCl2 
in the presence of caeruloplasmin (100 p.1 of 1 mg/ml, Ca. 4 units of activity). Time 
intervals shown are every 12 hours. Final reading taken at 96 hours. Appearance of 
the LMCT bands at 430 and 330 nm confirms the formation of Mn-hTf and increases 
with time. Conditions: 20 mM Hepes buffer, pH 7.4, 10 mM NaHCO3, 7.6 x 10' M 
apo-hTf, 310 K. 
UV/Vis and ICP-AES confirmed that Mn had been loaded onto the protein however, 
the protein was only partially loaded with a ratio of only 0.55 Mn : 1 protein. 
Although the process was faster when compared with loading transferrin with 
manganese in the absence of caeruloplasmin, it is still quite slow. Something that 
must be considered when using this system is the loss of bicarbonate from the 
solution to air. This would result in the increase in pH of the solution, which may be 
beyond the buffering capacity of the buffer under these conditions. As Mn(III) 
favours more acidic conditions and more acidic metal ions are known to bind to 
transferrin [13, 14], it seems plausible that any increase in pH could result in 
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decreased binding of Mn to transferrin. Further, any increase in pH could also 
inhibit the oxidase activity of caeruloplasmin. 
Due to these initial experiments giving slow and incomplete loading of manganese 
onto transferrin, an alternative method was investigated; rather than starting with 
Mn(II) and oxidising it to Mn(III) a higher oxidation state of Mn was used and 
reduced to Mn(Ill). For this reason KMn0 4 was introduced as a new source of 
manganese. Potassium permanganate is a well-known oxidising agent so this may 
also aid the loading of transferrin resulting in a faster reaction time. 
3.3.1.2 Uptake of Mn (III) from KMnO 4 by Apo -hTf 
KMn04  was used in future experiments as a source of loading apo-hTf with Mn(III). 
On addition of KMn04 to a solution of apo-hTf in Hepes buffer containing 
bicarbonate the solution turned immediately from colourless to yellow/brown, 
suggesting the formation of Mn-hTf. The process was much quicker compared with 
loading using MnC12 and caeruloplasmin as shown in Figure 3.2. The resulting 
protein was stable at 277 K for several months allowing further experiments to be 
carried out. 
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Figure 3.2 UVIVis timecourse of apo-hTf and one mol equivalent KMn04. Time 
intervals are initial reading and then every 30 minutes, final reading after 120 
minutes. Appearance of the LMCT bands at 430 and 330 nm confirms the formation 
of Mn-hTf. The reaction is complete after 60 mm. Conditions: 20 mM Hepes 
buffer, pH 7.4, 10 mMNaHCO3, 310K, 7.5 x 10 5 M apo-hTf. 
The spectrum clearly shows that the reaction is very rapid, being complete by 60 
minutes. Traces taken after 60 minutes are overlapped with that taken at 60 minutes 
so are not visible. There was no further change in the spectrum over a period of 24 
hours. As well as being a much quicker reaction, ICP-AES analysis of the protein 
formed confirmed improved loading with 0.77 Mn: 1 protein, suggesting that maybe 
both lobes are loaded when two or more molar equivalents of Mn are provided by 
this method. To study this, molar equivalents of KMn04 were added to apo-hTf and 
the reaction followed again by UV/Vis. A plot of AA430 against molar ratio (r) of 
KMn04 to apo-hTf is shown in Figure 3.3. It can be seen that with the increase of r, 
the band at 430 nm increases in intensity. 
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Figure 3.3 Variation in the absorbance at 430 nm (for Mn(llI) transferrin) in addition 
of various molar equivalents of KMn04 to apo-hTf. There appears to be a biophasic 
response during the reaction. Conditions: 20 mM Hepes buffer, pH 7.4, 310 K, 10 
mM NaHCO3, 24.8 jiM apo-hTf, KMn04 was added in 0.41 increments. 
However, a plateau at r2 is expected due to transferrin having two lobes available 
for metal binding but this is not seen. Rather, the intensity of the band at 430 nm 
continues to increase after addition of 0.41 - 4 molar equivalents Mn04 with 
evidence of a biphasic response occurring at two equivalents. This suggests that 
either more than two Mn(III) ions bind to transferrin or that a side reaction occurs so 
that not all of the Mn that is added to the reaction is taken up by the protein as 
Mn(ffl). 
To investigate further the loading of Mn onto hTf, apo-hTf was reacted with 1, 2, 3 
and 4 mol equivalents of KMn04 in 20 mM Hepes buffer with 10 mM bicarbonate 
present, pH 7.4. The reactions were left at 310 K and the ratio of metal-to-protein 
was determined using ICP-AES (Mn) and UV/Vis spectroscopy (protein). The molar 
extinction coefficient for the LMCT band at 430 nm was also calculated for each 
reaction. The results are shown in Table 3.1. 
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Table 3.1 Extent of loading hTf with Mn by reaction of apo-hTf with KMn0 4 
No. of KM1104 
equivalents 
added 
Ratio (Mn : hTf) 
determined by ICP-AES 
and UV/Vis 




coefficient at 430 
nm (M-1 cm-) 
1 0.76: 1 76 6228 
2 1.17: 	1 59 8533 
3 2.18: 1 73 8651 
4 2.8: 1 70 10776 
These results suggest that the expected stoichiometric loading of the protein with 2 
mol equivalents of Mn using KIvin0 4 is quite difficult to achieve, as when reacted at 
1:1 ratio this is not achieved. Further when more than two molar equivalents of 
KMn04  are added to the protein, again only partial loading is achieved, usually in the 
region of 70% of the equivalents added. It seems interesting that when two 
equivalents KMn04 are added loading drops considerably to only 59% of the 
manganese added binding to transferrin. Further, the calculated molar extinction 
coefficient for the LMCT band at 430 nm increases with additions of KMn0 4 
although there is only a slight increase following additions of two and three 
equivalents. This suggests that extra KlvIn04 is required to achieve full loading of 
transferrin and that more than two manganese ions can bind to transferrin. The 
observed molar extinction coefficient of Mn 2-hTf at 430 nm (ca. 8600 M' cm) is 
somewhat higher than that found for Fe 2-hTf (Ac465 = 4950 M' cm') [37] and T1* 2- 
hTf (Ac321 = 4830 M' cm-1 [38]. 	However a value of Ac 429 = 
8700 M- I  cm-1 has been cited previously in calculating Mn(III) binding to transferrin 
[39] supporting the values found here. These results support the possibility that more 
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than two Mn ions can bind to transferrin. Recent work on ferric binding protein 
(FBP), a bacterial protein similar to the two lobes of transferrin, has been shown to 
bind hafnium as a metal cluster whereby the protein remains in an open form. 
Human serum apo-transferrin was also treated with an excess of [Hf(NTA) 2] 2 which 
was found to result in a metal-to-protein ratio of 3.5: 1 [40]. The N-lobe of apo-
transferrin is thought to be wide open and capable of binding metal clusters whereas 
the C-lobe is not thought to be able to open wide enough for this. Open lobe 
transferrin conformations are known with a single Fe(III) ion bound [41-43]. 
Therefore, manganese may bind to transferrin as a cluster when added as the Mn0 4 
ion. 
If KMn04 is reacting so that Mn(VII) is being reduced to Mn(III) for loading onto 
the protein then something is being oxidised. Typically if Mn(VII) is reduced to 
Mn(II), then five electrons are gained. If we look at what compounds in the reaction 
are available, Hepes buffer might be a good candidate to act as a reductant. Possible 
reactions between Hepes buffer and KMn0 4 were therefore investigated. 
3.3.2 Reaction Between Hepes Buffer and KMnO 4 
To further investigate the course of the reactions between KMn0 4 and transferrin in 
Hepes buffer, reactions between Hepes and KMnO 4 were studied. When small 
amounts of KIVInO4 were added to Hepes e.g. to achieve a ratio of 220: 1 Hepes: 
KMnO4 as used for the reactions involving transferrin (1-lepes buffer 20 mM and 
KMn04 Ca. 9 x 10-5 mM, at pH 7.4 and 310 K) the solution immediately turned 
yellow/brown and then became colourless with time. This suggests that Mn(VII) 
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oxidation states of manganese appearing giving the yellow/brown colour. When 
high concentrations were used to give a 2:1 mol ratio of KMn04 (40 mM) to Hepes 
(20 mM), a brown precipitate developed which was filtered off and dried leaving a 
colourless clear solution. The brown precipitate was likely to be Mn02. The higher 
concentration of permanganate to Hepes may have resulted in Mn(VII) being 
reduced only as far as Mn(IV) rather than completely to the colourless Mn(II) seen 
previously when small ratios of KMn04 were reacted with Hepes. The reaction of 
Hepes buffer and KMn04 was followed by UV/Vis spectroscopy. Similar conditions 
were used as for reactions of apo-hTf and KMn04 except that the protein was 
omitted. The results are shown in Figure 3.4. 
Figure 3.4 Reaction of Hepes buffer and KMfl04 monitored by UY/Vis 
spectroscopy. The intense pink colour (indicated by arrow) of the permanganate 
disappears leaving a colourless solution. Conditions: 20 mm Hepes buffer, pH 7.4, 
8.96 x 10 M KMn04, 310 K. Readings shown immediate (Ca. 2 min mixing time) 
and every hour until 10 hours, then after 15, 20 and 30 hours. 
The reaction between Hepes buffer and KMn04 may be a necessary part of the 
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reaction, allowing Hepes buffer to be oxidised while Mn(Vll) is reduced to Mn(U) 
via Mn(Ill) which is taken up by transferrin. To investigate a possible role in the 
uptake of Mn(III) by transferrin, Hepes buffer and KMn04 were reacted prior to 
introduction of apo-hTf. If there was a necessary reaction between Hepes buffer and 
KMn04 that leads to the production of Mn(III) during reduction of Mn(VII) to 
Mn(II), then addition of the protein after this reaction finished should lead to little or 
no loading of Mn onto the protein. The uptake of Mn by apo-hTf following the 
reaction of Hepes and KMn04 was monitored by UV/Vis and is shown in Figure 3.5. 
Hepes buffer (20 mM) was reacted with KMn04 (7.9 x 10) at pH 7.4, 310 K. After 
8 hours bicarbonate (10 mM) and apo-hTf(7.9 x 10) were added to the reaction. 
0.15 — 	I 	 —HEPES + Mn(VII) after 8 hours 
Addition of apo-hTf 
0. 1 	1 	—Addition of apo-hTf + 4 hours 
—Addition of apo-hTf + 20 hours 
M 	
Addition of apo-hTf + 42 hours 
0.05 
0 pig 	 I 
200 	400 	600 	800 
Wavelength (nm) 
Figure 3.5 Reaction of Hepes buffer and KMn04 for 8 hours, followed by the 
addition of apo-hTf. Appearance of the LMCT band at 430 nm confirms the 
formation of Mn-hTf although the intensity is lower than that seen previously. 
Conditions: 20 mM Hepes buffer, pH 7.4, 7.9 x 10 M KMn04, 7.9 x 10 -5 M apo-
hTf, 10 mMNaHCO3, 310 K. 
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As can be seen from Figure 3.5 by the appearance of the LMCT band at 430 nm 
some Mn-hTf is being formed. However, when compared with previous experiments 
in which similar concentrations have been used, the reaction is much slower and the 
absorbance band at 430 nm is of much lower intensity suggesting a lower 
concentration of Mn-hTf has been formed. UV/Vis and ICP-AES confirmed poor 
loading of the protein with a final ratio of 0.11 Mn : 1 protein. This further suggests 
an intermediate during the reaction is active in inserting Mn(III) into the protein, 
otherwise the reaction is completed when Mn(II) is formed which has been shown to 
be slow to insert. To investigate the possible reduction of Mn(VII) to a lower 
oxidation state of manganese with the involvement of Hepes buffer EPR experiments 
were carried out. Once again, small ratios of KMn0 4 to Hepes were used to replicate 
conditions used when loading transferrin. The resulting EPR spectrum is shown in 
Figure 3.6. 
A g value of 2.01 with the hyperfine splitting into 6 lines typical of coupling to 55 M 
(I = 5/2) was determined which is indicative of the Mn(II) ion being present. The 
signal generated by EPR increases in amplitude with time. Presumably this strong 
signal must mean that most of the manganese ends up as the Mn(II) ion under these 
conditions. Due to the unusual relaxation properties of the paramagnetic Mn(III) ion 
it is difficult to detect it on the equipment used, therefore the production of Mn(III) 
during the reaction cannot be completely ruled out. 
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Figure 3.6 EPR Spectrum of Hepes buffer and KMn04. The trace is typical of that 
observed in the presence of Mn 2 . Conditions: 20 mM Hepes buffer, pH 7.4, 6.56 x 
10 M KMn04, room temperature (Ca. 298 K). Initial spectrum was recorded ca. 4 
mins after mixing and further spectra after 10, 20 60, 150, 240 and 330 mm. The 
signal increases with time. 
The EPR spectrum shows the formation of Mn(II) therefore it is possible that Mn(Ill) 
is being formed during the reduction of Mn(VI1) to Mn(II) and this is then being 
loaded onto transferrin. The reaction requires the oxidation of Hepes buffer (for 
structure of Hepes see Figure 3.7). In an attempt to determine which part of the 
Hepes molecule was being oxidised by KMn04, 'H NMIR was carried out on a 
solution of Hepes buffer and KMn04 to help to establish structural changes of Hepes 
which might be taking place due to oxidation. 
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HO 
OH 
Figure 3.7 Structure of Hepes. The hydroxy terminus (boxed) is the likely target for 
oxidation by permanganate during the reaction. 
Hepes buffer (20 mM) was reacted with 0.2 molar equivalents of KMn04 in D20 and 
spectra were recorded. 'H NMIR spectra are sensitive to the presence of 
paramagnetic species such Mn(U), however some information can still be obtained 
from the spectra. 1H NIMIR showed a broadening of the spectra when 0.2 molar 
equivalents of KMriO4 were added to Hepes buffer, along with the production of a 
brown precipitate (for NMIR spectra see Appendix D, Figure D. 1). With time the 
brown precipitate settled on the bottom and a clear yellow solution remained which 
gave a NMR spectrum still showing some broadening. Unfortunately no new peaks 
were detected in the resulting spectrum only a broadening of the original peaks, but 
this result and the information gathered from the EPR spectra, suggest that Mn(Vll) 
is reduced to Mn(II) in Hepes. 
To further support the theory that Hepes is a necessary part of the reaction which 
leads to the loading of transferrin with Mn(III) from Mn04, reactions of apo-hTf and 
KMn04 were carried out in other buffer types including Tris and phosphate buffer. 
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Once again the reactions were followed by UV/Vis spectroscopy and the results are 
shown in Figure 3.8. If Hepes was important to the reaction then there might be no 
formation of Mn-hTf in the other buffers. However, Mn-hlf was formed in both 
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Figure 3.8 UV/Vis spectra 60 min after reaction between KMn04 and apo-hTf in 
Hepes buffer, Tris buffer, Phosphate buffer and water. Appearance of the LMCT 
bands at 430 and 330 nm confirms the formation of Mn-hlf. Conditions: All buffers 
at 20 mM, pH 7.4, 310 K, 7.5 x 10-5 M apo-hTf, 7.5 x 10-5 M KMn04, 10 MM 
NaBCO3. 
On examination of the structure of Tris (shown in Figure 3.9) it can be seen there are 
groups that could be oxidised by KMn04. However Mn-hTf was also found to be 
formed from Mn04 in phosphate buffer (see Figure 3.8), as shown by the appearance 
of the LMCT band at 430 nm. Phosphate buffer has no group which could be 
oxidised during the reaction, thus questioning the role of Hepes in the reaction. To 
explore this further, experiments between apo-hTf and KMn04 in water were set up. 
[;II] 
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Somewhat surprisingly, reacting apo-hTf with KMn04 in water also led to the 
formation of Mn-hTf (also shown on Figure 3.8) as shown by the characteristic peak 
at 430 nm. 
CH2 




Figure 3.9 Structure of Tris Buffer 
permanganate are boxed. 
Groups which may be oxidised by 
This implies that some part of the transferrin molecule itself may be undergoing 
oxidation by the permanganate, possibly one or several amino acids of the transferrin 
molecule or even the glycan chains. However, all conditions were the same for these 
experiments but a slightly higher absorbance at 430 nm is reached when the reaction 
was carried out in Hepes and Tris buffers. It may be that Tris and Hepes both 
provide some form of protection against oxidation of the protein by permanganate by 
being oxidised themselves. To investigate this further, experiments were carried out 
on reactions of Mn04 with selected amino acids. 
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3.3.3 Oxidation of Amino Acids by Permanganate 
The amino acids studied for possible oxidation by permanganate during loading of 
Mn(III) onto transferrin were tyrosine, tryptophan, histidine and methionine (see 
Figure 3.10 for their structures). Solutions of the amino acids were made up at Ca. 10 
mM in D20 and reacted with one mol equivalent KMn04. Initial observations were 
made and 1 H NMR spectra were acquired. Where necessary, solutions were filtered 
using a syringe filter that had been washed through with D 20. Solutions were left to 
react over time and again observations made and spectra run. In most of the spectra, 
peaks appeared that were attributable to acetic acid (CH 3 singlet at Ca. 1.2 ppm), 
formic acid (Ca. 8.22 ppm) and in some cases glycerol (ca. 3.5 ppm). The glycerol is 
thought to originate from the plastic Eppendorf tubes, syringes and filters. These 
were washed through before use with D 20 in order to try and keep this to a 
minimum. 
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Figure 3.10 The amino acids used for NMIR analysis: L-tyrosine, L-tryptophan, L-
histidine and Nacetyl-L-methiOfline. Solutions of amino acids were made up at Ca. 
10 mM in D20. One mol equiv of 99 mM KMn04 (in D 20) was added to the amino 
acids and 1 H NMR spectra run immediately and after several hours. Initial 
observations were made such as colour change of solutions and formation of any 
precipitate. 
3.3.3.1 Tyrosine 
Tyrosine was found to be only slightly soluble in D20 so was filtered prior to 
spectrum acquisition to give a clear colourless solution. The lower spectrum in 
Figure 3.11 shows tyrosine alone. Upon addition of KMn04 to tyrosine, the solution 
immediately turned brown in colour with the slight formation of a brown precipitate. 
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The solution was filtered prior to spectrum acquisition. Figure 3.11 shows that the 
immediate spectrum following addition of KMn04 contains a broadening, most 
probably due to the presence of a paramagnetic species. This paramagnetic species 
could be either the Mn(II) or Mn(III) ion. After 18 hours the solution was brown in 
colour with a brown precipitate. This was again filtered to give a clear brown 
solution. The resulting NMR spectrum of the brown clear solution shows there is 
still some broadening of the peaks, however resolution appears to be returning. 
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Figure 3.11 ID 'H NIVIR spectra for reaction of tyrosine with KMn04. (a) Tyrosine 
alone, (b) tyrosine and KMn04 upon immediate mixing, (c) tyrosine and KMn04 
after 18 hours. Conditions: 9.25 mM tyrosine, 1 mol equivalent KMn0 4 added, 
reactions at room temperature. 
The brown precipitate seen after addition of permanganate to the solution of tyrosine 
is most likely to be due to the formation of manganese dioxide, Mn(IV)02. This 
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being the case then some part of the tyrosine molecule is being oxidised. The most 
likely part of the tyrosine molecule to be oxidised by permanganate is the amine 
group. There is a slight shift upfield of the peaks representing the c and 3 protons 
which could be as a result of the amine group being oxidised causing a slight change 
in the spectrum. However, the fact that there is still some tyrosine left following 18 
hours suggests that this oxidation may take time or that all the permanganate has 
reacted leaving a residual amount of tyrosine. 
3.3.3.2 Tryptophan 
Tryptophan was found to be poorly soluble in D 20 so again was filtered prior to 
spectrum acquisition to give a clear colourless solution. The NMR spectrum of 
tryptophan alone is the lower spectrum, a, in Figure 3.12. Upon addition of KMn04 
the solution immediately turned brown in colour but with no formation of a 
precipitate. The solution was filtered prior to spectral acquisition and gave the 
middle spectrum, b, in Figure 3.12. This spectrum again shows broadening, as was 
seen previously with tyrosine. After 18 hours, some brown precipitate had formed. 
Precipitates often lead to spectrum broadening due to the sample no longer being 
homogenous. The solution was filtered and the precipitate removed leaving a clear 
yellow/brown solution which gave rise to the upper spectrum, c, in Figure 3.12 
where the peak intensities began to return, with no obvious change to the spectrum. 
It is likely the situation with tryptophan is similar to that seen with tyrosine in that 
the amine group is being oxidised by permanganate resulting in the formation of 
manganese dioxide as seen by a brown precipitate. On closer inspection of the 
spectrum acquired after 18 hours there is a small shift upfield in the peaks 
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representing the ct and P protons which would support the notion of oxidation of the 
amine group occurring, however this could be due to a change in pH upon mixing 
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Figure 3.12 1D 1 H NMR spectra of tryptophan. (a) Tryptophan alone, (b) 
tryptophan and KMn04 upon immediate mixing, (c) tryptophan and KMn04 after 18 
hours. Conditions: 9.76 mM tryptophan, 1 mol equivalent KMn04 added, reactions 
at room temperature. 
3.3.3.3 Histidine 
Histidine was found to be readily soluble in D20 and dissolved to give a clear 
colourless solution. The NMR spectrum of histidine alone is the lower spectrum, a, 
in Figure 3.13. 
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Figure 3.13 1D 'H NN'liR spectra of histidine. (a) Histidine alone, (b) histidine and 
KMn04 upon immediate mixing, (c) histidine and KMn04 after 18 hours, (d) 
histidine and KMn04 after 24 hours. Conditions: 10.09 mM histidine, 1 mol 
equivalent KIMn04 added, reactions at room temperature. 
Upon addition of KMn04 the solution immediately turned a pink/purple colour with 
no formation of a precipitate. The solution was filtered prior to spectrum acquisition, 
which is spectrum b in Figure 3.13. This spectrum again shows some broadening as 
seen previously. New peaks have emerged at Ca. 8.1 and 8.5 ppm. These new peaks 
could be due to oxidation of the amino acid or the presence of formic acid. After 18 
hours, brown precipitate had formed. 
The solution was filtered and the precipitate removed leaving a clear yellow/brown 
solution which gave rise to spectrum c in Figure 3.13 with some changes to the 
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spectrum suggesting oxidation of histidine by permanganate. The new peaks first 
seen in spectrum b at Ca. 8.1 and 8.5 ppm are still present. Spectrum d is after 24 
hours reaction time. Brown precipitate had again formed and the resulting filtered 
solution was yellow/brown in colour. There is still some broadening of the spectrum 
but no new peaks compared with spectra b and c. The slight change of the original 
peaks seen in the spectrum after addition of permanganate may result from oxidation 
of histidine or could be due to the paramagnetic broadening by Mn(II). 
3.3.3.4 N-Acetyl L-Methionine 
N-acetyl L-methionine (NAc-met) was found to be readily soluble in D20 and 
dissolved to give a clear colourless solution. The NMR spectrum of NAc-met alone 
is the lower spectrum, a, in Figure 3.14. Upon addition of KMn04 a brown 
precipitate formed immediately. The solution was filtered to give a clear colourless 
solution, prior to spectral acquisition, which is spectrum b in Figure 3.14. This 
spectrum again shows some broadening as seen previously with the emergence of 
new peaks at ca. 2.7 ppm and 3.1 ppm. After 18 hours, some brown precipitate had 
again formed which was removed by filtering to give a clear colourless solution. The 
resulting spectrum is shown as c in Figure 3.14 with the same new peaks as seen in 
b, as indicated by green arrows. This suggests that NAc-met is being oxidised by 
permanganate. The most likely part of the amino acid to be oxidised is the sulfur 
group, which markedly changes the chemical shift of the c-CH 3 group. A peak at ca. 
2.1 ppm is assigned to the -CH 3 group of NAc-met, the two new peaks at 2.7 ppm 
and 3.1 ppm have shifted downfield by ca. 0.7 and 1.1 respectively. The sulfur 
group is probably being oxidised to produce methionine sulfoxide initially and then 
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to methionine sulfone shortly afterwards. To investigate this, NMR experiments 
were carried out on methionine sulfone and methionine sulfoxide. 
0 
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Figure 3.14 1D 1 H NIMIR spectra of NAc-met. (a) NAc-met alone, (b) NAc-met and 
KMn04 upon immediate mixing, (c) NAc-met and KMn0 4 after 18 hours. 
Conditions: 9.85 mM NAc-met, 1 mol equivalent KMn04 added, reactions at room 
temperature. 
3.3.3.5 Meihionine Su/foxide and Meihionine Suifone 
The structures of methionine sulfoxide and methionine sulfone are shown in Figure 
3.15. These amino acids were reacted with KMn04 following the same method as 
used previously with other amino acids and 1D NMR spectra obtained. Methionine 
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sulfoxide and sulfone were both readily soluble in D 20. 
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11 H2 H2 	I 
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L-methionine sulfoxide  
o 	NH2 
I H2 H2 	I 
H3C—S—C—C—CH—C—OH 
II 	II o 0 
L-methionine sulfone 
Figure 3.15 Structures of met-sulfoxide and met-sulfone 
Upon immediate mixing of methionine sulfoxide with one mot equivalent 
permanganate, the solution changed from colourless to brown but with no obvious 
precipitate. Prior to NMR analysis, the solution was filtered, resulting in a clear light 
brown solution. The spectrum for methionine sulfoxide alone is the lower spectrum 
in Figure 3.16 with the upper spectrum showing the reaction following mixing with 
permanganate. Arrows indicate the emergence of two new peaks. The E-CH 3 group 
of methionine sulfoxide gives a peak at Ca. 2.75 ppm. This is probably a similar 
peak as that at 2.7 ppm in the spectrum of NAc-met following reaction with 
permanganate (see Figure 3.14, spectra b and c) confirming the oxidation of 
methionine to methionine sulfoxide. The green arrow on the upper spectrum of 
Figure 3.16, where methionine sulfoxide has been reacted with permanganate, shows 
a shift downfield of the c-CH3 peak to Ca. 3.1 ppm. This shift was also seen 
previously with methionine upon addition of permanganate, again confirming that 
the same reaction has taken place. The blue arrow shows a shift downfield of the 
protons attached to the 13 carbon. Both these shifts suggest a change in the structure 
of the amino acid. Some of the methionine sulfoxide has possibly been oxidised to 
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methionine sulfone, however some of the original amino acid remains (as indicated 
by the presence of peaks for the original amino acid). 
o 	NH2 
S 	 C kH— c 	 1 —OH 
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Figure 3.16 
ID 'H NMR spectra of L-methionine sulfoxide (lower spectrum) and 
following immediate reaction with 1 mol equivalent permanganate (upper spectrum). 
Conditions: 10.08 mlvi L-met sulfoxide, 1 equivalent KMn04 added, reactions at 
room temperature. 
Methionine sulfone was also reacted with one mol equivalent of permanganate. 
Upon immediate mixing the clear colourless solution turned pink/purple with no 
formation of a precipitate. The lower spectrum in Figure 3.17 shows methionine 
sulfone alone, the upper spectrum is following addition of permanganate. As can be 
seen there is no obvious difference between spectra suggesting that no immediate 
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oxidation of methionine sulfone has taken place. The terminal methyl group shows a 
peak at Ca. 3.1 ppm. This is the same peak as seen in the spectrum showing 
methionine reacted with permanganate (Figure 3.14, spectra b and c) and methionine 
sulfoxide reacted with permanganate (Figure 3.16, upper spectrum). This confirms 
the oxidation of methionine and methionine sulfoxide to methionine sulfone 
following addition of permanganate. 
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Figure 3.17 1D 'H NMIR spectra of L-methionine sulfone and following reaction of 
permanganate. Lower spectrum shows met sulfone alone. Upper spectrum is 
following immediate reaction with permanganate. Conditions: 9.97 mM L-met 
sulfone, 1 mot equivalent KMn04 added, reactions at room temperature. 
3.3.4 Investigation into Oxidation of Methionine Residues 
of hTf 
These results suggest that of the amino acids looked at, methionine is the most likely 
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to be oxidised by permanganate as it is readily oxidised to the sulfoxide and sulfone. 
To investigate further the possibility that permanganate oxidises methionine residues 
of transferrin, 2D ['H, 13C] NMR spectra of recombinant non-glycosylated human 
transferrin with > 95% a-'3CH3 enrichment at all nine Met residues (for locations see 
Figure 3.18) were obtained using inverse detection [33, 44]. It is possible to detect 
peaks at micromolar concentrations. Further, the protein can be de-metallated and 
recycled as it was for this study. The recombinant hTf is non-glycosylated but there 
is no evidence that glycosylation interferes with metal uptake [31]. The SCH3 NIMIR 
peaks appear as singlets. Also the Met residues are well dispersed throughout the 





Figure 3.18 The locations of the nine Met residues in hTf (coordinates from the 
crystal structure of hTf with Fe(Ill) in C-lobe and no metal in N-lobe [45]. 
Cross-peaks for Met residues were assigned using work previously carried out by 
Beatty et a! [32]. The protein had been used in previous experiments where it had 
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been loaded with various metals and stripped. Prior to this work all metal was 
removed from the protein. The continuous loading and stripping of metal from the 
protein had gradually lowered the concentration and so the signals were relatively 
weak in these experiments. Although not all nine cross-peaks were initially visible 
(Figure 3.19) and some were slightly different to those reported previously, those 
matching most closely were assigned. As already mentioned the protein was 
recycled and had been stored for some time which may be why the peaks were 
different to those found previously [33, 38]. 
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'H 'H 
Figure 3.19 2D ['H, ' 3C] HSQC spectra of c-' 3CH3-Met-hTf (0.3 MM in 0. 1 KC1, 
10 mM bicarbonate, pH*  7.4) and after addition of 1.0, 2.0 and 2.5 mol equiv of 
KMn04 . The assignments are based on refs [32, 38, 44]. The solid boxes indicate 
initial peaks and possible shifts of those peaks. Dotted boxes indicate new peaks. 
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Table 3.2 'Hand '3C NMR chemical shifts of E-13 C113-Met residues for apo-form and after reaction with 1-2.5 mol equiv KMn04 
o ('11113C) (ppm)  
Residue Location 
Beatty 
et ar + 11CO3 + 1 KMnO4 + 2 KMnO4 + 2.5 KMnO4 
+2.5 KMnO4 
+ time ' 
'1 et:464 
Trp460 hydrophobic patch 
1.38/16.3 1.43/15.6 1.22/17.3 1.22/17.25 1.22/17.26 1.21/17.25 
of helix 5  
N1et499 C2, mostly exposed 1.86/15.41 1.92/14.6 1.94/14.72 1.94/14.7 1.94/14.7 1.94/14.7 




2.11/15.49 2.11/15.49  
let26 Ni, helix 1, buried 1.98/16,02 
1. 97/13. 9 1 	9 98/13 . . 
1.98/13.8 
1. 	8 98/13 . 
1.98/23.9 
1.99/13.9 2.04/13.8  2.04/13.7  
Cl, hinge region, partially 
2.08/15.22 2.14/14.5 2.15/14.3 2.14/14.3 2.15/14.3 2.14/14.3 
exposed _ ___________ ____________  
Met389 C 1, completely buried 202/1549b  2.11/15.49  2.11/15.49  
N1et256 NI, completely exposed 2.13/15.53 2.20/14.8 2.20/14.8 2.20/14.8 2.20/14.8 2.19/14.8 
Met3 13 
Ni, hinge region, partially 
2.29/15.18 2.35/14.7 2.39/14.8 2.39/14.8 
exposed  
Met309 
Ni, hinge region, mosity 




Met?  2.80/17.3 2.80/17.28 2.80/17.27 2.80/17.27 2.80/37.2  
3.1/19.8 
Met? 3.14/20.4 3.20/20.4 3.20/20.4 --r 3.22/20.4 3.20/40.4 
a  Apo-hTf used, pH 7.1, 310 K. b  Data collected at 318 K. C  Data collected with 13C spectral width altered to 40 ppm 
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The chemical shifts of the peaks observed following addition of HCO3 and KMn04 
and their assignments are given in Table 12 and the shift changes of peaks are given 
in Table 3.3. When the spectrum for apo-hTf with bicarbonate was collected eight 
cross peaks were observed. Of these eight peaks, six were assigned to possible Met 
residues. Assignment was initially based on peaks that most closely matched those 
found previously in terms of the pattern of the spectrum and position of peaks. 
Table 3.3 1 H and '3C NMR chemical shifts of apo-hTf, Mn(IH)-induced shifts 
for the Met-(e)- 13CH3 residues of hTf at 310 K. 
Residue Location Apo-hTf 2.5 KMn04 Aö ( 1H/13C) 
(ppm) 
M et464 Trp460 hydrophobic patch 1.43/15.6 1.22/17.26 -0.21/1.66 
of helix _5  
Met499 C2, mostly exposed 1.92/14.6 1.94/14.7 0.04/0.1 
Met109 N2, partially buried 2.04/15.3 2.05/15.3 0.01/0 
2,11/15.49 0.7/0.19 
Met26 Ni, helix 1, buried 1.97/13.9 1.98/13.8 0.01/0.1 
1.99/13.9 2.04/13.7 0.051-0.2 
Cl, hinge region, partially 2.14/14.5 2.15/14.3 0.01/42 
exposed __  
Met389 C1, completely buried 2 . 03/15 . 2a 2.05/15.3 0.02/0.1 
Met256 NI, completely exposed 2.20/14.8 2.20/14.8 0/0 
Met313 NI, hinge region, partially 2 . 35/14 . 7a 2.39/14.8 0.04/0.1 
exposed  
Met309 Ni, hinge region, moslty 2.80/17.3 2.80/17.27 0/0 





3.14/20.4 3.22/20.4  
a Chemical shift data taken from hlf+ I KMn0 4 as peak not present with apo-hTf 
Upon addition of the first mol equiv of KMn04 the cross-peak assigned to Met464 
instantly disappeared (Figure 3.19). A new peak appeared at a shift of ca. 1.7 ppm to 
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low field in the ' 3 C dimension and Ca. 0.2 ppm to high field in the 'H dimension 
(Table 3.3). Although the peak assignment is somewhat ambiguous the shift is 
comparable to that seen by previous workers on addition of a metal to apo-hTf [32, 
33, 38, 46]. There was no apparent further shift of this peak upon addition of more 
KMn04 or with time. This suggests a conformational change in the C-lobe upon 
binding the first equivalent of manganese. The Met464 residue is situated in the 
hydrophobic patch of helix 5 which backs onto the metal binding site and H-bonds to 
the synergistic anion [45, 47] which is disturbed by the loading of metal ions in the 
C-lobe. 
The cross-peak assigned to Met499 also disappeared and a new peak appeared which 
shifted slightly to low field (Figure 3.19, Table 3.2 and Table 3.3). When further 
molar equivalents of permanganate were added only slight additional shifts were 
seen for Met499. Again, this is similar to that seen previously following addition of 
metals. 
The peak assigned to Met26 (Figure 3.19) looks as if it is split into two upon addition 
of one equivalent of permanganate. The new peak is shifted slightly with the initial 
peak still visible (Table 3.2 and Table 3.3). The new peak then disappeared when 
two mol equivalents were added. However, the new peak then reappeared to a small 
extent when two and a half equivalents were added and the spectrum collected 
overnight. When the 'Fl spectral width was altered for collection of the spectrum 
following addition of 2.5 mol equivalents overnight, the peak now appeared at 
1.98/23.9 ppm (see Table 3.2). Met26 is buried in the N-lobe so would not thought 
to be a target for oxidation by permanganate. However, there may be a small 
conformational change which is only seen when one equivalent manganese binds to 
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the C-lobe. The second equivalent results in a further conformational change so that 
the new cross peak representing Met26 is no longer visible but this returns following 
addition of 2.5 mol equivalents KMn04. 
No shift was seen for the cross peak assigned to Met256. This is consistent with 
previous work where no change was observed on addition of metals suggesting no 
conformational change. However, if the methionines were being oxidised by 
permanganate then this residue would be a particularly susceptible target due to its 
position: it is completely exposed. 
The peak assigned to Met3 13 was not visible for the apo protein, only upon addition 
of permanganate. A small additional shift was seen when more permanganate was 
added. Shifts were only seen for this residue in previous work after the second mol 
equivalent of metal was added [33, 38, 46]. This peak then disappeared after 
addition of 2.5 molar equivalents and time with the spectrum collected overnight. 
The peak assigned to Met382 had a slight shift following addition of one molar 
equivalent KMn04 (Table 3.3) which remained following further additions of 
permanganate. 
There is some ambiguity in the assignments of peaks for Met109 and 389. Met109 
was assigned to the peak appearing at 2.04/15.3 ppm (Table 3.2). Upon addition of 
K1v1n04 this peak remains, with the exception of the spectrum collected following the 
addition of 2 molar equivalents, with a new peak appearing at 2.11/15.49 ppm 
(Table 3.2). This could be due to a conformational change or due to oxidation of the 
protein by permanganate. Alternatively, this new peak could be due to the 
appearance of Met389. Previously this residue had proved difficult to detect, only 
appearing on addition of oxalate [32], addition of one equivalent metal [38] or the 
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raising of the temperature [33]. 
In previous work on metal binding, only a small shift was seen for Metl09, however, 
no strong oxidant such as permanganate was used. This may have an influence on 
some of the peak shifts if in fact the shifts are due to oxidation and/or conformational 
change. 
The peaks visible at low field have in some cases been assigned (see Figure 3.19 and 
Table 3.2). For example a peak for Met309 has been assigned although this is 
tentative as the peak is outside the expected range. It is difficult to assign these extra 
peaks. They could be due to already oxidised methionines or a conformational 
change from the continuous recycling and storage of the protein. 
There are a few additional peaks that appeared in the spectrum following addition of 
two and a half molar equivalents permanganate. These could be due to oxidation of 
the methionines. The change in chemical shifts seen in the 1D ['H] NMR spectrum 
(Figure 3.14) of NAc-met following addition of one mol equivalent KMn04 of Ca. 
0.7 and 1.1 ppm downfield were attributed to the oxidation of methionine to the 
sulfoxide and sulfone by permanganate. To establish the chemical shift for ' 3 C for 
comparison with the 2D NMR, 1D [' 3 C] experiments were carried out on NAc-met, 
methionine sulfoxide, methionine sulfone and NAc-met following reaction with one 
mol equivalent permanganate. The results are given in Appendix E. A shift of 10 
ppm downfield is seen for the c-CH 3 group following oxidation of methionine with 
permanganate which corresponds to the c-CH 3 peak assigned to methionine sulfoxide 
and sulfone. The only instance where a 10 ppm chemical shift is seen in the HSQC 
data is for the peak representing Met26 where the spectral width of ' 3C had been 
expanded (see Table 3.2). However, this residue is found in the N-lobe so would not 
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be an obvious target for oxidation by permanganate. It is possible that any 
methionine residues that have been oxidised by permanganate do not generate a 
strong enough signal to be detected during these experiments. 
Any paramagnetic effects from Mn(III) are probably not seen due to the binding site 
being some distance from the methionine residues. However, if manganese is 
binding to areas of the protein other than the two binding sites this may have effects 
on peaks for other residues. 
These experiments show that a conformational change is observed when 
permanganate is added to apo-transferrin which is of a similar nature to that observed 
for other metal binding to transferrin. However, it is important to consider the 
reaction occurring when Mn(VII) from permanganate is being reduced to Mn(III) for 
binding to transferrin. During this reaction a redox process is occurring; Mn(VII) is 
gaining four electrons in order to be reduced to Mn(III) for transferrin binding. 
Permanganate has already been shown in section 3.3.3.4 and section 3.3.3.5 to 
oxidise N-acetyl methionine to the corresponding sulfoxide and sulfone. The sulfur 
of N-acetyl methionine is losing two electrons to be oxidised to the sulfoxide and 
then a further two to be oxidised to the sulfone. This then accounts for the four 
electrons required for the reduction of Mn(VII) to Mn(III). Further, the one 
methionine residue (Met26) on the protein that is seen to shift in a similar manner to 
oxidation of N-acetyl methioine in 1D spectra ([H'], [C 13]) could be due to this 
reaction mechanism. The remaining eight methionine residues then shift in 
accordance to metal binding and change in protein conformation as seen previously 
with other metal binding to transferrin [33, 44, 46] 
These experiments need to be repeated with a batch of new protein although the 
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labelling is an expensive process. 
3.3.5 Order of lobe loading of apo-hTf with Mn (III) 
Previously work has been carried out on transferrin to investigate the order of lobe-
loading by metal ions. It is of interest to determine which lobe is loaded 
preferentially by Mn 3 . Owing to the paramagnetism of IVIn 3 alternative techniques 
were investigated to determine the order of lobe loading of transferrin by manganese. 
It had not been possible to examine the two monoferric transferrins (Fe c-hTf and 
FeN-hTf) until Mackey and Seal described their technique of urea gel electrophoresis 
[48]. In this procedure a 6 M urea gel is used to separate the different forms of 
transferrin resulting in the production of four visible bands on the gel representing, 
from top (the well end of the gel) to bottom, apo-hTf, Fe c-hTf, FeN-hTf and Fe2-hTf. 
This separation appears to be related to the increase in protein stability as iron is 
bound to transferrin, the net negative charge of the protein increases with each iron 
atom bound and the asymmetrical distribution of amino acids in the transferrin 
molecule [49]. There are more disulfide bridges in the C-terminal domain than in the 
N-terminal domain which may explain the separation of the two mono-ferric forms 
of Fe-hTf. In the absence of bound metal, 6 M urea causes a partial unfolding of the 
protein and consequent reduction in electrophoretic mobility. The unfolding of the 
N-terminal domain causes a greater decrease in mobility than does the unfolding of 
the C-terminal domain and this may be due to the greater number of disulfide bridges 
in the latter. 
This technique has been adopted by others with slight modifications to identify lobe 
loading of iron by transferrin [49, 50] and ovotransferrin [51]. In an attempt to 
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separate and distinguish the different forms of Mn-hTf, this method was used. 
Initially however, Fe-hTf was run on gels to determine the correct conditions, 
unfortunately with limited success. An example of this is shown in Figure 3.20. 
Apo-hTf and Fe-hTf of varying concentrations, ranging from Ca.! X 10 6  M to 2.5 x 






- Fe-hTf 11 *1, 
Figure 3.20 6 M Urea gel electrophoresis of apo-hTf, monoferric hTf and diferric 
hTf. Lanes run from 1 (left) to 8 (right). Lanes 1,2 and 8 loaded with apo-hTf, lanes 
3, 5 and 7 loaded with Fe-hTf, lanes 4 and 6 loaded with mixture of apo-hTf and Fe-
hTf Appearance of bands identifies the different forms of transferrin. Gel run for 5 
hours at 100 V. 
As can be seen in Figure 3.20, four distinct bands appeared indicating the presence of 
the four different forms of transferrin in the samples. However, some bands are 
missing when they would be expected to appear, such as a band representing apo-hlf 
when mixtures of apo- and Fe-hTf are loaded. Slight modifications were made to the 
method such as length of time the gel was run, up to 7 hours, but with no 
improvement. Problems of missing bands may include faulty gel composition when 
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gels were cast manually, however pre-cast gels seemed to give no improvement, the 
use of chelates in the buffer that could mediate iron exchange among iron-binding 
sites, technical problems with the electrophoreses procedure such as heating up of the 
equipment during the process or possibly iron contamination in the gel or buffer. 
The technique was applied to Mn-hTf with the aim of characterising Mn c-hTf, MnN-
hTf and Mn2-hTf but no distinct bands appeared. Samples of Mn-hTf that had been 
prepared by reaction of apo-hTf with MnC1 2 or KMn04 were both used. The method 
was modified slightly by altering the pH of the tank buffer using HC1 and NaOH but 
this gave no improvement. The lack of success of separating Mn-hTf by this method 
of electrophoresis may be due to the difference in binding of Mn(III) to transferrin 
compared to Fe(III). The harsh conditions of a 6 M urea gel may lead to the 
manganese dissociating from the protein during the separation. 
3.3.6 Fe(III) displacement of Mn (IH) from Mn2-h Tf 
Experiments were carried out to determine the ability of iron to displace manganese 
from transferrin (Figure 3.21). 
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Figure 3.21 UVIVis absorption spectrum of Mn2hTf following addition of 3 mol 
equivalents of Fe(NTA)2. Conditions: Mn 2hTf prepared using MnC1 2 and 
caeruloplasmin, 20 mM Hepes buffer, 10 mM NaHCO3, pH 7.4, 310 K, 50 gM 
Mn2hTf (upper spectrum), 65 tM Mn2hTf (middle and lower spectra). Immediate 
reading shown as 1 minute to allow for mixing time. Shifts of LMCT bands 
indicates displacement of Mn(III) by Fe(III). 
When 3 mol equivalents of Fe(NTA)2 was added to a solution of Mn2-hTf (20 mM 
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Hepes buffer, 10 mM bicarbonate, pH 7.4, 310 K), which had been prepared by 
reacting MnCl 2 in the presence of caeruloplasmin, a new broad band in the visible 
region appeared immediately (mixing time of ca. 1 minute) at ca. 440 nm (see lower 
spectrum in Figure 3.21). This band then appeared to decrease in intensity and 
moved to a longer wavelength until centred at Ca. 465 nm after about 6 hours (see 
middle spectrum Figure 3.21) and then gradually increased in intensity again over a 
period of 48 hours (see upper spectrum Figure 3.21). There appears to be an initial 
and immediate reaction, which is seen as the LMCT band of Mn-hTf at 430 nm shifts 
towards the position associated with the LMCT band of Fe-hTf at 465 nm. Once this 
initial reaction, which is most likely to be the displacement of manganese from 
transferrin, is complete, the band seen at 465 nrn then increases in intensity 
representing binding of iron to transferrin. 
TCP-AES analysis of the Mn 2-hTf used gave a metal-to-protein ratio of 2.1 Mn: I 
hTf. On completion of the reaction (total reaction time of 48 hours) of Mn 2-hTf with 
Fe(NTA)2, the protein was found to have a very small amount of Mn bound (4.7 x 
10-3 Mn: 1 hTf) but some Fe had bound to the protein to give a ratio of 1.4 Fe: 1 hTf. 
This suggests that the majority of the Mn has been removed and Fe has taken its 
place on the protein but has not achieved full loading. 
The experiment was repeated using Mn 2-hTf that had been produced using KMn0 4 
to load the protein to investigate if there were any differences in displacement of Mn 
from Mn2-hTf when permanganate was used to see if this supported any theory of the 
nature of the protein being altered by this method of loading. The UVIVis spectra 
collected are shown in Figure 3.22. 
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Figure 3.22 UV/Vis absorption spectrum of Mn 2hTf following addition of 
Fe(NTA)2 . Conditions: Mn2hTf prepared using KMn04, 20 mM Hepes buffer, 10 
mM NaHCO3, pH 7.4, 310 K, 24 p.M Mn2hTf (upper spectrum), 40 p.M (middle and 
lower spectra). Immediate reading shown as 1 minute to allow for mixing time. 
Shifts of LMCT bands indicates displacement of Mn(III) by Fe(III). 
Compared with the previous experiment the nature of the displacement of Mn 
appears to have altered. The reaction appears to proceed more slowly with the 
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immediate change being very slight. There is a change over a period of 42 hours 
although this is much more gradual when compared with the change seen in the 
upper spectrum of Figure 3.21. This gradual change is more obvious during the first 
six hours (see middle and lower spectra of Figure 3.22). What is apparent is not only 
the much slower change in peak at 430 nm but also the persistence of a peak at 330 
nm, characteristic of Mn2-hTf. 
This supports the theory that the loading of hTf with Mn by KMn0 4 does induce 
different changes to the protein compared with loading by Mud 2 . ICP-AES analysis 
showed the protein to have a metal: protein ratio of 2 Fe: 1 hTf but surprisingly some 
Mn was still found to be bound to the protein at a ratio of 0.7 Mn: 1 hTf. This 
supports previous experiments carried out on hTf loaded with Mn by KMn0 4 in that 
a greater ratio of 2 metals per protein molecule can be achieved. This may be due to 
some extra or alternative binding sites for Mn on hTf. The fact that Mn is not so 
readily displaced from Mn2-hTf when KMn04 is used to load the protein also 
supports the theory that in some way the protein and its binding capability is altered. 
3.3.7 Mn (III) displacement of Fe(III) from Fe 2-hTf 
To try to establish whether the binding of Mn(III) to hTf using KMn0 4 was strong 
and comparable to binding of Fe(III) to hTf, KMn0 4 was reacted with Fe 2-hTf to see 
if manganese could displace iron. Fully loaded Fe 2-hTf as determined by ICP-AES 
was reacted with 2.5 molar equivalents of KMn0 4 and the reaction followed by 
UV/Vis spectroscopy. The results are shown in Figure 3.23. 
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Figure 3.23 UV/Vis absorption spectrum of Fe2-hTf following addition of KMn0 4 . 
Conditions: 20 mM Hepes buffer, 10 mM NaHCO 3 , pH 74, 310 K, 24 i.tM Fe2-hTf 
(upper spectrum), 40 j.tM Fe 2-hTf (middle and lower spectra). Immediate reading 
shown as 1 minute to allow for mixing time. Strong band of Fe2-hTf remains 
following addition of KMn04. 
As can be seen in the upper spectrum, when KMn0 4 is initially added the strong pink 
colour of the permanganate hides any immediate shifts in peaks. However, this soon 
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subsides as can be seen in the lower spectrum of Figure 3.23. This change in the 
spectrum may be due to the reaction between Hepes buffer and permanganate 
already discussed (section 3.3.2) or as a result of the permanganate reacting with the 
Fe2 -hTf. 
There is a slight change in the spectrum of Fe 2 -hTf following addition of KMn0 4 in 
the first 6 hours although this is probably due to any residual colour of the 
permanganate as there is no emergence of new peaks or change in wavelength of the 
original peak. ICP-AES and UVIVis results confirmed that Mn had not displaced Fe 
from Fe2-hTf. However, UV/Vis spectroscopy does not show any structural changes 
that may have occurred therefore further work would be necessary in order to 
establish if KMn04 had any effect on Fe 2-hTf. 
ICP-AES found no manganese bound to Fe 2-hTf even though it appears that Mn0 4 
may bind to transferrin in sites other than the usual metal binding sites. It may be 
that once a metal is bound to both lobes of the protein it prevents further addition of 
manganese. This may be due to both lobes being fully closed when occupied by 
Fe (III) 
3.3.8 Mn (III) Release from Mn 2-hTf 
As described in Section 1.3.1 transferrin takes up Fe(III) at pH 7.4 and delivers it to 
cells via receptor-mediated endocytosis. Once inside the mildly acidic endosomes 
(pH 5.0-5.5) Fe(III) is released [11, 12, 52, 53]. Release of Mn(III) from Mn 2-hTf 
following a fall in p1-I was investigated using UVIVis spectroscopy. 
Fully loaded Mn2-hTf with a ratio of 2.17 Mn: I hTf (as determined by ICP-AES) 
was used and the pH lowered by 0.5 (± 0.05) increments using 1 M HCI. UV/Vis 
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spectra were collected after equilibrium for 30 min at 310 K at each pH using a Cary 
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Figure 3.24 UV/Vis spectra showing release of Mn(III) from Mn 2-hTf following 
reduction in pH. The disappearance of the LMCT band at 430 nm of Mn 2-hTf 
suggests Mn(III) dissociates from transferrin with a fall in pH. Conditions: 20 MM 
Hepes buffer, 54.24 tM Mn 2-hTf. Initial reading at pH 7.0 (+0.05), pH then 
reduced in 0.5 increments to pH 3.0 (±0.05). 
The results show that following a reduction in pH, Mn(III) is released from Mn-hTf 
as indicated by a fall in intensity of the LMCT associated with Mn-hTf (430 nm). 
The decrease in intensity is consistent until a pH of 3.5. The calculated molar 
extinction coefficients are 6747 M' cm' at pH 7.0 and 415 M' cm -1 at pH 3.0. This 
is most probably indicative of virtually all of the Mn(III) no longer being bound to 
transferrin. During the course of the experiment the solution changed colour from 
brown to colourless. These results are consistent with those seen with Fe 2-hTf where 
in the absence of chelators Fe(llI) is released over the pH range 6.0 to 4.0. One site 
loses Fe(HI) at a pH near 6.0 (N-lobe) the other nearer 5.0 (C-lobe) [53, 54]. The 
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results found here suggest a higher pH of 6.5 leads to the initial dissociation of 
Mn(III) from transferrin and that a lower pH is required before full dissociation of 
Mn(III) is reached as indicated by the continuous fall in intensity of the LMCT band 
at 430 nrn until pH 3.5. However, this slightly wider pH range may arise from 
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Figure 3.25 Variation in absorbance at 430 nm (Tyr to Mn(III) LMCT band) of a 
Mn2-hTf solution with pH. For conditions see Figure 3.24. Dissociation appears to 
be a two-stage process. 
There is a plateau reached at a pH of Ca. 5.5 which suggests that one Mn(III) ion has 
been released between pH 7 and 5.5. This would suggest that the dissociation occurs 
in two stages whereby one lobe is vacated preferentially. It is most likely that the N-
lobe is vacated first followed by dissociation from the more acid-stable C-lobe at a 
pH below 5.5. These results support the hypothesis that Mn(III) release from 
transferrin could occur in the endosomes in the same manner as it does for Fe(III). 
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3.4 Conclusions 
The natural cycle of delivery of iron to cells by transferrin offers a great potential for 
targeting metals to target tissues. In particular to tissues where there is a high level 
of transferrin for example, the liver. This potential is vastly increased by the ability 
of transferrin to carry other metals [13, 14, 19, 38, 46, 52, 53, 55]. In blood serum, 
transferrin is only 30% fully loaded with iron, therefore the vacant sites of apo-
transferrin could be used to act as a transport mechanism for other metals such as 
manganese. 
Binding of metal ions to the phenolic oxygen of the tyrosine residues in the specific 
metal binding sites of apo-hTf perturbs the i-it' transitions of the aromatic rings and 
leads to the production of two new absorption bands near 241 and 295 nm [14, 53]. 
These new bands can be seen in the UV spectra of apo-hTf and metal-hTf. Specific 
binding by certain metals such as Fe(III), Ti(IV) and Cu(II) also give rise to LMCT 
bands in the visible region of the spectrum. This can provide a convenient way to 
detect metal binding to transferrin, specific metal binding and also its release. 
This work has shown that manganese can be loaded onto transferrin. The serum 
oxidant caeruloplasmin has been found to speed up the process. However, by using 
potassium permanganate as a source of manganese, transferrin can be loaded quickly 
and efficiently. However, this may be of some consequence to the protein due to the 
strong oxidising nature of potassium permanganate. NMR studies have shown that 
methionine is readily oxidised to methionine sulfoxide and sulfone following 
addition of permanganate. 
2D [ 1 H, ' 3C] NMR provides a method of determining the order of lobe loading of 
transferrin with various metal ions using 6-[ 13 C]Met-labelled recombinant transferrin. 
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Under the conditions used here, Mn(III) appears to preferentially load the C-lobe 
when introduced as permanganate. This is in agreement with previous work which 
has shown that NTA complexes of Fe(III) and Bi(III) both preferentially bind the C-
lobe [33]. The conformational changes seen by shift changes of Met464 induced by 
Fe(III), Bi(III), Al(III), Ti(IV) and Ga(III) are all similar [33, 38]. A similar shift 
was seen with Mn(III). The slight discrepancies between the shifts seen for 
methionine residues in this work compared with previous work may support the 
theory of Mn04 loading transferrin in a different manner. If the C-lobe remains 
open following binding of Mn(III) or due to a cluster binding then this may result in 
a slight modification in chemical shifts of the peaks representing the methionine 
residues. 
The methionine residues of hTf are well distributed throughout the protein and the 
changes in their 'H and ' 3C NMR resonances can provide a useful tool for 
determining the conformational changes of transferrin that occur during metal 
binding. This can then be useful to compare various metals. However, new protein 
would enable more definitive results to be obtained. 
Although apo-hTf can sometimes be separated from mono- and di-ferric transferrin 
by electrophoresis, harsh conditions are required and these could not be used to 
separate Mn-hTf suggesting that only tightly bound metals can be separated. This is 
supported by the fact that iron is able to displace manganese from transferrin, 
whether loaded by MnC12 or KMn04, but manganese (added as Mn0 4 ) is unable to 
displace iron from the protein. Mn(III) dissociates from Mn 2-hTf following a 
reduction of pH in a manner similar to that observed for Fe 2-hTf. The results suggest 
that Mn(III) dissociates from one lobe first, probably the N-lobe which is more 
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facile, followed by the C-lobe at pH < 5.5. This is consistent with the pH 
dependence of Fe(III) release observed for Fe2-hTf [53] suggesting that once inside 
the cell Mn(III) will dissociate from Mn2-hTf in a similar fashion to that seen with 
Fe(III) under the acidic conditions found in endosomes. 
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Chapter 4 Crystallisation of Transferrin 
4.1 Introduction 
One of the best methods of investigating the structures of proteins is by X-ray 
crystallography. This allows similarities between families of proteins and structural 
changes when metals are bound to proteins to be studied. The main aim of this 
chapter was to develop a method of crystallisation of transferrin with iron or 
manganese bound in order to investigate structural changes induced by these metals. 
4.1.1 Crystallisation Theory 
Crystals packed into a regular lattice of repeating subunits, or unit cells, diffract X-
ray wavelength light at certain angles depending on their size and composition and 
this provides structural information on the protein [1]. 
The formation of ordered crystals is thermodynamically unfavourable due to a drive 
towards maximum entropy. However, under the right conditions that include exact 
kinetic rate and thermodynamic change in enthalpy and entropy, crystals do fonm 
The most successful way to control these is to force the compound, in this case 
protein, out of a supersaturated solution. As moisture is lost from the solution, the 
protein concentration is gradually increased until the protein cannot maintain its 
supersaturation. At this point the protein begins to precipitate out of solution. The 
rate of this precipitation determines whether it will randomly nucleate or crystallise 
correctly. Nucleation is the process where molecules or non-crystalline aggregates 
free in solution come together to form a stable aggregate with a repeating lattice. 
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must reach a critical size for further growth of the nucleus to take place. The extent 
of supersaturation and hence degree of nucleation is determined by the solubility of 
the protein. A phase diagram can be used to show protein solubility and saturation 
(Figure 4.1). Higher solubility increases the chances of stable nuclei being formed. 
Precipitant concentration 
Figure 4.1 Phase diagram for crystallisation of proteins. Proteins are in equilibrium 
between solution and crystal on the curve. Crystals will not grow in the 
undersaturation area. Supersaturation is further divided. In the metastable zone 
nucleation may not occur for some time but growth is sustained, seeding may be 
successful here. In the nucleation zone protein crystals will grow. Protein will 
precipitate out of solution in the precipitation zone (adapted from [2]). 
Protein purity can be an influencing factor in the crystallisation process as impurities 
can lead to poor diffraction. 
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4.1.2 Previous Crystallisation of Transferrins 
The first crystallographic studies on transferrins were carried out in 1970 [3] with 
limited success, as was the case in 1978 also [4]. Crystals of various transferrins 
have since been reported (see Table 4.1) although as yet there is no published 
structure of intact human serum transferrrin. 
Table 4.1 X-Ray crystal structures of Transferrins 
Transferrin Residues Geometry Resolution (A) 
Fec-hTf [5]a 679 Distorted Octahedral 2.6 
Fe-hTf/2N [6] 337 (N-lobe) Distorted Octahedral 1.6 
Fe-hTf/2N [6] 337 (N-lobe) Distorted Octahedral 1.8 
Apo-hTf'2N [7] 337 (N-lobe) Distorted Octahedral 2.2, 3.2 
Fe2-rTf [8]b 676 Distorted Octahedral 3.3 
Fe2-oTf (chicken) [9] 686 Distorted Octahedral 2.4 
Fe2-oTf (duck) [10] 686 Distorted Octahedral 2.35 
hTf: human serum transferrin, 2N: N-lobe only, rTf: rabbit transferrin, olf: ovotransferrin 
a Terminal sialic acid residues removed. b  Glycan chains not defined. 
However, the crystals are often difficult to handle and the X-ray analysis somewhat 
challenging. Numerous attempts to alter the crystallisation conditions to try and 
improve upon the quality of diffraction patterns have been met with only partial 
success. A low resolution analysis of rabbit serum transferrin in 1979 showed the 
bilobal structure of the molecule [I I] but more complete details of the structure 
emerged with the publication of the structure of human lactoferrin in 1987 [12]. The 
structure of rabbit serum transferrin soon followed at a resolution of 3.3 A [8], 
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confirming information already gained. More recently the crystal structure of 
diferric porcine transferrin at a resolution of 2.15 A has been published [13]. It has 
been shown by many workers that transferrins can be proteolytically cleaved to give 
half-molecular-weight fragments corresponding to individual lobes with each 
containing a single iron-binding site [7]. As the glycan chains are on the C-lobe of 
human serum transferrin, and the N-lobe fragments are not glycosylated, this 
eliminates any problems during crystallisation that may be due to glycosylation. In 
some cases further cleavage can occur to produce stable quarter-sized fragments (half 
lobe, single domain) which can bind iron [14, 15]. It was therefore believed that 
crystallisation of these fragments might give rise to better-ordered, more closely 
packed crystals which would then give higher resolution diffraction patterns and 
hence finer details of protein structure. In some cases mutants of transferrins and 
transferrin fragments have been crystallised providing information on the binding of 
metals to the protein [16, 17]. 
The structure of an iron-containing half N-lobe fragment (39 kDa) of rabbit 
transferrin [18] was not found to be significantly altered by proteolysis and it is 
thought that this may be due to the fragment being a stable structural unit which can 
fold in an independent manner. The environment and hydrogen bonding of the anion 
to Fe 3+  confirmed that the anion bound is carbonate and not bicarbonate. Further, the 
residues surrounding the anion (Asp63, Gly65, Tyr95, Thrl20, Arg124, Ser125, 
A1a126, G1y127, Tyr188 and His249) are conserved in all transferrins [19, 20] and 
the attachment of the carbonate anion is a general feature in all members of the 
transferrin family. An exception to this, however, is the C-lobe of melanotransferrin 
(a membrane bound protein) [21], where Thrl20 and Arg124 have been replaced by 
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Ala and Ser respectively, and also Asp63 has been substituted by a Ser residue. 
4.1.2.1 Structure of Transferrin 
All the transferrins with the exception of fish transferrin are glycoproteins [22, 23]. 
The polypeptide folding is very similar for all proteins of the transferrin family. The 
polypeptide chain is folded into two globular lobes representing the N-terminal and 
the C-terminal halves which are known as the N- and C-lobe respectively. Human 
serum transferrin has two bi-antennary carbohydrate chains, both on the C-lobe 
attached to asparagine residues (Asn413 and Asn6l 1) [23, 24]. The structure of 
these are shown in Figure 1.2, Chapter 1. The polypeptide chain of human 
transferrin contains 678 amino acids, with two glycan chains each of a molecular 
weight of 2207 Da, giving an overall molecular weight of 79, 550 Da [25]. When 
residues 1-336 are aligned with residues 337-678 the two sequences are 40% 
identical and those residues that are not identical are similar in chemical nature. 
These similar regions form the two Fe-binding lobes of the protein [25]. When the 
nature of the amino acids conserved between the two domains is analysed, a large 
portion appears to be of potential structural significance such as cystines, glycines 
and hydrophobic residues. This could reflect the preservation of a similar three 
dimensional structure in two domains. Some conserved residues are likely to have a 
functional significance. 
There are some differences between the NH 2 -terminal (N) and COOH-terminal (C) 
lobe. The N-lobe contains fewer disulfide bonds than the C-lobe (8 compared to 11), 
whereas the C domain is home to both glycosylation sites of human transferrin [25]. 
Within each lobe there is a further subdivision into two separately folded domains. 
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The cleft separating the two domains of each lobe contains the metal binding site. 
Each domain is made up of a mixed 13-sheet overlaid with cc-helices. This is 
important since the N-termini of many helices are directed toward the central binding 
cleft and the partial positive charges they carry may help to attract anions to the 
binding cleft. Two extended 13-strands run behind the iron site to act as a backbone 
which is vital to the conformational change during metal ion binding [24]. 
4.1.2.2 Metal Co-ordination 
The iron co-ordination is distorted octahedral with ligands provided by four amino 
acid side chains from the protein, 2 Tyr, 1 His and I Asp with a synergistically 
bound bicarbonate anion. Metal-ligand bond lengths are all around 2.0 - 2.2 A. The 
bond angles show larger deviations from ideal because of the small chelate 'bite' 
angle of the bicarbonate anion of Ca. 65° [23]. The involvement of tyrosine ligands 
is expected as indicated by the absorption band seen at 465 rim in the visible 
spectrum, typical of iron-phenolate interaction [26, 27]. It is this that gives rise to 
the orange-red colour of iron transfenmn. EPR [28, 29] and NMR [30] studies have 
suggested metal-histidine co-ordination. 
Extended X-ray absorption fine structure (EXAFS) spectroscopy can provide 
relatively accurate information on the metal environment. Average metal-ligand 
bond lengths and co-ordination numbers can be determined but oxygen cannot be 
distinguished from nitrogen as a ligand. The two metal sites in doubly-loaded 
transfenmn cannot be distinguished either. However, EXAFS can provide useful 
information on proteins where crystallisation is very difficult as is the case with 
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transferrin, particularly when loaded with various metals such as manganese. 
Previous work in this laboratory by S. Bihari [31] on Mn-hTf has given the bond 
lengths shown in Table 4.2. These values suggest small differences between the 
bonding of iron and manganese to transfenin. Both manganese and iron have a 
distorted octahedral geometry but whereas with Fe(III) the co-ordination sphere is 
more nearly regular octahedral, Mn(III) shows a reverse Jahn-Teller distortion with 
two short axial bonds and four long equatorial bonds. 
Table 4.2 Metal-ligand bond lengths for the N-lobe of hTf with Mn(1II) or 
Fe(III) bound determined by EXAFS and X-ray crystallography respectively. 
Mn Bond Length (A) 1311 Fe Bond Length (A) 161 
2 Mn-O/N 1.937 5 Fe-O 1.99, 1.90 (Tyr) 
2.02 (Asp) 
2.06, 2.24 (C03 2 ) 
4 Mn-OIN 2.204 1 Fe-N 2.10 (His) 
Further information on the geometry of metal-ligand interactions in proteins can be 
gained by comparing structures of metalloproteins deposited in the Protein Data 
Bank (PDB) and from information on small molecule complexes in the Cambridge 
Structural Database (CSD). Predications can then aid refinement of structures when 
resolution is poor. An example of predicted metal-donor distances for manganese 
and iron is shown in Table 4.3. If these values are compared with those shown in 
Table 4.2, it can be seen that the distances for Fe(III) in transferrin are quite similar 
to those predicted whereas the distances found with Mn(III) by EXAFS are quite 
different. This may be in part due to averages being used where more than one 
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oxidation state of the metal is given. 
Table 4.3 Metal-donor distances [321. Metal-donor target distances (A). These 
values are based on distances found in the CSD. 
= 0 water 0 Asp or Glu, monodentate 0 Ser or Thr 0 Tyr N His S Cys 
Mn 2.21 221b 2.25 1.88 2.19 2.35 
Fe 2.09 2.01 2.13 1.93 2.08 2.27 
In bidentate carboxylates these values are increased by 0.11 A. Values derived from the PDB. 
Distances found in CSD with the use of weighted averages where distances given for more than one 
oxidation state or co-ordination number 
Ideally the best way to investigate the binding of manganese to transferrin would be 
to obtain a crystal structure and then to compare this to the structures previously 
found for members of the transferrin family with and without iron bound. 
4.2 Materials and Methods 
A number of factors can affect the solubility of a protein and the rate of precipitation. 
These include temperature, original concentration of the protein, purity of the 
protein, type and concentration of additives used in the crystallisation process. The 
most difficult part of protein crystallography is determining the correct conditions for 
crystallisation of the protein being studied. A number of texts including Practical 
Protein Crystallography [1] give information and techniques for crystallisation of 
proteins. 
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4.2.1 Crystallisation Techniques 
As already mentioned, crystallisation of a protein is achieved by the gradual removal 
of solvent from a solution containing the protein. A common method of 
crystallisation is by vapour diffusion whereby a droplet of protein solution containing 
precipitant is equilibrated with a reservoir solution containing a higher concentration 
of precipitant so that water preferentially evaporates from the drop. In the correct 
conditions, this will allow a few crystals to develop as protein and precipitant 
concentrations are gradually increased. Conditions can be achieved using the 
hanging drop and sitting-drop methods as shown in Figure 4.2. The coverslip is 
sealed with vacuum grease so as to create a closed system with the drop of the well. 
The concentrations of the precipitants in the drop are half of what they are in the well 
and this results in a vapour equilibration from the drop to the well. As the drop 
evaporates the protein becomes further concentrated until it is forced out of solution. 
The sitting drop technique is similar to the hanging drop except that the drop is 
placed on a pedestal above the well solution; this is often used for larger drops, 
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Figure 4.2 Vapour diffusion methods used for crystallisation of proteins. Both 
methods have a well solution containing buffered precipitate solution. The drop 
contains well solution and the protein to be crystallised. 
Iron transferrin was prepared as described in Chapter 3, section 3.2.3. Briefly, holo-
hTf was reacted with 2 mol equivalents Fe(NTA)2 to ensure full saturation of the 
metal binding sites. The Fe2-hTf was set up on 24 well plates as hanging drops using 
similar conditions to those used previously by Zuccola [5]. Protein samples of ca. 1 
niM (5 Ill) and precipitant well solution (5 p1) made up of 20-26% PEG 400, 100 
mM Na cacodylate buffer, pH 5.4 - 5.6 was used. Exact conditions can be found in 
Appendix G. Plates were then kept at 277 K and checked on a regular basis for signs 
of crystal formation. Plates were set up with similar conditions using Mn-hTf. Mn-
hTf was prepared as described in Chapter 3, section 3.2.2. Briefly, apo-hTf was 
reacted with MnC12 in the presence of caeruloplasmin or alternatively with KMn0 4 . 
Mn-hTf with differing ratios of metal to protein were used for crystallisation 
experiments and details are given in the text where appropriate. 
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4.2.1.1 Screening Technique 
Screening techniques can often be employed in order to help determine suitable 
conditions for crystal growth. The screening solutions are of a varying range of pH 
and precipitants. They take the form of a number of solutions selected from 
previously published works in which crystallisation of a protein has been achieved. 
Two 24 well plates were used to screen for conditions of Mn-hTf crystallisation. A 
set of solutions were obtained from Structure Screen 1, Molecular Dimensions Ltd. 
The conditions used can be found in Appendix H. The hanging drop method was 
used as in previous experiments and the drop consisted of the reservoir liquid and 
Mn-hTf to give protein concentrations in the drop of Ca. 175 PM. The Mn-hTf used 
for screening experiments had been made by reacting molar equivalents of KvIn0 4 
with apo-hTf to produce singly and doubly loaded Mn-hTf. Plates were kept at 277 
K and monitored for any signs of crystal formation or precipitation. 
4.2.1.2 Seeding from Crystals 
Crystals may form but may not be of a high enough quality to collect data. In this 
case the poor quality crystals can be used to seed better ones. Cat's whiskers provide 
a good tool for seeding from grown crystals. Whiskers were kindly supplied by cat 
owners from members of the School of Chemistry, Edinburgh University. The 
whiskers were cut at 1 cm intervals using a sharp sterile scalpel so that pieces of 
whisker of varying thickness were obtained. These were then glued onto the ends of 
disposable pipette tips to act as a handle. The whiskers were labelled so that later 
identification could be made if necessary. The whiskers were then washed in 
ultrapure water and 70% ethanol and allowed to air dry before use. Seeding was 
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done from Fe-hTf crystals that had formed but were of poor diffraction quality. 
Plates were set up using conditions similar to those in plates where crystals were 
found except that the protein concentration in the drop was reduced to approximately 
half or a quarter of that used previously, i.e. 0.25 and 0.125 mM Fe-hTf. The plates 
were then allowed to equilibrate overnight after which time the coverslips were 
removed ensuring that the drop was not disturbed. The cat's whisker was then used 
to gently stroke the already-formed crystal. The whisker was then dragged through 
the drop on the new plate. This procedure was repeated for each drop. Plates were 
then incubated at 277 K as before. 
4.2.2 Data Collection 
Once crystals were grown data collections were kindly carried out by Stephen 
Robinson and Malcolm Walkinshaw (Department of Structural Biochemistry, 
Edinburgh University) and using the synchrotron (SRS, Daresbury). To increase 
lifetime, it is often necessary to freeze the crystals. Cryo-preserved crystals often 
ensure longer data collection before crystal degradation. However, there are 
problems in ensuring the correct freezing conditions are achieved so that the crystal 
is not destroyed during the freezing process [33]. 
4.2.3 Freezing Solutions 
One approach to establish freezing conditions is to use the mother liquor as the 
freezing solution. This can be frozen without the crystal initially to determine if the 
solution is suitable. If ice-rings form in the mother liquor then glycerol can be added 
at 10% (vlv) to see if this improves conditions. The amount of glycerol can be 
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increased until optimum freezing solutions are obtained. Crystals can then be picked 
out using an appropriately sized cryoloop (Hampton Research, UK), dipped in the 
freezing solution for 1-5 seconds and then immediately submerged in liquid nitrogen 
in a cryovial (Hampton Research, UK). 
4,3 Results and Discussion 
4.3.1 Crystallisation of Fe-hTf 
Fe2-hTf was prepared as described earlier. Crystallisation was carried out following 
the method of Zuccola [5]. Zuccola managed to crystallise monoferric transferrin 
with iron bound in the C-lobe; the N-lobe remained open. The transferrin used by 
Zuccola had been treated with neuraminidase to remove all terminal sialic acid 
residues. These conditions were repeated in this current work but without treatment 
of transferrin with neuraminidase. Reservoir conditions were set up as shown in 
Appendix G, plates G.1 - G4. A 5 tL volume of drop of Ca. 1 mM Fe2-hTf 
(approximately 78 mg/ml) was mixed with 5 V il drop of reservoir solution. These 
mixtures formed the drops which were spotted on silicanised coverslips. These were 
then placed over the tops of the wells and sealed with vacuum grease as shown in 
Figure 4.2. The plates were then incubated at 277 K. The plates were checked for 
appearance of crystals. After approximately six weeks ellipsoidal crystals were 
observed in the precipitant of wells on plate G.2. The crystals were red in colour and 
were visible to the naked eye. Further crystals were found on plates G.3 and G.4. 
All Fe-hTf crystals were red in colour with the same ellipsoidal shape. An example 
of the crystals formed can be seen in Figure 4.3. The crystals were quite large, 
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around 0.8 - 1 mm across with the absence of any flat surfaces which are normally 
expected for crystals. Although crystals appeared after approx six weeks on plate 
G.2, others formed after only two weeks on plate G.3. Some crystals appeared after 
several months. An example of these can be seen in Figure 4.4. Unfortunately these 
were found to give no better resolution. 
1mm 
Figure 4.3 Crystals obtained from a solution of Fe 2-hTf. Crystals found in wells 
where there is some precipitate giving a tinted background. Approximate scale bar 
shown. Crystals shown were grown in 100 mM Na cacodylate, pH 5.43, 24% PEG 
400 at 277 K. 
Freezing conditions for these crystals were found to be the mother liquor with 30% 
added glycerol. Crystals were picked out using a cryoloop and transferred to a 
cryovial. 
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Figure 4.4 Crystals obtained from a solution of Fe2-hTf. Crystals shown were grown 
in 100 mM Na cacodylate, pH 5.6, 26% PEG 400 at 277 K. Approximate scale bar 
shown. 
4.3.1.1 Data collection and Processing 
This was kindly carried out by Stephen Robinson and Prof. M. Walkinshaw of the 
Institute of Cell and Molecular Biology. The crystal was mounted on a Monnius 571 
rotating anode X-ray generator. The X-ray source was a copper anode, wavelength 
of 1.542 A. A test exposure was taken over 15 minutes with the image plate at 250 
mm and with an oscillation angle of 1.50  traversed once. A repeat exposure with the 
image plate at 240 mm for 20 minutes showed diffraction spots to approximately 2.9 
A resolution. An example of the diffraction image of an intact Fe 2-hTf crystal 
collected on the home source is shown in Figure 4.5. 
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Figure 4.5 Diffraction image of Fe 2-hTf crystal taken at Edinburgh. Diffracted X-
rays are seen as black spots on the film. 
This image was indexed using DENZO to give the parameters shown in Table 4.4 
along with the values obtained from Zuccola's crystal structure [5]. Measurements 
a, b and c are the lengths of the three axes of the parallelipiped making up the unit 
cell. The angle a is that made by the axis b and c around a. The measurements for 
the crystal grown here are similar to those gained by Zuccola except for a, which 
may be an indication of a different crystal packing. However, the terminal sialic acid 
had been removed from the transferrin Zuccola used to crystallise but no such 
treatment was applied to the Fe-hTf crystal used here. Further, only one iron was 
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bound to the transfenin that had been crystallised by Zuccola [5]. The transferrin 
used in this work was confirmed to be diferric in solution (by ICP-AES) but at the 
low pH (Ca. 5.5) of the buffer used for crystallisation, it is likely that one Fe(III) ion 
has dissociated from transferrin, probably the N-lobe. Fe(III) is known to dissociate 
from transferrin under acidic conditions, with the C-lobe being more acid-stable [23, 
34]. 
Table 4.4 Initial crystal parameters obtained from Fe-hTf diffraction image 
Parameter a (A) b (A) c (A) cc (°) P  (°) y  (°) 
This Thesis 82.61 133.35 147.73 90.00 90.00 90.00 
Zuccola's Thesis [5] 127.19 127.19 144.85 90.00 90.00 90.00 
The diffraction patterns proved to be too close together and incomplete so data were 
not collected. This was largely because the diffraction spots appeared to be 
composed of multiple overlaying spots suggesting a split crystal. The intensity of the 
diffraction spots was insufficient beyond 2.9 A so a dataset could not be collected. 
The crystals were taken to the SRS station 14.2 at Daresbury Laboratory for further 
screening. This confirmed that most crystals were split to some extent. However, 
the crystal was cleaved and a fragment mounted which gave reasonably good quality 
diffraction. An image taken at Daresbury laboratory is shown in Figure 4.6. 
Diffraction extended to 2.2 A resolution and a dataset was collected and processed 
using DENZO [35] and Scalepak [35] to give fully scaled data 90% complete to 
3.3 A in space group P21212 1 with 30024 unique reflections. 
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Figure 4.6 Diffraction image of Fe 2-hTf taken at the SRS, Daresbury Laboratories. 
A fragment of the original crystal was mounted to give good quality single crystal 
diffraction. 
4.3.1.2 Model Building 
Attempts were made by Stephen Robinson to solve the structure using molecular 
replacement. Full details of the procedure and computer software packages used can 
be found in his thesis [36]. A variety of search models were used for molecular 
replacement including the previously solved N-terminal half-molecule of human 
transferrin (PDB ID 1A8E) [6] and rabbit transferrin (PDB 1TFD) [18]. It was 
concluded that two molecules per unit cell were present. The main statistics from 
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collection and processing of data from the iron transferrin crystal are shown in Table 
4.5. 
Table 4.5 Statistics for Fe-hTf data collection and processing 
Parameter Value 
Wavelength (A) 0.978 
Space Group (A) P2 1 2121 
Unit Cell Vector Lengths (A) a = 82.77, b = 132.14, c = 146.68 
Unit Cell Angles (°) c'. = 13 = 	= 90 
Unit Cell Volume (A3) 1604430.375 
Estimated Water Content (%) 50.5 
Resolution Range (A) 100 - 2,988 
No. of Measurements 550967 
No. of Unique Deflections 33320 
Completeness (%) 90 
Rmerge 14.9 
Average 1Ic 4.6 
Further modelling was carried out using a previous human transferrin model kindly 
made available by Dr H. J. Zuccola, Harvard University Medical School. However, 
the structure was for a singly loaded Fe-hTf molecule with Fe 3+ bound in the C-lobe. 
Unfortunately the deficiencies in the dataset due to poor crystal quality resulted in no 
solution of the crystal structure. 
The rather odd shape and lack of flat surfaces suggests disorder of the crystals and 
helps explain the relatively low resolution. 
Glycoslylation levels may differ between molecules within a sample, potentially 
promoting disorder in crystal packing. This may be overcome by treatment with 
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neuraminidase as was used by Zuccola [5] to remove the terminal sialic acid from the 
protein. 
The unusual ellipsoidal shape of the Fe-hTf crystals suggests a disordered growth 
phase following initial nucleation and resulting in poorly ordered crystals. The 
transferrin supplied by Sigma was washed with KC1 to remove low molecular weight 
impurities prior to use, as described in Chapter 3, section 3.2. However, the mixture 
may not be entirely homogenous. Prior to further crystallisation studies it may be 
necessary to develop an HPLC technique to ensure a homogenous mixture. It is 
possible that some of the iron may be released from the protein during the 
crystallisation process thus contributing to the lack of homogeneity. The dissociation 
of Fe(III) is due to the acidic pH of the crystallisation process, as discussed earlier. 
Further, lack of bicarbonate in the crystallisation process may result in lobe opening 
and hence release of the iron. 
4.3.1.3 Seeding of Crystals 
Seeding of crystals was carried out using Fe-hTf crystals already obtained. A plate 
was set up using the conditions shown in Appendix G, plate G.5. Briefly Fe-hTf was 
used to give a concentration of 0.26 or 0.128 mM in the drop. The reservoir solution 
contained PEG 400 at 20 - 26 % with 100 mM sodium cacodylate buffer at pH 
values of 5.4, 5.5 and 5.6. These were a repeat of the conditions used to grow 
crystals previously (see Section 4.2.1) but using a lower concentration of Fe-hTf. 
The plate was kept at 277 K and checked for crystal growth. Unfortunately no 
crystals formed over a period of eight weeks. This may be due to the lower protein 
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concentration. Crystals may have required a longer time period to form. 
4.3.2 Crystallisation of Mn-hTf 
Mn-hTf was prepared as described previously in Chapter 3, Section 3.2.2. 
Attempted crystallisation of Mn-hTf was carried out using Mn-hTf produced by 
loading of apo-transferrin using MnC1 2 in the presence of caerulopiasmin or by using 
KMn04. Similar conditions were used to those for Fe-hTf in the first attempt to 
crystallise Mn-hTf, as described in Appendix G, plate G. 1. A 5 tl volume of drop of 
Ca. 1 mM Mn2-hlf (approximately 78 mg/ml, which had been prepared using 
MnC12) was mixed with 5 tl drop of reservoir solution. The reservoir solution was 
made up of PEG 400 at 20 - 26 % and 100 mM sodium cacodylate at pH 5.6. These 
mixtures formed drops which were spotted onto siiicanised coverslips. These were 
then placed over the tops of the wells and sealed with vacuum grease as shown in 
Figure 4.2. The plates were then incubated at 277 K and were checked for 
appearance of crystals over a period of 3 months. Unfortunately no crystals formed 
just a precipitate within 3 weeks. Another plate was set up using the same conditions 
except with a range of pH values of 5.4 - 5.6. The conditions can be found in 
Appendix G, plate G.6. The Mn-hTf used had been prepared using KMn0 4 . 
Precipitate formed in most of the wells but some crystals had formed after a period of 
Ca. eight weeks. They were of similar shape to those seen for Fe-hTf but were pale 
brown in colour rather than red. An image of the crystals is shown in Figure 4.7 
where the high level of precipitate is clearly visible. 
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1mm 
Figure 4.7 Crystals of Mn-hTf. Crystals found in wells where there is much 
precipitate. Crystals shown grown in 100 mM Na cacodylate, pH 5.6, 26 % PEG 400 
at 277 K. Arrows indicate crystals. Approximate scale bar shown. 
These crystals took much longer to appear and were much smaller than the Fe-hTf 
crystals found being approximately 0.3 mm in length. A diffraction pattern for one 
of these crystals found is shown in Figure 4.8. The Mn-hTf crystals did not diffract 
so no further work could be carried out on them. The Mn-hTf that had been used 
was found to have a ratio of 3 Mn: I hTf by UV/Vis spectroscopy and ICP-AES. 
The possibility of more than two manganese ions being bound to a transferrin 
molecule is discussed in Chapter 3 where experiments showed that this could be 
achieved, although where the extra manganese binds and if it is as Mn(HI) is still yet 
to be determined. The manganese ions may form a cluster which then binds to 
transferrin. This may then greatly influence the growth of crystals and the necessary 
conditions required. Further, the Mn-hTf produced using KMn04 may not be 
homogenous which would again greatly affect the growth of crystals. 
The crystallisation process used quite acidic conditions, in the region of pH 5.5. 
Results of the experiment detailed in Section 3.3.8 show that Mn(ll1) dissociates 
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from transferrin in a manner similar to that seen with Fe-hTf. It is likely that at the 
pH used for these crystallisation experiments, only one Mn(III) is bound to 
transferrin. The lack of bicarbonate in the conditions used may also contribute to 
dissociation of Mn(III). These factors could contribute to lack of success of 
crystallisation due to a heterogenous solution of Mn-hTf. 
Figure 4.8 Diffraction image of Mn-hTf crystal taken at Edinburgh. There is an 
absence of black spots on the film showing that the crystals did not diffract. 
4.3.2.1 Screening Technique 
A crystal screen was set up in order to try to optimise the crystallisation conditions 
required for Mn-hTf. A screen containing fifty solutions was purchased (Structure 
Screen 1, Molecular Dimensions Ltd., UK). The composition of the solutions used 
are given in Appendix H. Of each solution, 1 ml was used as the reservoir solution 
and a hanging drop set up using 5 p.1 of the reservoir solution and 5 p.! Mn-hTf. Two 
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screens were set up on 24 well plates as before using Mn-hTf that had been loaded 
using KMn04 to give 1 and 2 metals loaded onto the transferrin as determined by 
UV/Vis spectroscopy and ICP-AES. The Mn-hTf was used at a concentration of Ca. 
0.15 mM in the drop. A full list of the solutions used is shown in Appendix H with 
the results. Unfortunately no evidence of crystal formation was found, with only 
precipitate forming in some of the wells with possible aggregation seen with one of 
the solutions. This was the case for both Mn-hTfs used in the screening test. Again, 
the problems may arise from the heterogeneity of the Mn-hTf used. 
4.4 Conclusions 
The disordered growth phase suggested by the unusual shapes of the Fe-hTf crystals 
needs to be overcome before good X-ray data can be obtained. Although the 
transferrin used is of high purity it may be necessary to subject the protein to further 
purification after metal loading in order to achieve a greater homogeneity. The 
development of a high performance liquid chromatography (HPLC) method may 
prove beneficial particularly in the case of Mn-hTf where use of KMn0 4 may result 
in a mixture of Mn-hTf with varying loading and variable modification of amino acid 
side chains (e.g. oxidation of methionine to the sulfoxide and sulfone). This may 
then reduce stress in the crystals. 
It may also be worthwhile to treat all transferrins with neuraminidase to remove the 
terminal sialic acid from the protein. Alternatively, treatment of proteins with 
endoglycosidase F has shown to remove all glycan chains from proteins [37]. Again, 
HPLC methods may be useful in then separating protein that has had all glycan 
chains removed or just its terminal sialic acid residues from any remaining protein 
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which has not to achieve a homogenous mixture. This may allow the formation of an 
ordered crystal lattice which should produce crystals of a higher quality. 
Deglycosylated transferrin has not been shown to behave differently to glycosylated 
protein in biological assays [38, 39] therefore the only effect would be to aid 
crystallisation. Refinement of conditions and seeding failed to yield better quality 
crystals, although it may take longer than the time available in this present study for 
crystals to form from seeding. Alternatively, better crystals may be grown by 
collecting already formed crystals, re-dissolving them and allowing to grow under 
refined conditions. 
Mn-hTf crystals grew only in conditions similar to those required for growing Fe-hTf 
crystals suggesting these are the best conditions. However, the crystals were not of 
very good quality and took a considerable length of time to grow so these conditions 
may need to be refined although it is a good starting point. Further, no crystals 
formed in the screening solutions suggesting the current conditions are close to 
optimum. 
The current conditions used to crystallise transferrin are acidic (pH Ca. 5.5) which is 
known to result in dissociation of Fe(III) from the N-lobe. The results shown in 
Section 3.3.8 show that Mn(III) also dissociates from transferrin under acidic 
conditions, although it is not possible to say which lobe loses Mn(III) first. 
Therefore in these crystallisation experiments, any crystals that form are likely to 
have only one lobe of transferrin occupied by metal. Also, the lack of carbonate in 
these conditions may also contribute to loss of metal from the protein. 
Within any metal-donor atom combination, the co-ordination number and its 
oxidation state (spin state) of the metal may affect the bond distance, the chemical 
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nature of the ligand, in particular its charge and also can affect other surrounding 
ligands around the metal atom. This may be the case with Mn-hTf with regards to 
the chemical and physical behavioural differences compared with Fe-hTf. The 
EXAFS data have shown there is a slight difference in the metal binding site of 
transferrin when Mn(III) is bound rather than Fe(III). However, this may not have 
such an effect to warrant entirely different growth conditions for crystallisation. 
Further, loading transferrin with Mn(III) from different sources such as MnC1 2 and 
KMn04 may also affect transferrin and its behaviour and it may not be until a crystal 
structure is solved that these differences become clear. From the evidence in Chapter 
3 it seems likely that the addition of KMn0 4 to transferrin may also result in 
oxidation of the protein, in particular the methionine residues. This alteration of the 
protein structure and perhaps the chemical nature of the residues in the protein may 
then alter the crystallisation conditions required and make successful crystallisation 
much more difficult to achieve. The glycan chains may also be targets of oxidation 
so removal of these may be beneficial when attempting to crystallise Mn-hTf that has 
been produced using KMn04. Further, manganese may bind to transferrin at sites 
other than the two identified metal binding sites or may bind as a cluster when loaded 
using Mn04 . This may result in different crystallisation conditions being required 
when different sources of manganese are used to produce Mn-hTf. 
All of the conditions mentioned above would contribute to the difficulty in 
crystallising transferrin. While some crystals have formed under the conditions used 
different forms of the protein, particularly in the case of Mn-hTf produced using 
KMn04, may pack onto the crystal resulting in stress and disorganisation. Once 
these problems are resolved better crystals should be obtainable. 
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Chapter 5 Effects of Manganese Transferrin on 
Hep atocytes 
5.1 Introduction 
Work reported in this thesis and that of Bihari [1] has shown that Mn is able to bind 
to the iron transport protein transferrin. Therefore, the next step is to determine if 
Mn-hTf can be used as a transport mechanism for Mn delivery to hepatocytes. Mn is 
known for its redox chemistry therefore it is of interest to observe the effects that Mn 
may have on hepatocytes, in particular on the mitochondria which is where Mn is 
found in high concentrations [2]. 
There is little information on the pharmacokinetics of manganese. Absorption 
appears to occur through the small intestine by both active transport and passive 
diffusion mechanisms. Mn ions are transported via the portal circulation to the liver. 
In what forms manganese is transported to the liver, for example bound to albumin or 
alpha2-macroglobulin or as aqua manganese complexes., is also unclear. A fraction 
of Mn is taken up by hepatocytes and a fraction is transported by the systemic 
circulation to the various tissues of the body. Absorbed Mn is excreted via the 
billiary route with very little manganese being excreted in the urine. Tissues with 
high levels of mitochondria tend to have high levels of manganese, as the manganese 
concentration of mitochondria is higher than that found in the cytoplasm [3]. 
Using a homologous competition of 54Mn-transferrin with Mn-transferrin and 65Zn-
transferrin with Zn-transferrin, it was found that there are receptors which bind Mi- 
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transferrin and Zn-transferrin on the plasma membrane of lactating mouse mammary 
gland cells confirming that the same receptor accepts all three (Fe, Mn and Zn) 
metals from transferrin [4]. 
5. 1.1 Hepatocyte Iron Metabolism 
The liver is a major storage site for iron and is a principal site of synthesis of 
transferrin, the transport protein for iron. As a result the liver has a major function in 
the maintenance of whole body iron homeostasis. Under normal conditions, storage 
iron is found mainly in hepatocytes with small quantities found in Kupffer cells [5]. 
Hepatic iron totals Ca. 0.4 g and is localised mainly in the hepatocytes where it can 
be found in the form of ferritin, haemosiderin, haem and transferrin-bound iron [5]. 
The hepatocyte synthesises and secretes transferrin into the plasma where it 
circulates and delivers iron from absorptive sites in the small intestine to storage sites 
in the liver and reticuloendothelial system and to sites of utilisation, principally the 
bone marrow, muscle and the liver [5]. 
Hepatocytes take up transferrin-bound iron by two mechanisms. One pathway 
consists in the binding of transferrin to high affinity receptor sites and uptake via 
receptor-mediated endocytosis. The other mechanism involves low affinity, non-
specific and non-saturable internalisation of transferrin-bound iron, probably through 
pinocytosis, adsorptive endocytosis or low affinity binding sites [6]. 
Changes in hepatic storage are regulated by a complex series of interactions in the 
liver including availability of iron, storage of the protein ferritin, haem synthesis, 
release of iron from transfelTin and circulating iron-bound transferrin [5]. 
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The mechanisms of delivery of iron to mitochondrial membranes and uptake into 
mitochondria are still unclear. Within mitochondria, iron is found in three 
biochemical forms: approximately one third is found in haemoproteins such as the 
cytochromes, a third is located in iron-sulfur clusters found in enzymes within the 
inner and outer membrane such as succinate dehydrogenase and cytochrome c and 
the remaining third is thought to represent a mitochondrial transit pool that provides 
iron for incorporation into haem [7]. 
5.1.2 Manganese Uptake 
Using kinetic studies, Bertini et al [8] suggested that manganese is released from 
transferrin in the same manner as iron. Manganese transferrin binds to the transferrin 
receptor on cells and is internalised by receptor mediated endocytosis [9]. The 
endosome vesicles probably undergo acidification as seen with the intemalisation of 
iron transferrin whereby Mn 3 is released by transferrin. The Mn 3 generated in the 
endosomes is thought to be reduced to Mn 2 prior to its transportation across the 
endosomal membrane into the cell via the transport protein DMTI (also referred to 
as Nramp2 or DCT1). A proton gradient across the endosornal membrane is thought 
to be the force behind metal ion/proton transport out of the endosomes by DMT 1. 
Manganese can also be directly taken up into the cell by a transferrin-independent 
mechanism requiring DMT1 [9, 10]. DMT1 has a broad substrate specificity and is 
likely to be the transmembrane protein responsible for the uptake of many divalent 
cations including Mn2 , Cd2 , Zn2 , Co', Ni", Pb2 and Cu2 [11]. 
Thermodynamic modelling of Mn(II) in serum suggests it exists in several forms, 
including an albumin-bound species (84%), as a hydrated ion (6.4%) and in 1:1 
163 
Chapter 5: Effects of Manganese Transferrin on Hepatocytes 
complexes with HCO3 (5.8%), citrate 3- (2.0%) and other small molecular weight 
ligands [12]. Similar modelling of Mn(III) in serum predicts that it is almost 100% 
bound to transferrin [12, 13]. Diffusion and transport of substances across 
membranes depend on the size, charge and shape of the molecule. 
Finley [14] has shown that the hepato-carcinoma cell line Hep-G2, like isolated rat 
hepatocytes, has an efficient homeostatic mechanism for uptake and regulation of 
Mn, and that the uptake of Mn is by a facilitated mechanism. Galeotti et al [15] 
obtained evidence for three Mn uptake systems in rat liver slices incubated in vitro: a 
low affinity system suggested to be receptor-operated Ca channels, a system whereby 
Mn entered the cell via the Ca/Na exchange pump of medium affinity and a third 
Mn-specific high affinity system. 
Chua et al [16] have found three manganese transport mechanisms in rabbit erythroid 
cells: two for Mn 2 (high and low affinity processes) and one for manganese bound 
to transferrin. Manganese metabolism has been reported to be abnormal in the 
Belgrade rat which is characterised by defects in transferrin metabolism [17]. Thus 
there appears to be evidence that the plasma and transmembrane transport of Mn and 
Fe share common mechanisms [17, 18]. 
Once manganese enters the liver it can enter one of several pools. A high percentage 
enters the lysosome pool, from which it is transferred to the bile canaliculus. A 
second pool of manganese is associated with the mitochondria; the uptake and 
release of manganese by mitochondria is thought to be linked to calcium flux, and 
manganese may move through calcium channels. A third pool is found in the nuclear 
fraction of the cell although its role is poorly understood. A fourth pool is 
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incorporated into, or associated with, newly synthesised manganese proteins. A fifth 
pool is free Msi2 [2]. Under physiological conditions, Mn in serum would be 
surrounded by potential ligands and so very little would be expected to exist as the 
free (aqua) ion. 
The rate of uptake of Mn by enterocytes within the intestinal lining and its overall 
hepatic elimination in bile tightly regulates systemic Mn levels [9]. A complex 
series of events including uptake, retention and release, regulates cellular levels of 
Mn. However, manganese deposition can be influenced by iron intake since both 
metals appear to be transported by the same protein in serum and other cellular 
transport systems, thus complicating the process further [9]. Manganese is supplied 
to the brain as Mn(II) and MIn(III) via both the blood-brain and the blood-
cerebrospinal fluid barriers and transferrin is thought to be involved in these 
processes [19]. It is unclear whether there is a predominant Mn species crossing the 
blood-brain barrier (BBB). Crossgrove et al [20] show evidence for carrier mediated 
transport of Mn(II) by DCT1, Mn-hTf and manganese citrate across the BBB. 
Transporters for Mn citrate have yet to be confirmed although likely candidates 
include a monocarboxylate transporter (MCT) and/or members of the organic anion 
transporter polypeptide (OATP) or ATP-binding cassette (ABC) superfamilies [17]. 
The transport mechanism for Mn may depend upon the tissue itself. The liver is 
known to have a high number of transferrin receptors [6, 21] 50 transferrin may 
provide a favourable transport mechanism for delivery of manganese to hepatocytes. 
This allows delivery of manganese to hepatocytes in a bound non-toxic form where it 
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can then be removed using a method already established for iron and then 
incorporated into enzymes such as SOD. Further, work on the Belgrade rat supports 
this as a mode of transport. 
5.1.3 Manganese Toxicity 
Chronic exposure to metals such as iron, lead, manganese and chromium has been 
linked to the development of severe and often irreversible, neurological disorders. 
This neurotoxicity is most probably due to the transport of these metals across the 
blood-brain barrier and their uptake into targeted cells within the brain. Once inside 
the brain biochemical changes caused by the metals may lead to apoptosis and/or 
necrosis [9]. Owing to the increased use of manganese as the petrol additive, 
rnethylcyclopentadienyl manganese tricarbonyl (MMT), the metal and its potential 
health risks are being studied more closely. Exposure to high environmental levels 
of Mn produces a syndrome known as manganism which displays symptoms similar 
to that seen in Parkinson's disease [9]. Mn is normally eliminated in bile and 
anything that compromises normal liver function potentially can lead to Mn 
intoxication. The mechanism by which Mn exerts its cytotoxicity is still under 
discussion but it is likely that both apoptosis and necrosis are responsible [10]. 
One mechanism by which manganese is thought to exert its toxicity is by alteration 
of mitochondrial function. Manganese promotes calcium accumulation in 
mitochondria by inhibiting sodium- dependent and independent exporters thus 
activating the permeability transition pore (PTP), which eventually leads to 
disruption of mitochondrial function [22, 23]. Gavin et a! [24] have shown that 
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uptake of Mn2 into mitochondria leads to inhibition of oxidative phosphorylation 
and thus decreased cell respiration. During their studies there was no evidence of 
oxidative stress from the metal ion. Inhibition of oxidative phosphorylation would 
have the greatest effect in cells experiencing a constant high demand for ATP. Cells 
with high energy requirements include the central and peripheral nervous system and 
the liver which both contain many mitochondria. 
5.1.4 Mitochondrial Transin embrane Potential 
The mitochondrial transmembrane potential, which is essential for mitochondrial 
function, results from the asymmetric distribution of protons and other ions on both 
sides of the inner mitochondrial membrane. This gives rise to chemical, (pH) and 
electric gradients which are essential for mitochondrial function [25]. The inner side 
of the inner mitochondrial membrane is negatively charged. As a result, cationic 
lipophilic fluorochromes such as chlorornethyl-X-rosamine (CMXRos) distribute to 
the mitochondrial matrix [25]. These dyes can then be used to measure variations in 
the mitochondrial membrane potential. The extent of dye uptake is dependent upon 
the size of the membrane potential; dissipation of the membrane potential results in a 
decrease in cell-associated fluorescence. This can be useful when investigating the 
decrease in membrane potential of mitochondria prior to apoptosis, irrespective of 
the stimulating factor. 
5.1.5 Cell Adhesion and Divalent Cations 
Cell adhesion receptors are important in maintenance and promotion of cell 
anchorage, migration and differentiation. Many of the known adhesion receptors 
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belong to the integrin family. Gailit and Rouslahti [26] have shown that Mn 2 
increases the binding of the fibronectin receptor to fibronectin compared with Ca 2 
and Mg2 , suggesting that Mn 2 is able to compete with Ca 
2+  for the same cation-
binding sites. 
An insoluble meshwork of proteins and carbohydrates that fill most of the 
intercellular spaces make up the extracellular matrix (ECM). The interaction of cells 
with the adhesive proteins in the ECM not only supports proper attachment of the 
cells to maintain tissue and organ integrity, but also plays an important role in the 
morphological and functional development of the cells. Integrins are a superfamily 
of membrane receptors for a variety of ECM proteins. They are heterodimers made 
up of an a and 13  subunit. The integrin receptor for several ECM proteins including 
vitronectin, fibronectin and thrombospondin recognise a tripeptide sequence Arg-
Gly-Asp (RGD) in the ligand molecules. This RGD-dependent binding has been 
shown to require the presence of divalent cations, particularly Mn 2 [27]. Changes in 
the binding characteristics of integrins are thought to be responsible for the Mn 2t 
stimulated cell-substrate adhesion and cell spreading seen in a variety of cell culture 
systems [28-32]). 
5.1.6 WRL-68 Cells 
Studies with isolated rat hepatocytes have elucidated some major events in 
hepatocytic uptake of Mn. However rats and swine differ in their ability to secrete 
Mn into the bile [33], so rat hepatocytes may be a poor model in which to study 
human hepatic Mn uptake and metabolism. Therefore the development of a model 
for hepatocyte uptake and metabolism of Mn from a human cell line would be of 
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great benefit. Although the human hepatic cell line WRL-68 is of foetal origin, it 
still exhibits many liver specific functions [34]. WRL-68 cells are not grown in 
human serum and therefore should not have the added complication of requiring 
endogenous human transferrin. However, some bovine transferrin may be present in 
the growth medium used to cultivate the cells and so may influence metal uptake. 
Hamilton et a! [35] have shown that transferrin receptors are present on four 
phenotypically-distinct cell lines, supporting the theory that WRL-68 cells are 
capable of transferrin uptake. 
The work in this Chapter is concerned with the uptake of Mn from Mn-hTf by WRL-
68 cells and its subsequent effects. The comparative effect of apo- Fe- and Mn-hTf 
on the growth, viability and mitochondrial function of WRL-68 cells is studied. The 
use of Trypan blue, MTT assay and Feulgan stain was used to study the cells 
response to treatment. As manganese is known to alter mitochondrial function, the 
effect of Mn-hTf on the mitochondria of the cells was also investigated using the 
fluorochrome CMXRos. This allows visualisation of changes in mitochondrial 
membrane potential. This also served as a useful stain for observing the cells 
following treatment. 
5.2 Materials and Methods 
5.2.1 Cell Culture 
The human hepatocyte cell line WRL-68 was used in cell experiments. The standard 
cell culture conditions are described in Section 2.10.1. Cell viability and number 
was established prior to experiments using trypan blue exclusion. A detailed 
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description of this is given in Section 2.10.2. 
5.2.2 Production of Fe-hTf and Mn-hTf 
Iron-free apo-transferrin of the highest grade was purchased from Sigma (catalogue 
number Ti 147) and weighed into a sample vial. It was then fully dissolved in 0.1 M 
KCI and transferred to a 'Centricon 30' ultrafilter and washed three times using 0.1 
M KC1 to remove low-molecular-weight impurities. The Centricon tube was then 
inverted and the purified apo-hTf collected for further use. Concentrations of apo-
hTf and other hTfs were determined by UV/Vis spectroscopy using 6280 93, 000 
M'cm' [36]. To produce Fe 2-hTf and Mn2-hTf (herein referred to as Fe- and Mn-
hTf), apo-hTf was reacted with Fe(NTA) 2 or KMn04 in 20 mM Hepes buffer, pH 7.4 
with 10 mM bicarbonate. The solution was kept at 310 K for approximately one 
hour. After this time the solutions were washed using 0.1 M KCI in Centricon tubes 
and then collected and concentrated. ICP-AES and UV/Vis spectroscopy were then 
used to determine metal and protein concentrations, respectively (a more detailed 
description can be found in Section 3.2). The transferrins were subsequently diluted 
using the same medium used to grow cells (supplemented DMEM). Prior to addition 
to cells all solutions were filter-sterilised (0.2 im filters). 
5.2.3 Analysis of Cellular Metal Content 
5.2.3.1 Growth of Cells Under Standard Conditions 
WRL-68 cells were grown in large (175 cm 2)  tissue culture grade flasks under 
normal conditions with supplemented DMEM (see Section 2.10.1). Once fully 
confluent, cells were removed using trypsin-EDTA and washed twice with PBS 
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which was added to the cell suspension. Cells were then pelleted using a Mistral 
MSE centrifuge and counted using trypan blue (see Section 2.10.2). The cell 
suspension was again centrifuged and the remaining pellet was then frozen and kept 
at 253 K. Once removed from the freezer, 5 ml of ultrapure water was added to the 
pellet to ensure rupture of the cells. Metal content was then determined using ICP-
AES (Section 5.2.3.3). 
5.2.3.2 Growth qf Cells in Transferrin 
Cells were seeded into large (175 cm 2)  tissue culture grade flasks at an initial 
concentration of Ca. 106  cells/ml using 1 ml per flask and medium added. Cells were 
then left to equilibrate overnight and medium containing apo-hTf, Mn-hTf or Fe-hTf 
at a concentration of 25 iM was added to the flasks. Medium alone was added to 
cells to act as a control. After two days, the medium was removed and kept for 
analysis and fresh medium applied using the same concentration of transferrins as 
previously. Once the cells were confluent, the medium was removed and retained for 
metal analysis. Cells grown in medium, apo-hTf and Fe-hTf were confluent on the 
fourth day. However, those treated with Mn-hTf were not, so medium was removed 
and kept and fresh medium containing Mn-hTf added and the cells incubated for a 
further two days. The cells were then harvested as before. The medium removed 
from the cells treated with Mn-hTf on the final day of incubation was centrifuged 
and a small pellet of cells was collected for metal content analysis. 
Trypsin-EDTA was used to remove the cells from the layer and washed twice with 
PBS. The cell suspension was then centrifuged using a MSE Mistral 1000 
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centrifuge. The pellet was then re-suspended and a cell and viability count made 
using trypan blue. The cell suspension was again centrifuged and the remaining 
pellet was then frozen and kept at 253 K. Once removed from the freezer, 5 ml of 
ultrapure water was added to the pellet to ensure rupture of the cells. 
5.2.3.3 Determination of Cellular Metal Content Using ICT-AES 
Metal content was determined using ICP-AES. Prior to introduction of samples the 
machine was calibrated to detect Mn, Fe, Cu and Zn (further details are given in 
Section 2.3). Aqueous standard solutions were prepared from appropriate dilutions 
of 1000 ppm certified standard element solutions. Samples of medium, trypsin-
EDTA and the growth medium aspirated from the cells were analysed without 
dilution. Metal concentration was calculated as mg/ml. Samples of the cells were 
studied as the 5 ml solution obtained from the pellet re-suspended in ultrapure water. 
Cellular metal content was then calculated as mg metal in 1010  cells. 
5.2.4 MTT Assay of Hepatocyte Viability Following Treatment with Transftrrins 
Cells were seeded at Ca. 3 x 10 cells/ml in 24 well plates at 0.5 ml/well and allowed 
to equilibrate overnight. Apo-hTf, Fe-hTf and Mn-hTf were added to the cells at 
concentrations of 25, 2.5 and 0.25 VtM. Medium alone was used for controls. The 
medium and medium containing transferrin was changed after two days and 
following a further two days the cells were ready for analysis. 
MTT was added to the cells to give a final concentration of 1 mg/ml in the medium 
and the plate incubated at 310 K for 3 hours. The medium was removed and the cells 
were washed twice with PBS and allowed to dry completely. DMSO was then added 
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and 100 tl of the cells transferred to a 96 well plate, with dilution if necessary, and 
absorbance read at 490 nm. 
This experiment was also carried out using 96 well plates where cells were seeded at 
Ca. 6 x 10 3  cells/ml at 150 tl/well. In this instance all conditions were the same 
except the cells were left for two days following treatment, one plate had MTT at 1 
mg/ml and absorbance was read directly without transfer or dilution. A second plate 
had the medium and medium containing transferrin replaced after two days and was 
left for a further two days before the MTT was added and absorbance read as for the 
first plate. 
5.2.5 Evaluation of Apoptosis and Mitosis Following Treatment with 
Transferrins 
Cells were seeded at ca. 6 x 10 cells/ml at 150 t1/well on 96 well plates and left to 
equilibrate overnight. Medium was aspirated off and the cells washed with PBS. 
Apo-hTf, Fe-hTf and Mn-hTf were added to the cells at concentrations of 25, 2.5 and 
0.25 tiM. Medium alone was used for controls. After two days, the medium was 
aspirated off one plate and the cells washed twice with PBS and Bouins solution 
added to each well. A second plate had the medium and medium containing 
transferrin replaced and left for a further two days after which time medium was 
removed, cells washed and fixed with Bouins as before. Both plates were then 
stained with Feulgan stain as described in section 2.10.4. 
Cells were seeded at Ca. 2.5 x 104 cells/ml at 0.5 ml/well onto 4 well chamber slides 
and allowed to equilibrate overnight. Medium was then removed and cells washed 
with PBS. Mn-hTf made up in medium was added to the wells to give 
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concentrations of 25, 2.5 and 0.25 M. Medium alone was used as a control. After 
two days, the medium was removed and fresh medium and transferrin added to cells. 
After a further two days all medium was removed and cells were washed and fixed 
with Bouins solution. Cells were then stained with Feulgan stain and assessed for 
apoptosis and mitosis. 
5.2.6 Assessment of Mitochondrial Effect of Transftrrins on Hepatocytes 
Cells were seeded at Ca. 2.5 x 104 cells/ml at 0.5 ml/well onto 4-well chamber slides 
and allowed to equilibrate overnight. Medium was then removed and cells washed 
with PBS. Apo-hTf, Fe-hTf and Mn-hTf were made up in medium and added to the 
wells to give concentrations of 25, 2.5 and 0.25 tM. Medium alone was used as a 
control. After two days the medium was removed and fresh medium and transferrin 
added to cells. After a further two days, CMX-Ros was added to all wells to give a 
concentration of 100 nM and slides incubated in the dark at 310 K for 45 minutes. 
Slides were then protected from light from this point onwards. The medium was 
then aspirated and the cells washed twice with PBS and slides fixed in 4% 
paraforrnaldehyde for 10 minutes and washed again in PBS. Slides were then 
allowed to dry before being cover-slipped with mowiol. Slides were then assessed 
for any visible mitochondrial changes including depolarisation. 
5.2.6.1 Induction of Mitochondrial Depolarisation 
Cells were seeded at Ca. 4 x 104 cells/ml at 0.5 ml/well onto 4 well chamber slides 
and allowed to equilibrate overnight. Medium was then aspirated, cells washed and 
fresh medium applied. The mitochondrial depolariser, mCICCP, was made up in 
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DMSO and added to the cells to give concentrations of 30, 40 and 50 mM. CMX-
Ros was also added to the cells to give a concentration of 100 nM and slides were 
incubated in the dark at 310 K for 45 minutes. From this stage onwards the slides 
were protected from light. Following incubation the medium was removed and 
slides fixed in 4% paraformaldehyde for 10 minutes and washed again in PBS. Once 
dry, slides were then cover-slipped using mowiol and assessed visually for 
mitochondrial depolarisation. 
5.3 Results and Discussion 
5.3.1 Analysis of Cellular Metal Content 
Due to the high numbers of cells required to allow determination of the metal content 
using ICP-AES (detection limits are given in Table 2.2, Chapter 2), large flasks were 
used to grow cells. Preliminary work was carried out to ensure there were enough 
cells in a large flask to allow metal detection. Unfortunately this meant that large 
quantities of apo and metal-loaded transferrins were required in order to obtain 
transferrin concentrations similar to those found in serum, 35 i.tM [37]. 
Consequently the metal determinations on cells were carried out only once. Due to 
limited quantities of metal-loaded transferrin available cells were incubated with 
25 M transferrin. 
First, preliminary experiments were carried out. These included growing four large 
flasks of cells in normal medium and analysing these for Cu, Fe, Mn and Zn content. 
The results of the cellular metal content grown under standard conditions are given in 
Table 5.1 (the data for these results can be found in Appendix F, Figure F.1 and 
Table F.1). 
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Table 5.1 Average cellular metal content of 4 flasks grown under standard 
conditions. 
Metal Average mg metal in lO' ° cells Standard Deviation (±) 
Cu 1.39x 10 1 0.013 
Fe 9.61 x 10' 0.036 
Mn 6.88 x 10.2 0.002 
Zn 5.37 0.113 
The cellular metal content of the four flasks are similar with little variation between 
cells cultured in parallel. WRL-68 cells were also grown as previously described and 
cells pelleted. When the four samples were made ready for metal analysis, internal 
standards were added to two of the cell suspensions at concentrations of 0.01 and 
0.05 ppm for each metal analysed. This was done to confirm that small increases in 
metal content could be detected by ICP-AES. The results in Table 5.2 (full results 
are shown in Appendix F, Figure F.2 and Table F.2) show that increases in metal 
content can be detected at the 0.01 ppm level. 
Table 5.2 Cellular metal content (ppm) detected in cells grown under standard 
conditions and with addition of internal standards prior to analysis 
Metal Cells (average) + 0.01 ppm metal std + 0.05 ppm metal std 
Cu 0.010±0.0011 0.019 0.046 
Fe 0.030±0.0003 0.039 0.081 
Mn 0.001±0.0001 0.010 0.044 
Zn 0.256 ±0.0014 0.264 0.291 
The growth medium used for cell culture was also analysed for metal content and 
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again internal standards were added. These results can be seen in Table 5.3 (results 
also in Appendix F, Figure F.3 and Table F.3). Trypsin-EDTA was also analysed for 
metal content to ensure that metal levels were low. Internal standards were again 
added to trypsin-EDTA and analysed. The results can be found in Table 5.3 (results 
also shown in Appendix F, Figure F.4 and Table F.4) 
Table 5.3 Metal content (ppm) detected in DMEM and Trypsin-EDTA and 













Cu 0.052±0.0054 0.057 0.085 0.0014 0.010 0.043 
Fe 0.127±0.0028 0.134 0.174 0.012 0.023 0.069 
Mn 0.001 ±0.0001 0.010 0.047 0.000 0.010 0.051 
Zn 0.076±0.0006 0.085 0.118 0.003 0.022 0.053 
5.3.1.1 Cell Numbers Following Treatment 
After four days of treatment with transferrin, all cells except those treated with Mn-
hTf were confluent. Cells incubated with Mn-hTf had not grown as well as the 
others and the medium had turned yellow in colour. This was not the case for any of 
the other flasks. When medium containing 25 jiM Mn-hTf only was incubated there 
was no colour change suggesting that the colour change of the medium in the flasks 
containing Mn-hTf is due to a metabolic process. The medium often changes colour 
from red to yellow when cells are overgrown and the medium requires changing. 
Phenol red has a transition range of pH 6.5 to 8. Thus, the medium is red at 
physiological pH levels and turns yellow in acidic conditions indicating a loss of 
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buffering capacity due to the metabolic activity of the cells. This supports the idea of 
the colour change being due to a metabolic effect. It is notable that the medium did 
not undergo any colour change following the first two days of the cells incubation 
with Mn-hTf. Although there were fewer cells grown on the layer, there did not 
appear to be any more dead cells floating in the medium compared with the other 
flasks. Further, the cells that had grown on the flask surface had a dendritic-like 
appearance with finger like projections protruding from the cells. No change was 
apparent for cells incubated with medium alone, apo-hTf or Fe-hTf. Due to the cells 
treated with Mn-hlf not reaching confluence simultaneously with the other flasks, 
they were left for an extra two days, with fresh medium and Mn-hTf, to try and 
ensure that enough cells were obtained to carry out ICP-AES. The medium removed 
on the sixth day following treatment with Mn-hTf had also changed colour. This 
medium was kept for analysis of cell numbers and cell viability of any non-adherent 
cells found in the medium. Cell numbers and viability of the cells are shown in 
Table 5.4. When cell numbers are compared between groups there is no obvious 
difference between the control cells and those treated with apo-hTf, there being a 
5-fold increase in cell numbers from plating. There is a slight fall in numbers in cells 
treated with Fe-hTf but this is close to a 5-fold increase in cell numbers. There is a 
considerable drop in cell numbers from flasks treated with Mn-hTf, with only a 3.5-
fold increase in numbers from initial plating values. When comparing viability, 
although numbers of cells in apo-hTf are still high, cell viability has decreased 
slightly. However, for cells treated with Fe-hTf, although cell numbers have fallen, 
cell viability is still high. 
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Table 5.4 Cell numbers and viability of cultured cells 
Condition Total cell number % Cell viability 
Medium only 51 x 106 96 
Apo-hTf 51.2 x 106 86 
Fe-hTf 47 x 106 96 
Mn-hTf 35 x 106 82 
Mn-hTf(medium) a 6.05 x 106 64 
' Medium removed from flask and non-adherent cells analysed 
Viability had decreased in cells treated with Mn-hTf but only to the same extent as 
that seen with apo-hTf. It is typical in cell culture to consider anything above 85% 
(B. Tura, personal communication) as a high viability indicating a healthy cell 
population. The medium that had been removed from the flask of cells treated with 
Mn-hTf, was also spun down to determine if there were many non-adherent cells 
floating in the medium. Some cells were present, which were found to have quite 
low viability, perhaps representing dead cells that had lifted off the flask surface. 
However, if Mn-hTf was exerting a cytotoxic effect, then cell viability would be low 
in the cell layer and the cells found in the medium would be expected to have 
extremely low cell viability consisting of mostly dead cells and not just non-adherent 
cells. 
5.3.1.2 Iron Content 
In cells treated with Fe-hTf, quite noticeably cells have a much higher content of iron 
(see Figure 5.1). 
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Figure 5.1 Comparison of iron content in cells treated with DMEM alone, apo-hTf, 
Fe-hTf and Mn-hTf. Transferrin added to give 25 tM. Cells grown in DMEM, apo-
hTf and Fe-hTf confluent after 4 days and harvested. Mn-hTf treated cells left for 6 
days when still not confluent. Mn-hTf (medium) represents non-adherent cells 
collected from the medium that had been removed from the flasks on the final day. 
Cells treated with apo-hTf have a slightly elevated iron content when compared with 
cells grown in medium alone. This could be due to apo-hTf binding any available 
iron present in the medium and transporting this to the cells. From the results shown 
in Appendix F, Figure P.3, there is some iron present in the medium (1.27 x 10 
mg/ml). This may explain the small increase seen in number for cells treated with 
apo-hTf. Cells treated with Mn-hTf showed no increase in iron content compared 
with those grown in medium alone. The non-adherent cells extracted from the 
medium after the sixth day of treatment with Mn-hTf showed no increase in iron 
content. 
For medium removed from flasks containing the cells treated with Fe-hTf (Figure 
5.2), the level of iron is higher than all other treatment groups and control group, as 
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Figure 5.2 Comparison of iron content in growth medium removed from flasks 
containing cells. Cells grown in DMEM, apo-hTf, Fe-hTf and Mn-hf at 25p.M. 
Medium removed after 2, 4 and 6 (Mn-hlf treated only) days of growth of cells. 
There is a slight decrease in the level of iron found in the first and second medium 
removed from the cells treated with Fe-hTf (days 2 and 4), which is surprising as Fe-
hTf was given at the same concentration. This suggests that more iron was taken up 
by the cells between days 2 and 4. However, this is probably merely due to higher 
cell numbers from cell growth and hence more iron overall has been absorbed from 
the solution. There is no difference in iron content in medium removed from the 
other groups. 
5.3.1.3 Manganese Content 
In cells treated with Mn-hTf, there is a noticeable increase in manganese levels 
compared with the control group and other treatment groups, see Figure 5.3. The 
cells removed from the medium taken on the last day of incubation also show an 
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increase in manganese content. This suggests that manganese is being taken up from 
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Figure 5.3 Comparison of manganese content in cells treated with DMEM alone, 
apo-hTf, Fe-hTf and Mn-hTf. Transferrin added to give 25jtM. Cells grown in 
DMEM, apo-hTf and Fe-hTf confluent after 4 days and harvested. Mn-hTf treated 
cells left for 6 days when still not confluent. Mn-hTf (medium) represents non-
adherent cells collected from the medium removed from the flask on the final day. 
The cells recovered from the medium collected on day six also appear to have 
absorbed manganese from transferrin. The levels are slightly higher in these cells 
suggesting that more manganese was absorbed, possibly at toxic levels resulting in 
the cells detaching from the flask. However, without the experiment being repeated 
it is difficult to say if this is a significant increase. 
The manganese content of the medium removed from the flasks containing the cells 
was in quite different ranges between treatment groups, so in order to see the levels 
more clearly the results are displayed as two graphs (Figure 5.4). 
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Figure 5.4 Comparison of manganese content in medium removed from cells. Cells 
grown in DMEM, apo-hTf, Fe-hTf and Mn-hTf at 25 l.IM. Medium removed from 
flasks containing cells after 2, 4 and 6 (Mn-hTf treated only) days. Due to a much 
higher level of Mn compared with other metals a different vertical scale has been 
used. 
Medium removed from cells treated with Mn-hTf was found to have considerably 
higher manganese levels. The difference is probably more noticeable as there is very 
little base level of manganese found in the medium (approximately 0.00 15 ppm Mn, 
Appendix F, Figure F.3). However, the levels of manganese in the medium removed 
from flasks containing the cells on the fourth and sixth days of treatment, are higher 
compared with that found in medium removed after two days. This is the opposite to 
that seen with iron which was found to decrease over treatment days. 
Cells had not grown as well as with the other groups but cell numbers and confluence 
had increased in the cell layer during the six days of growth. This suggests that 
although there are more cells to take up manganese this does not appear to occur. 
The cells do seem to be taking up the manganese from transferrin, as shown by the 
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metal content analysis of the cells, but it may be that some level is reached whereby 
the cells then actively stop taking up the Mn-hTf. Alternatively, internal manganese 
may be under tight regulation by the cell via an efflux pump. The cells may be 
taking up manganese for the first two days, during which time the cells are behaving 
normally, then changes start to occur once a certain level of manganese intake is 
reached. It may be that normal proliferation of the cells slows or stops, as indicated 
by the low cell numbers compared with other groups, shown in Table 5.4. There is a 
very small increase in manganese content in the medium removed from cells treated 
with apo-hTf which may be due to apo-hTf being passively loaded with any 
manganese present. However, as the experiment was only carried out once we are 
unable to say if this is a significant increase. 
5.3.1.4 Copper and Zinc Content 
Cells were monitored for copper and zinc levels to see if these were altered by 
treatment of cells with transferrins. The results are shown in Figure 5.5. 
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Figure 5.5 Comparison of copper and zinc content in cells treated with DMEM 
alone, apo-hTf, Fe-hTf and Mn-hTf. Transferrin added to give 25j.x M. Cells grown 
in DMEM, apo-hTf and Fe-hTf harvested after 4 days, Mn-hTf after 6 days. Mn-hTf 
(medium) represents non-adherent cells collected from medium removed on final 
day. 
The copper content is somewhat higher in cells treated with Mn-hTf whereas zinc is 
slightly lower. However, at such low levels with just a single set of results it is 
difficult to interpret this as an effect of treatment with Mn-hTf. 
The results of the copper content found in medium removed from cells during growth 
are shown in Figure 5.6. There is no noticeable difference in copper levels between 
treatment groups. 
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Figure 5.6 Comparison of copper content in medium removed from flasks during 
cell growth. Cells grown in DMEM, apo-hTf, Fe-hTf and Mn-hTf at 25 p.M. 
Medium removed after 2, 4 and 6 (W-hTf treated only) days. 
The zinc contents of the media removed from cells during growth are shown in 
Figure 5.7. There is a decrease in zinc in the medium removed from the flasks after 
four days of growth in cells treated with medium alone, apo-hTf and Fe-hTf, 
consistent with zinc uptake during cell growth. 
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Figure 5.7 Comparison of zinc content of the media removed from flasks during cell 
growth. Cells grown in DMEM, apo-hTf, Fe-hTf and Mn-hTf at 25p.M. Medium 
removed after 2, 4 and 6 days (Mn-hTf treated only). 
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In cells treated with Mn-hTf there is a small increase in zinc levels in the medium 
during growth. This could be due to efflux of zinc from WRL-68 cells treated with 
manganese. The medium removed from flasks containing cells treated with Mn-hTf 
had changed in colour from red to yellow indicating a drop in pH; this suggests a 
metabolic effect that may involve zinc. Furthermore, the cell morphology had 
changed compared to other groups (this is described in more detail later in Section 
5.3.4) and this process may involve manganese and zinc. This could be due to 
interference with the cells cytoskeleton, and perhaps relates to the metal transporter 
DMTI which is responsible for transporting a number of divalent cations including 
Mn(II), Cu(II) and Zn(II) [11]. 
5.3.2 Analysis of Hepatocyte Viability 
The MTT assay is used to assay cell proliferation as an alternative to 'H-thymidine 
uptake. Active mitochondrial dehydrogenases of living cells cause the conversion of 
the soluble yellow dye to the insoluble purple formazan. Dead cells do not cause this 
change. While the assay gives information on cell proliferation, it also provides 
some information on mitochondnal function. This combined with other data can 
help to determine the state of the cells following treatment. 
Plates (24 wells) were set up in which cells were treated with medium only, apo-hTf, 
Fe-hTf and Mn-hTf at 0.25, 2.5 and 25 .iM concentrations of transferrin. All 
treatments were carried out in quadruplicate. Two plates were required to 
accommodate all experimental conditions. Therefore two sets of results are obtained 
for control groups of medium alone. The results of the MTT assay are displayed in 
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Figure 5.8. Treated cells are compared to the corresponding controls on the same 
plate (displayed to the left of them). As can be seen from Figure 5.8, there is a slight 
difference in cell numbers between the two control groups (Med). The plates were 
grown under the same conditions using the same number of plating cells. After four 
days incubation with the transferrins, the medium for the cell groups treated with 25 
tM manganese transferrin had again changed colour from red to yellow. Medium in 
sealed tubes containing Mn-hTf at this concentration that had been placed in the 
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Figure 5.8 MTT assays for WRL-68 cells following treatment with transferrins. 
Cells grown on 24-well plates in medium alone, apo-hTf, Fe-hTf and Mn-hTf at 25, 
2.5 and 0.25 jiM. Standard deviation bars are shown. Medium changed after two 
days, MTT assay run after four days. Treatment groups can be compared to the 
control groups (Mcd) to the left of them. The absorbance of MTT (formazan) at 490 
nm is indicative of viable cells. 
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It can be seen from Figure 5.8 that treatment of cells with transferrin, with the 
exception of 25 p.M Mn-hTf, has either no effect compared with the control groups 
or results in an increase in cell growth. All transferrins added at 2.5 p.M increase cell 
growth. Cells treat with 25 p.M Mn-hTf show a decrease in cell growth. 
The above experiment was repeated using the same conditions as before but the MTT 
assay was performed after only two days incubation instead of four days in an 
attempt to detect changes at an earlier time. No colour change of the medium was 
noted in any of the treatment groups after only two days. The results of the MTT 
assay can be seen in Figure 5.9. 
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Figure 5.9 MTT assay of WRL-68 cells following treatment with transferrins. Cells 
grown on 24 well plates in medium alone, apo-hTf, Fe-hTf and Mn-hTf at 25, 2.5 
and 0.25 i.iM. Standard deviation bars are shown. MTT assay run after two days. 
Treatment groups should be compared to control groups to the left of them. 
Initially the standard deviations are rather large. This may be attributable to the fact 
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that the cell population may not have stabilised after only two days. Other errors 
arise from pipetting when cells are plated, and also the cells tend to form clumps 
which could lead to variations in growth patterns between wells in the first two days. 
In order to establish if there was any effect after two days which then became more 
pronounced after four days, the experiment was repeated using 96 well plates. As 96 
well plates were used, this allowed treatments to be applied in duplicate (i.e. 2 sets of 
results obtained for each treatment group). After two days, one plate was assayed 
using MIT; the other plate had the medium changed and was incubated for a further 
two days and then assayed using MT T. Data from the plate assayed after two days 
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Figure 5.10 MIT assay of WRL-68 cells following treatment with transferrins. 
Cells grown on 96 well plates in medium alone, apo-hTf, Fe-hTf and Mn-hTf at 25, 
2.5 and 0.25 jiM. Two groups grown on plate. MiTT assay run after two days. 
Standard deviation bars shown. 
With the exception of treatment groups of apo-hTf at 25 p.M and Mn-hTf at 2.5 p.M, 
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the two groups gave similar results to the experiment carried out previously on 24- 
well plates (Figure 5.9). 
The second 96-well plate was incubated for four days, having the medium changed 
on the second day. The results of the MTT assay for this second plate are shown in 
Figure 5.11 Again, the lack of cell growth in wells treated with 25 iM Mn-hTf 
compared with other groups is noticeable, confirming the result seen in Figure 5.8. 
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Figure 5.11 MTT assay of WRL-68 cells following treatment with transferrins. 
Cells grown on 96 well plates in medium alone, apo-hTf, Fe-hTf and Mn-hTf at 25, 
2.5 and 0.25 .iM. Medium changed after two days. Two groups grown on plate. 
MTT assay run after four days. Standard deviation bars shown. 
The results of the experiments using the two 96 well plates being grown and treated 
simultaneously show that Mn-hTf gives rise to a pronounced effect after four days 
incubation. These results suggest that the effect of Mn-hTf is first evident between 
two and four days, although this may be due to the nature of growth of the cells 
masking any real effect that occurs during the first days of cell growth. 
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Although the MIT assay gives only an indication of cell numbers in the mono-layer, 
it does provide some information on the activity of the cell in terms of cell 
proliferation and rates of mitosis and cell death. To further complicate results, cells 
grown on 24 well plates form a better mono-layer and have greater room in which to 
settle following plating and growth. However, for the MTT assay these cells are then 
transferred to a 96-well plate in order for the absorbance to be read. When cells are 
grown on 96 well plates no transfer is necessary for the plate reader. However, cells 
do not form such a good mono-layer and conditions are somewhat more cramped for 
cell growth and the wells can quickly become overgrown. 
5.3.3 Analysis of Hepatocyte Mitosis and Apoptosis 
To investigate the number of cells undergoing cell death and mitosis, a DNA stain 
can be used so that mitotic and apoptotic cells can be quantified in a cell population. 
Initially cells were seeded on 96-well plates simultaneously with cells used for the 
MIT assay described in Section 5.3.2. This was then used in parallel with the MTT 
assay to provide further information on the effect of transferrins on hepatocytes. 
Cells were treated with the same conditions as used in the MTT assay. Again after 
two days one of the plates had the medium removed and was stained using Feulgan 
stain as described Section 5.2.5. The second plate had fresh medium and transferrins 
applied. On the fourth day this plate had medium removed and was stained using 
Feulgan stain. Cells were then assessed for apoptosis. 
It proved to be quite difficult to assess cells grown in 96-well plates due to poor 
visibility and due to clumps of cells forming at the bottom of the individual wells. 
This was particularly evident after four days of growth when, in some cases, the well 
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had become quite overgrown. Unlike the MTT assay, the use of Feulgan stain relies 
quite heavily on the formation of an even mono-layer of cells to allow reliable 
counting. 
There appeared to be no noticeable increase in apoptosis in any of the treatment 
groups, including Mn-hTf where cell numbers were less than for other groups as 
shown by the MTT assay. The only difference between groups was in cell 
morphology. Unfortunately no further information could be gained from the 96 well 
plates. 
As there was no difference between treatment groups to suggest that counting of 
apoptotic cells was required, attention was focused on the cells in the group showing 
a difference in morphology and growth, that is treatment with Mn-hTf. In order to 
look more closely at the effect of Mn-hTf on WRL-68 cells, cells were seeded onto 4 
well chamber slides. One of the wells was incubated with medium alone. Mn-hTf 
was added at concentrations of 0.25, 2.5 and 25 jiM. After two days, the medium 
was changed, and on the fourth day all medium was removed and cells stained using 
Feulgan stain. Slides were then examined and counted for mitotic activity. Cells 
were counted in the field of view until at least 100 cells in total were counted. This 
was repeated five times in order to obtain average counts of mitotic and non-mitotic 
cells. The results are shown in Figure 5.12. It became apparent during the counting 
of these cells that there were considerably fewer cells on the area of the slide that had 
been treated with 25 jiM Mn-hTf. There did however appear to be slightly more 
cells undergoing mitosis with increasing concentrations of Mn-hTf. This seems to 
contradict the result of there being fewer cells which suggests that the cell cycle itself 
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Figure 5.12 Number of mitotic cells after treatment with Mn-hTf. Cells were 
plated on 4-well chamber slides and left overnight then treated with Mn-hlf at 0.25, 
2.5 and 25 p.M with medium alone as controls. Medium changed after 2 days, then 
cells fixed and stained with Feulgans stain after 4 days treatment. Lower standard 
deviation bars for non-mitotic counts, upper bars for mitotic counts. 
5.3.4 Investigation into the Effect of Mn-h Tf on Hepatocytes 
This work was initially carried out to investigate if treating cells with Mn-hTf could 
result in an increase in uptake of manganese by hepatocytes. If this was the case, 
there was a possibility that the manganese could be directed to the mitochondria 
where it could be used by Mn-SOD for protection against oxidative stress. Mn-hlf 
when used at doses of 25 p.M, has been shown to be taken up by the WRL-68 cells 
resulting in increased manganese levels in the cells but there is also another effect at 
these concentrations. To try and determine if this is a mitochondrial effect, cells 
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were treated with Mn-hTf over the same range of concentrations used previously and 
stained using CMX-Ros. This is a fluorescent stain used to detect mitochondrial 
depolarisation. As manganese is redox active it may be taken up by cells via 
transferrin and could alter the redox status of the cell, possibly leading to oxidative 
stress and alteration of mitochondrial function. 
5.3.4.1 Induction of Mitochondrial Depolarisation by in C1CCP 
In order to determine if a mitochondrial effect was observed following treatment 
with Mn-hTf, WRL-68 cells were first treated with mCICCP, a well known 
mitochondrial depolariser, to give a positive result. Cells were seeded on 4-well 
chamber slides and were treated with mCICCP at concentrations of 30, 40 and 50 
j..tM and with medium alone to act as a control. Once cells were stained with CMX-
Ros they were analysed using fluorescence microscopy with the kind help of Mrs. 
Linda Wilson (Pathology department, University of Edinburgh). The results of 
treating cells with mC1CCP at 50 iM compared with control are shown in Figure 
5.13. 
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Figure 5.13 CMIX-Ros stained WRL-68 cells. Cells were incubated with medium 
alone (control, left) or with the mitochondrial depolariser mC1CCP (right). Image 
shown when treated with 50 tM. Cells grown in 4-well chamber slides for 2 days. 
Cells treated with mC1CCP for 45 mins. Brightly fluorescing mitochondria are 
shown by a circle. 
In the control image the mitochondria can be seen as fluorescing brightly as punctate 
staining of red. The majority of the mitochondria surround the nucleus and are 
highlighted in Figure 5.13 by a circle. In the cells treated with mC1CCP there is a 
distinct lack of these brightly fluorescing pinpricks of red. The stain surrounding the 
nucleus is much duller, this indicates that the mitochondria have become depolarised. 
Depolarisation of the mitochondrial membrane can then lead to membrane 
permeabilisation and cell death as described in Chapter 1. Signs of mitochondrial 
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5.3.4.2 Effect ofMn-hTf on Hepatocytes 
Cells were incubated with apo-hTf ,  Fe-hTf and Mn-hTF at concentrations of 0.25, 
2.5 and 25 j.tM on 4-well chamber slides with medium alone as controls. The images 
taken from the slides shown in Figure 5.14 are for the highest concentration of 
transferrin added (25 LM)- 
Figure 5.14 Comparison of transferrin treated cells stained with CMX-Ros. 
Images shown are for cells grown in the presence of 25 i.LM transferrin for 4 days, 
with the medium changed after 2 days. 
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As can be seen in the images, all show the brightly fluorescing punctate staining 
representing fully functional mitochondria. None of the treatment groups showed 
any signs of mitochondrial depolarisation. This result suggests that any effect of 
manganese on cells does not appear to include alteration of mitochondrial 
transmembrane potential. There is, however a definite effect on the cells which is 
clearly visible on the fluorescent images. An example of this is shown below in 
Figure 5.15. 
Figure 5.15 Effect of 25j.tM Mn-hTf on WRL-68 cells. Cells grown on 4 well 
chamber slides, incubated with 25 .tM Mn-hTf for 4 days, medium changed on day 
2. Slides stained with CMX-Ros and fluorescent images taken. Image on right is a 
magnification of image on left. 
When the cells were treated with 25 p.M Mn-hTf the morphology of the cells 
changed. The cells became dendritic in appearance with a stretched effect as if the 
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cells were spreading. As can be seen in Figure 5.15, the cell contains many 
mitochondria in these finger-like protrusions from the cells. Nothing like this was 
observed following treatment with other transferrins or at other doses. 
Grinnell [28] has shown that in the presence of Mn 2 , baby hamster kidney cells 
(BHK) are able to attach and spread on substrata without the usually necessary 
adhesion factors. This adhesion was able to take place even in the presence of 
treatments that would usually inhibit cell attachment. This suggests that manganese 
plays an important role in cell attachment. Mn 2 was found to be more effective than 
CO2, M g  2+  and Ca 2+  in adhesion and spreading of BHK21 cells in serum [38]. 
Interactions of extracellular matrix (ECM) molecules with integrins have been shown 
to either directly stimulate neurite outgrowth or facilitate neurite outgrowth induced 
by other factors in cultures or neurons or neuron-like cells, including rat 
pheochromocytoma (PC 12) cells [31, 39]. Lin et al [31] report that Mn2 causes not 
only cell spreading but also stimulates extension of neurite-like processes in PC12 
cells through a mechanism related to its ability to enhance an RGD-dependent ECM-
integrin interaction. Further, they showed that the growth required new synthesis of 
proteins. Lin et al [31] went on to show that these long processes were not due to 
stimulation of adenylate cyclase and were dependent on RGD receptors and ECM 
molecules. PC12 cells do not extend neurites in response to Mn unless grown in 
substrates treated with vitronectin, fibronectin or culture medium containing serum 
[31, 40]. Binding of ligand to integrin receptors activates intracellular signalling 
cascades that may alter gene transcription [40]. 
The results in this study are similar to those found by Lin et a! [3 1] in that the 
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outgrowth from the cells took at least two days of growth. Unlike previous studies 
where cell spreading was seen immediately [28-30], cells were left overnight so that 
cell attachment was allowed to take place. This suggests that more complex 
intracellular events may be involved to promote this effect in cells that are already 
attached, other than integrin-mediated effects. 
These results are consistent with the hypothesis that manganese is able to stimulate 
projection-like growths in serum containing medium on tissue culture plates. Further 
studies should include growth of cells treated with transferrins on uncoated tissue 
culture plates and with minimal medium. From these studies alone it is not possible 
to say whether Mn 3 is removed from transferrin and then reduced in the cell to Mn 2 
which then exerts its effect, although this seems the most likely event. 
The possibility that the phenotype of a clonal cell line such as WRL-68, maintained 
for long periods of time may drift in subtle ways cannot be ruled out. However, no 
obvious changes were observed in the cell behaviour, and culture conditions 
remained the same during standard cell culture. Further, the lack of dendritic-like 
processes from cells grown as controls, other transferrins and low dose Mn-hTf 
treatment groups, confirms the specificity of this morphological change. 
5.4 Conclusions 
These studies show that manganese and iron are taken up by WRL-68 cells when 
incubated with Mn2-hTf and Fe2-hTf respectively as shown by ICP.-AES studies. 
This supports previous work using inhibition studies which has shown that addition 
of Fe2-hTf, Ga2-hTf, Bi 2-hTf and Ti2-hTf to placental BeWo cells results in uptake of 
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the metals [41]. Further, at higher Mn-hTf concentrations of 25 jiM, cell numbers 
decreased compared with controls and other treatment groups but this was not a 
cytotoxic effect, and the cell morphology changed. Transferrin is found in blood 
serum at concentrations of ca. 35 p.M. However, human serum manganese levels are 
considerably lower than this at typically 0.057 p.g/100 ml (9.8 nM) [42]. Therefore 
the results seen here at 25 p.M Mn2-hTf are under extreme conditions with much 
higher than normal cellular manganese levels. The Mn-hTf used in these cell studies 
was produced using KMn04. This suggests that although transferrin may be altered 
by the use of KIVIn0 4 to load Mn(III) onto the protein, the cellular receptors still 
recognise manganese-transferrin and actively absorb it. 
The MTT assays have shown that there is a decrease in cell metabolic activity in 
cells treated with 25 p.M Mn-hTf compared with other treatment groups and controls. 
Further, staining of cells treated with Mn-hTf at varying concentrations suggests an 
increase in mitosis or alteration of the cell cycle with increasing concentrations of 
Mn-hTf although this finding needs to be confirmed in future work. 
Doses of 25 p.M Mn-hTf result in finger-like protrusions from the cells. These 
protrusions contain mitochondria but there is no alteration of the mitochondrial 
transrnembrane potential following treatment. 
Manganese, when added as manganese transferrin, is capable of inducing the process 
of outgrowth from WRL-68 cells. These morphological changes appear to be time 
and dose-dependent. It is likely that new protein synthesis is required to allow these 
processes to occur and that they form due to an interaction of Mn(II) or Mn(III) with 
RGD-dependent ECM-integrin interactions. This interaction probably takes the form 
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of either increasing affinity of the binding or by a change in specificity. Further 
studies are required in order to determine the ECM molecule(s) and integrin(s) 
involved in this process. 
It could be that Mn-hTf delivers Mn to the cell which then leads to up-regulation of 
expression of integrins on the plasma membranes of WRL-68 cells. The effect could 
also be a result of the subcellular distribution of integrins or from alteration of 
receptor affinity. Alterations may be due to transcription and translation and 
modification of various signalling pathways. Further work studying any up-
regulation of gene transcription would need to be carried out in order to determine 
this. Also, in order to investigate the possibility of manganese being delivered to the 
cell by Mn-hTf to increase MnSOD activity, a model system of oxidative stress in 
cells needs to be established. This model would have to ensure that the reactive 
oxygen species were created specifically in the mitochondria in order to best test this 
theory. 
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6.1 Conclusions 
Transferrin is the natural transport protein for iron to cells and delivers iron by 
receptor mediated endocytosis [1, 2]. Other metals have been shown to bind 
transferrin and occupy the same metal binding site [3-6] thereby providing a specific 
pathway for the delivery of other metal ions into cells. The work in this thesis has 
investigated the binding of manganese to transferrin, and some chemical and 
biological characterisation of the metal loaded protein. 
In vitro oxidation coupled uptake of Mn2 to Mn3 by transferrin is very slow and 
incomplete. The use of the blood serum oxidant caeruloplasmin, was shown to speed 
up this oxidation, however, not at rates that would be likely to occur in vivo. The 
slow rate and only partial loading of Mn 3 in the presence of caeruloplasmin may in 
fact be due to pH changes that could occur during the reaction. Carbonate may be 
lost to the air resulting in increased pH which may inhibit binding and the 
oxidative action of caeruloplasmin by inactivating the protein. The oxidant 
potassium permanganate was found to give much faster and more complete loading. 
Interestingly, it was found that more than two manganese ions were able to be bind 
to one transferrin molecule. This suggested either that manganese was binding as a 
cluster, with more than one metal binding to each site, or that the metal was binding 
to other areas of the protein. Ferric Binding protein (FBP), which belongs to the 
transferrin superfamily, was recently found to bind Hafnium as a metal cluster. 
Hafnium was also found to bind to transferrin in ratios exceeding 2:1 [7]. The N- 
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lobe of transferrin is thought in this instance to remain open and hence be capable of 
binding more than one metal ion. Open lobe conformations with a single Fe 3+ bound 
are known supporting this notion [8-10]. 
The use of potassium permanganate also raised questions pertaining to oxidation. 
The hepes buffer used during reactions was found to be oxidised, thus contributing to 
the loading of Mn3 onto transferrin but also it became apparent that the protein itself 
could be being oxidised during the reaction. NMR studies of amino acids confirmed 
this suggesting that the methionine residues were likely targets for oxidation. The 
use of F_[ 13 C]Met -labelled recombinant transferrin allowed 2D NMR analysis of the 
protein following reaction with potassium permanganate. It was found that the 
protein underwent conformational changes similar to those seen previously with 
other metal binding [4]. Further, a chemical shift was seen for Met26 which could be 
attributable to the oxidation of the residue to the corresponding sulfoxide and sulfone 
as a result of the reaction. 
Other characteristics of Mn-hTf were investigated. It was found that the addition of 
KMn04 was unable to displace Fe 3+  from transferrin but Fe(NTA)3 when added to 
Mn-hTf, was able to displace Mn from the protein suggesting that Mn 3 is not as 
tightly bound to transferrin as Fe 3 . However, pH studies of Mn-hTf confirmed that 
metal dissociation at low pH occurred in a similar manner for the two metal ions 
supporting the theory that if Mn-hTf could be transported to the cell by receptor 
mediated endocytosis then dissociation in the endosomes would occur due to the 
acidic conditions. 
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The fact that metal ions dissociate from transferrin at low pH (Ca. pH 5.0-6.0) may 
have impaired the attempts to crystallise transferrin. Although crystals did form for 
both Fe-hTf and Mn-hTf the former were of quite low quality and the latter of very 
poor quality. The crystallisation conditions used were of low pH (Ca pH 5.5) so it 
seems likely that one of the metal ions will have dissociated which can contribute to 
crystal stress. So far the only crystal structure obtained for iron loaded human serum 
transferrin is that found in a thesis [11]. The conditions used for crystallisation in the 
work presented here were close to those given previously in Zuccola's thesis 
suggesting that these are close to optimal as crystals grew from untreated and 
unpurified transferrin with relative ease. It seems that the purity is of importance 
when attempting to grow good quality crystals. 
The information gained from the experiments carried out in chapters 3 and 4 suggest 
that there are some similarities between Fe-hTf and Mn-hTf. Work was carried out 
to try and establish if the similarities between the two proteins could be used to some 
advantage in cell systems in terms of uptake of Mn-hTf by the same pathway in 
hepatocytes as Fe-hTf, to enable delivery of the metal ion to cells. Levels of cellular 
metal ion were found to alter following treatment with Fe- and Mn-hTf suggesting 
that uptake of the metals from transferrin by the human hepatocyte WRL-68 cells, 
had occurred. However, the method of cellular metal detection needs to be optimised 
to ensure accurate readings in the future. The metal may form a precipitate if 
released from transferrin in the medium solution which may then result in 
sedimentation during ICP-AES analysis of the medium removed. Sedimentation 
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would also be a problem when analysing cells for metal content. These problems 
need to be addressed in the future. 
The expected changes in mitochondrial function due to excess manganese did not 
occur; that is mitochondrial function and membrane polarisation remained normal. 
Cell metabolism was found to decrease at the highest dose of Mn-hTf (25 kiM), and 
mitosis appeared to have increased. There was no evidence of increased apoptosis 
compared to other treatment groups. Changes of a more morphological nature also 
took place; the hepatocytes became dendritic in appearance with finger-like 
protrusions occurring. This effect could be the result of the interference of 
manganese with RGD-dependent ECM-integrin interactions. Alternatively, 
alterations of cell signalling could be occurring. The cell line used was of foetal 
origin so pathways may be being induced thus changing the behaviour and 
morphology of the cells to that seen in other tissues i.e. neurons. 
These results presented in this thesis support the ability of transferrin to load Mn 3 
but the choice of the donating salt used may have an effect on the protein, this could 
then result in altered function of the protein in terms of binding affinity to the 
receptor and metal ion release. Another important factor to consider is the effect of 
pH on the loading of the protein and also the consequences to the cell. A decrease in 
cell metabolism was observed in cells treated with the highest dose of Mn-hTf 
coupled with a change in colour of the medium suggesting a change in pH which 
may or may not be related to change in metabolism. A lower pH has also been 
shown to result in metal ion dissociation from transferrin. Therefore, pH may be an 
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important contributing factor in cells systems and in vitro investigations which needs 
further consideration. 
The cell studies suggest the possibility of using transferrin as a delivery mechanism 
for manganese to cells thus creating potential for its use as a therapeutic agent. 
However, much more further work is required in this field before this potential can 
be reached. Some of the interactions that have been observed in this thesis are 
artificial in terms of a functioning biological system, for example, how likely is it 
that transferrin is loaded with Mn from Mn 7 ? However, investigations into all 
aspects of the chemical and biological nature of the protein may provide us with 
insights into the possible transport mechanism(s) of manganese and other metals. 
6.2 Future Work 
Although in this thesis loading of transferrin using caeruloplasmin as an oxidant did 
not provide good results this method should still be explored. Optimum conditions 
need to be found which closely resemble those found in vivo and this may lead to 
successful and fast loading of transferrin with manganese when caeruloplasmin is 
present. The p1-I of the system plays an important part so should be investigated 
further. This can also be investigated when loading the protein using permanganate. 
Further work needs to be done in this system to investigate the theory of manganese 
clusters and to determine if the manganese is binding as Mn04. 
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Reactions of manganese with transferrin need to be carried out in the absence of 
carbonate to investigate if this perturbs loading. This should be done using MnCl 2 as 
a source of manganese and using KMn0 4 to aid the investigations of altered metal 
binding. The results could then help confirm if carbonate is required as a synergistic 
anion in all cases of metal loading or if binding as Mn0 4 negates the necessity for 
this extra ligand. Further work on manganese binding by the different methods 
should also include determination of lobe-loading preference under various 
conditions and if there appears to be any favoured lobe. The work on manganese 
binding to transferrin could also be applied to the similar proteins lactoferrin and 
ferric binding protein (FBP). This may again provide further insights into metal 
binding and alteration of binding sites. 
The use of 2D NMR provides an effective tool for investigating metal loading of 
transferrin. Unfortunately, in this study the -[ 13C]Met-labelled recombinant 
transferrin was quite old and had been used several times. Therefore to obtain more 
definitive answers with respect to the action of KMn0 4 on transferrin it would be 
beneficial to use fresh samples of the protein. This could then go on to be used in 
further displacement studies to investigate if there has been a permanent change to 
the transferrin molecule as a result of the use of a strong oxidant 
Ultimately a crystal structure of Mn-hTf will provide definitive answers to the many 
questions that arose throughout this thesis. Ideally, crystals of the protein will 
obtained where Mn3 is bound using MnCl2 and KMn04 to enable a direct 
comparison between the two methods of loading. This will then allow further 
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investigations into metal binding of the protein. To help obtain crystals of transferrin 
the issue of purity needs to be addressed. In this study, the transferrin used was 
obtained from Sigma with no further purification. Purification is an important factor 
in protein crystallisation. Future methods of purification could include development 
of a good I-IPLC technique in order to separate different forms of the protein i.e. 
mono- and di-metal loaded protein. Treatment of the protein to remove the glycan 
chains may also help facilitate crystallisation. HPLC could again then be employed 
to separate the de-glycosylated protein. Seeding from crystals obtained from this 
method may then also be more successful. Attempts could be made to load 
fragments of transferrin with manganese which would not include the problem of 
glycosylation. This may then prove easier to crystallise. 
Extended X-ray Absorption Fine Structure (EXAFS) and X-ray Absorption Near 
Edge Structure (XANES) can provide much useful information when it is difficult to 
crystallise compounds such as transferrin. Although the information is not as 
detailed as with a crystal structure they can still give some insights into the metal 
binding site and the oxidation state of the metal. This may be of use again when 
comparing the different methods employed in this study to load transferrin with Mn 3 
and how this compares with the binding site with Fe 3+  loaded. 
Once successful crystallisation conditions have been determined the use of mutants 
could be used to provide further information on Mn-hTf such as alterations to the 
metal binding site. Mutations could also provide information on receptor binding to 
transferrin and release of manganese from the binding site. 
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Further work is required on the release of Mn 3 from transferrin in terms of 
biological and chemical characteristics. It may be of benefit to attempt competition 
studies between the different transferrins and cell uptake, i.e. between Fe-hTf and 
Mn-hTf that has been loaded with Mn 3 using different methods. Use of radio-
isotopes may prove productive in this area to allow detection of the metal loaded 
transferrins and metal deposition in the cell. Time-lapse microscopy may also help 
provide further information into the unusual effect of higher doses of Mn-hTf on 
cells. Also, the use of cell markers may give some insight into the mechanisms of 
action although various endpoints and potential altered markers would initially have 
to be determined. 
To investigate what cell signalling may be occurring polymerase chain reaction 
(PCR) could provide answers on gene activation due to increased levels of 
manganese in cells. This may also be of use to investigate the prospect of cell 
adhesion molecules and the extracellular matrix being affected by Mn-hTf. Further 
studies on this effect could include the use of different mediums, lack of serum 
supplementation and cell culture wear, e.g. specifically coated plastics. 
The use of different cell lines may also prove beneficial in this work to investigate if 
the effect of high dose Mn-hTf is specific to the cell line used here, which as 
mentioned earlier are of foetal origin. The cell lines used need not be restricted to 
humans or liver cells. Cancer cell lines may provide some useful information on the 
transferrin receptor and metal requirement and uptake. The transferrin used in cell 
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studies was not purified any further upon receipt. More purification steps may again 
be useful when investigating the effect of Mn-hTf on cells to eliminate the possibility 
of toxic side effects from impurities. 
A model system for oxidative stress in cells would also help to provide information 
on the potential use as Mn-hTf as a therapeutic against oxidative stress. The model 
would have to ensure that it mimicked that of reperfusion injury and that the reactive 
oxygen species were being generated in the mitochondria. Various chemicals may 
provide the necessary response or alternatively some form of a hypoxic tank may 
more closely mimic the conditions seen during of ischaemia. This may then allow 
testing of Mn-hTf to see if the desired action is achieved. 
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Buffer for Caeruloplasmin 
0.25 M NaCl 
0.05 M Na Acetate 
pH 7.0 
1 mg caeruloplasmin dissolved in 1 ml of buffer and kept at 253 K in 50 tl aliquots. 
1 unit of oxidative activity = 20-33 [tl of caeruloplasmin 
Appendix B 
Schiff Reagent 
2.5 g Fuschin Basic (99% pure grade, Sigma) in 500 ml boiled 1120 	 - 
Cool to 323 K, add 50 ml 10% HC1 
Cool to 298 K, add S g metabisulphite 
Incubate in dark at room temperature, 24-48 hours 
Filter using a no.1 filter, solution should be clear. 
Sore at 277 K in dark where the solution will remain stable for 6 weeks. 
Appendix C 
Mowiol Mountant 
Mowiol 4-88 (Calbiochem) 





Add 2.4 g Mowiol to 6 g glycerol and stir briefly with a pipette. 
Add 12 ml Ff20 and stir at room temp for several hours. 
Add 12 ml of 0.2 M Tris (pH 8.5) and heat to 323 K for 1-2 Ins while stirring. 
When the Mowiol has dissolved, clarify by centrifugation at 500 x g for 15 mins. 
Add DABCO to 2.5% (0.72 g), aliquot and store at 253 C. Bubbles can be 
removed by centrifugation. Aliquots can be stored for up to 2 weeks at 277 K or 
frozen at 253 K. 
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Appendix D 1H NMR Spectra 
a 	water 
4.8 	4.6 	4.4 	4.2 	4.0 	3.8 	3.6 	3.4 	3.2 	3.0 	2.8 	ppm 
Figure D.1 'H NMR spectra for the reaction between HEPES buffer and KMn0 4 . 
Spectrum a) 20 mM HEPES (pH 7.4) alone, b) HEPES buffer with 0.2 molar 
equivalents KMn04, c) same solution as in b after 4 hours, d) after 24 hours. All 
solutions were made up in D20 and internally referenced to TSP (0 ppm). The water 
peak has broadened considerably and shifted by Ca. 0.2 ppm. 
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Appendix E '3C NMR Spectra 
Figure E.1 13C- { 1 H} NIMR spectrum of N-acetyl-L-methionine (100 mM), 
referenced to TSP (0.0 ppm). The cCH3 peak is at 15.14 ppm, labelled as 1. 
0 	 NH 
i 	H2 H2 	
2 
H3C—S—C—C—CH—C—OH 4~v O~Oj 2 3 4  11 0 
56 55 54 53 52 51 54) 49 48 47 46 45 44 43 42 41 ppm 
4 	 13 	 II 	 TSP 
PA 
55 50 45 	40 35 	30 25 20 15 	10 	5 	Oppm 
Figure E.2 ' 3 C - {'H} NMR spectrum of L-methionine sulfoxide (101 mlvi). The 
gCH3 peak is at 26.65 ppm, labelled as 1. The formation of doublets is due to the 
presence of diastereomers (S configuration at Ca (labelled as 4 on the spectrum), R 
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Figure E.3 ' 3C NIVIR spectrum of L-methioriine sulfone (102 mM). The 6CH3 
peak is at 26.08 ppm, labelled as 1. 
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Figure E.4 ' 3C NMR spectrum of N-acetyl-L-methionine (100 mM) following 
addition of 1 molar equivalent KMn04 (1.02 M). Peaks at 17.15 and 25.43 ppm 
most probably represent gCH3. The paramagnetic effect causes a shift of the original 
cCH3 peak to 17.15 ppm and a new peak at 25.43 ppm. This peak is probably 
attributable to oxidation of methionine to sulfoxide and sulfone where the eCH3 peak 
is at 26.65 and 26.08 ppm respectively. 
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Flasks 
Figure F.1 Metal content of WRL-68 cells (mg metal in 10 10 cells). Cells grown 
in large flasks with medium alone until confluent. Cells then harvested and pelleted. 
Pellet then re-suspended in ultrapure water for metal analysis by ICP-AES. 
Table F.! Metal content (ppm) of cells grown in large flasks determined by 
ICP-AES 
Metal Flask 1 Flask 2 Flask 3 Flask 4 
Cu 0.0179 0.0172 0.017 0.0143 
Fe 0.1192 0.1163 0.1133 0.1092 
Mn 0.0085 0.0082 0.0081 0.008 
Zn 0.6497 0.6504 0.6364 0.6218 
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Figure F.2 Metal content of WRL-68 cells. Cells grown in large flasks with 
medium alone. Cells then harvested and pelleted then resuspended in ultrapure water 
for metal analysis by ICP-AES. Two cells suspensions run with no additions. 
Internal metal standards added to give 0.01 and 0.05 ppm to two separate cell 
suspensions. 
Table P.2 Cellular metal content (ppm) in cells grown in medium atone and 
after addition of internal standard to the sample prior to analysis by ICP-AES 
Metal Medium8 Medium' + 0.01 ppm metal + 0.05 ppm metal 
Cu 0.0104 0.0089 0.0186 0.0456 
Fe 0.0297 0.0293 0.0389 0.0809 
Mn 0.0006 0.0004 0.0098 0.0441 
Zn 0.255 0.257 0.2908 0.2908 
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Figure F.3 Metal content of the medium DMEM (two samples used) and DMEM 
with added internal standards to give additional 0.01 and 0.05 ppm. DMEM was 
used as medium for all cell experiments. 
Table F.3 Metal content (ppm) of the culture medium DMEM and after 
addition of internal standards determined by ICP-AES 
Metal DMEMa DMEM + 0.01 ppm metal + 0.05 ppm metal 
Cu 0.0554 0.0478 0.0566 0.0851 
Fe 0.1253 0.1292 0.1338 0.1737 
Mn 0.0015 0.0013 0.0104 0.0468 
Zn 0.0757 0.0765 0.085 0.1179 
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Figure F.4 Metal content of trypsin-EDTA and after addition of internal 
standards to give additional 0.01 and 0.05 ppm. Trypsin-EDTA was used in all cell 
experiments to remove the cell layer from flasks. 
Table F.4 Metal content (ppm) of trypsin-EDTA and after addition of internal 
standards determined by ICP-AES 
Metal Trypsin-EDTA + 0.01 ppm metal + 0.05 ppm metal 
Cu 0.0014 0.0095 0.0425 
Fe 0.0122 0.0232 0.0692 
Mn 0.0002 0.0098 0.051 
Zn 0.0034 0.0222 0,0531 
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Appendix G 	Crystallisation Experiments 
Plates are labelled as wells 1-6 along the horizontal from left to right and A-D along 
the vertical from top to bottom. 
Plate G.1 
20°! ° PEG 400 200/ ° PEG 400 20°! "' 400 
20% PEG 400 20% PEG 400 20% PEG 400 
PH 5.6 p115.6 pH 5.6 pH 5.6 pH 5.6 pH 5.6 
Fe-hTf Fe-hTf Fe-hTf Mn-hTf Mn-hTf Mn-hTf 
22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 
pH 5.6 pH 5.6 pH 5.6 pH 5.6 pH 5.6 pH 5.6 
Fe-hTf Fe-hTf Fe-hTf Mn-hTf Mn-hTf Mn-hTf 
24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 
pH 5.6 pH 5.6 pH 5.6 pH 5.6 pH 5.6 pH 5.6 
Fe-hTf Fe-hTf Fe-hTf Mn-hTf Mn-hTf Mn-hTf 
26% PEG 400 267/, PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 
pH 5.6 p1-I 5.6 pH 5.6 pH 5.6 pH 5.6 pH 5.6 
Fe-hTf Fe-hTf Fe-hTf Mn-hTf Mn-hTf Mn-hTf 
All wells contained PEG 400 at 20 to 26%, 100 mM sodium cacodylate pH 5.6. Fe2-
hlf or Ivlri2-hTf (produced using MnC12 with caeruloplasmin) at a concentration of 
Ca. 0.5 mM in the drop. Plate kept at 277 K. Crystals were found in wells Al, 131-3, 




22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 
p115.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 
PH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 
pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 
PH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
All wells contained PEG 400 at 22 or 24%, 100 mM sodium cacodylate pH 5.43. 
Fe2-hTf in the drop. Plate kept at 277 K. Ellipsoidal red crystals found in wells Dl 




20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 
pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 
pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
24% PEG 400 24% PEG 400 24% PEG 400 2401. PEG 400 24% PEG 400 24% PEG 400 
ph 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 
pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 pH 5.43 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
All wells contained PEG 400 at 20 to 26%, 100 mlvi sodium cacodylate pH 5.43. 
Fe2-hTf in the drop at Ca. 0.6 mlvi. Plate kept at 277 K. First crystal found in well 




20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 
pH 5.6 p11 5.6 p1-I 5.5 pH 5.5 pH 5.4 pH 5.4 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTff Fe-hTf 
22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 
pH 5.6 p115.6 pH 5.5 pH 5.5 pH 5.4 pH 5.4 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 
pH 5.6 pH 5.6 pH 5.5 pH 5.5 pH 5.4 p115.4 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hlf 
26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 
pH 5.6 pH 5.6 pH 5.5 pH 5.5 pH 5.4 pH 5.4 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
All wells contained PEG 400 at 20 to 26%, 100 niM sodium cacodylate pH 5.4— 5.6. 
Fe2-hTf in the drop at Ca. 0.6 mM. Plate kept at 277 K. Crystals found in wells A2, 




20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 
pH 5.4 pH 5.4 pH 5.6 pH 5.6 p115.5 pH 5.5 
Fe-hTf Fe-hlf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
0.26mM 0.128mM 0.26mM 0.128mM 0.26mM 0.128mM 
22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 
PH 5.4 pH 5.4 pH 5.6 pH 5.6 pH 5.5 pH 5.5 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
0.26mM 0.128 mlvi 0.26mM 0.128 mlvi 0.26mM 0.128 mlvi 
24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 
PH 5.4 p1-1 5.4 pH 5.6 pH 5.6 pH 5.5 pH 5.5 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
0.26 mlvi 0.128 mlvi 0.26 mlvi 0.128 mlvi 0.26mM 0.128mM 
26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 
pH 5.4 pH 5.4 pH 5.6 pH 5.6 pH 5.5 pH 5.5 
Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf Fe-hTf 
0.26mM 0.128 mlvi 0.26mM 0.128 mlvi 0.26mM 0.128mM 
All wells contained PEG 400 at 20 to 26%, 100 mM sodium cacodylate pH 5.4 -5.6. 
All wells contained Fe2-hlf at the concentrations shown, i.e. 0.26mM or 0.128 mlvi. 




20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 20% PEG 400 
pH 5.6 pH 5.6 pH 5.5 pH 5.5 pH 5.4 pH 5.4 
Mn-hTf Mn-hTf Mn-hTf Mn-hlf Mn-hTf Mn-hTf 
22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 22% PEG 400 
PH 5.6 pH 5.6 pH 5.5 pH 5.5 pH 5.4 pH 5.4 
Mn-hTf Mn-hTf Mn-hTf Mn-hTf Mn-hTf Mn-hTf 
24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 24% PEG 400 
pH 5.6 pH 5.6 pH 5.5 pH 5.5 pH 5.4 pH 5.4 
Mn-hTf Mn-hTf Mn-hTf Mn-hTf Mn-hTf Mn-hTf 
26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 26% PEG 400 
pH 5.6 pH 5.6 pH 5.5 pH 5.5 pH 5.4 pH 5.4 
Mn-hTf Mn-hTf Mn-hTf Mn-hTf Mn-hTf Mn-hTf 
All wells contained PEG 400 at 20 to 26%, 100 mM sodium cacodylate pH 5.4-5.6. 
Mn-hTf (produced using KMn04 and found to have ratio of 1 hlf: 3 Mn determined 
by UV/Vis spectroscopy and ICP-AES as described in Chapter 2) in the drop at Ca. 
0.5 mM protein. Crystals found in wells Dl and D3. 
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Appendix H 	Crystallisation Screening Technique 
Solution Buffer Precipitant Additional Result Result 
No. component lMn:lTf 2Mn:ITf 
1 0.1 M Na acetate 30% 2-methyl-2,4 0.02 M calcium P/A P 
trihydrate pH 4.6 pentanediol chloride dihydrate 
2 0.1 MNa acetate 30% PEG 4000 0.2Mammonium p P 
trihydrate pH 4.6 acetate 
3 0.1 MNaacetate 25% PEG 4000 0.2Mammonium p P 
trihydrate pH 4.6 sulphate 
4 0.1 MNa acetate 2.0M sodium None 
trihydrate pH 4.6 formate 
5 0.1 M Na acetate 2.0 M ammonium None p P 
trihydrate pH 4.6 sulfate 
6 0.1 M Na acetate 8% PEG 4000 None 
trihydrate pH 4.6 
7 0.1 M fri-sodium 30% PEG 4000 0.2 M ammonium 
citrate dihydrate pH acetate 
5.6 
8 0.1 M fri-sodium 30% 2-methyl- 0.2 M ammonium 
citrate dihydrate pH 2,4-pentanediol acetate 
5.6 
9 0.1 M tn-sodium 20% 2-propanol, None 
citrate dihydrate pH 20% PEG 4000 
5.6 
10 0.1 MNa citrate pH 1.OMammonium None 
5.6 dihydrogen 
phosphate 
11 0.1 M Na acetate 20% 2-propanol 0.2 M calcium 
trihydrate pH 4.6 chloride dihydrate 
12 0.1 M Na cacodylate 1.4 M Na acetate None 
pH 6.5 trihydrate 
13 0.1 M Na cacodylate 30% 2-propanol 0.2 M tn-sodium 
pH 6.5 citrate dihydrate 
14 0.1 M Na cacodylate 30% PEG 8000 0.2 M ammonium 
pH 6.5 sulphate 
15 0.1 M Na cacodylate 20% PEG 8000 0.2 M magnesium 




16 0.1 M Na cacodylate 30% 2-methyl- 0.2M magnesium 
pH 6.5 2,4-pentanediol acetate 
tetrahydrate 
17 0.1 MimidazolepH 1.0M sodium None 
6.5 acetate trihydrate 
18 0.1 M Na cacodylate 30% PEG 8000 0.2Msodium p P 
pH 6.5 acetate trihydrate 
19 0.1 M Na cacodylate 18% PEG 8000 0.2 M zinc acetate P P 
pH 6.5 dihydrate 
20 0.1 M Na cacodylate 18% PEG 8000 0.2 M calcium 
pH 6.5 acetate hydrate 
21 0.1 M Na hepes pH 30% 2-methyl- 0.2 M fri-sodium 
7.5 2,4-pentanediol citrate dihydrate 
22 0.1 M Na hepes p11 30% 2-propanol 0.2 M magnesium 
7.5 chloride 
hexahydrate 
23 0.1 MNahepespH 28% PEG 400 0.2Mcalcium p P 
7.5 chloride dihydrate 
24 0.1 MNahepespH 30% PEG 400 0.2 M magnesium 
7.5 chloride P P 
hexahydrate 
25 0.1 M Na hepes pH 20% 2-propanol 0.2 M fri-sodium 
7.5 citrate dihydrate 
26 0.1 MNahepespll 0.8MK,Na None 
7.5 tartrate 
tetrahydrate 
27 0.1 M Na hepes pH 1.5 M lithium None 
7.5 sulphate 
mono hydrate 
28 0.1 M Na hepes pH 0.8 M Na None 
7.5 and 0.8M K dihydrogen 
dihydrogen phosphate phosphate 
monohyd. 
29 0.1 M Na hepes p11 1.4 M fri-sodium None 
7.5 citrate dihydrate 
30 0.1 MNahepespH 2% PEG 400,2.0 None 
7.5 Mammsulfate 
31 0.1 M Na hepes pH 10% 2-propanol, None p P 
7.5 20% PEG 4000 




33 0.1 M tris HCI pH 8.5 30% PEG 4000 0.2 M magnesium 
chloride P P 
hex ahydrate 
34 0.1 M tris HCI p1-I 8.5 30% PEG 400 0.2 M tri-sodum 
citrate dihydrate 
35 0.1 M tris HCl pH 8.5 30% PEG 4000 0.2 M lithium 
sulphate P P 
mono hydrate 
36 0.1 M tris FIC1 pH 8.5 30% 2-propanot 0.2 M ammonium 
acetate 
37 0.1 M his HCI pH 8.5 30% PEG 4000 0.2 M sodium p P 
acetate trihydrate 
38 0.1 M his MCI pH 8.5 8% PEG 8000 None 
39 0.1 M tris MCI p118.5 2.0 M ammonium None 
dihydrogen 
phosphate 
40 None 0.4 M K, Na None 
tartrate 
tetrahydrate 
41 None 0.4 M ammonium None 
dihydrogen 
phosphate 
42 None 30% PEG 8000 0.2 M ammonium p P 
sulfate 
43 None 30% PEG 4000 0.2 M ammonium P P 
sulfate 
44 None 2.0 M ammonium None p 
sulfate 
45 None 20% PEG 8000 0.05 M potassium 
dihydrogen A A 
phosphate 
46 None 30% PEG 1500 None 
None 2% PEG 8000 1.0 M lithium 
47 sulfate ' P 
mo no hydrate  
None 15% PEG 8000 0.5 M lithium 
48 sulfate 
monohydrate  
P = Precipitate formed. A = Aggregation 
Plates were set up using Mn-hTf to give concentrations of 175 iM in the drop. 
XVIII 
Appendix 
Conditions 1 - 24 used Mn-hlf with 1 Mn bound to the protein, as determined by 
UV/Vis and ICP-AES. Conditions 25-48 used Mn-hTf where 2 Mn were bound to 
the protein. Mn-hTf used had been prepared from apo-hTf using KMn0 4 . 
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